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Abstract.
Rat Mast Cell Proteinase II (RMCPII) from mucosal mast cell was
titrated into rat serum and the resulting serpin:enzyme complex (SEC ) was
purified by affinity chromatography on anti-RMCPII Sepharose 4B and by
MonoQ anion exchange. The purified complex was used to raise polyclonal
antibodies which, after cross-absorption against RMCPII Sepharose 4B,
were specific for serpin and were used to affinity purify two rat serpin
molecules (RSI and RSII) which inhibit RMCPII in rat serum. The kinetic
and thermodynamic constants characterising the interaction between
RMCPII and RSI and RSII are: kass 2.2xl05 M'V1 and 1.65xlOsM-Vl
respectively; Kt, 3.6xlO~10M and 1.0xlCT9M; kdiss, T.QxlO^s"1 and 1.65x10"
V1. Amino-terminal sequence analysis indicated that RSI and II were
distinct, differing at the N-terminal residues and were products of the rat
SPI-1 locus. Rat Mast Cell Proteinase I (RMCPI) from connective tissue
mast cells cleaved both RSI and RSII and was not inhibited.
Further antibodies were generated against RSI and II, and partially
successful attempts were made to raise a monoclonal antibody against rat
serpin in complex with Mouse Mast Cell Proteinase Ie. Two polyclonal
antibody preparations, raised in rabbit and sheep, were used to develop
an ELISA that was specific for rat serpins, although no assay developed in
this work would differentiate RSI from RSII. The change in serpin
concentrations in serum and perfused tissues during helminth infection was
monitored with the ELISA. Serpins concentrations in control plasma were
determined to be 3mg/mL. Helminth infection caused a significant (p<0.001)
increase in this serpin concentration by day 7 of infection. Significant
changes in serpin concentration were also monitored in pulmonary, and
intestinal homogenates. Differences in timing, duration and intensity of
acute phase response in these tissues suggested the existence of tissue
specific serpins. Western blotting showed subtle differences in Mr between
serpins from different sites. Purification and preliminary characterisation
of pulmonary serpins showed that a pulmonary specific serpin does exist.
The implications of these findings, with regard to control of serpin
synthesis during acute phase response, are discussed. Theoretical
considerations indicate that RSI and RSII will modulate RMCPII activity
during helminth infection.
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Proteolytic cleavage of peptide bonds is one of the most frequent and
important enzymatic modifications of proteins. Historically, the earliest
experimental studies were on the enzymatic degradation of proteins associated with
digestion, and for this reason the proteinases of the pancreatic and gastric secretions
are among the best characterized enzymes.
Proteinases can be categorized into 4 classes, based on structures and
mechanisms of action. These are serine, cysteine, aspartic and metallo-proteinase.
There are six families recognised within these 4 classes: serine proteinases
(mammalian), serine proteinases (bacterial), metallo-proteinases (mammalian),
metallo-proteinaes (bacterial), cysteine proteinases, and aspartic proteinases. Table
1.1 displays an archetype for each family and the characteristic active site residues.
The active site is a configuration of functional residues specific to each family.
Members of each family are believed to have descended from a common ancestor
by divergent evolution.
The catalytic site of each class of proteinases resides in a cleft or in the case
of the serine proteinases, with the notable exception of trypsin and chymotrypsin
(Fersht, 1984), on the surface of the enzyme molecule. The substrate polypeptide
lies along the cleft or surface, and on either side of the catalytic site are specificity
subsites adapted to the binding of amino acid side chains, or the polypeptide
backbone. The subsites SI, S2 and S3 bind the side chains of residues PI, P2, P3 etc
numbered from the scissile bond toward the N-terminus of the substrate, whilst the
Table 1.1




























Thermolysin Zn, Glu-143, His-231
From Neurath, 1989
The numbering applies to the proteinase listed in bold in column 2.
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sites SI', S2', S3' etc accept side chains of substrate residues PI', P2', P3' etc,
numbered from the scissile bond towards the C-terminus of the substrate.
1.1.1. Serine Proteinases
Serine proteinases (mammalian) are the best characterized andphysiologically
most diversified proteinases in mammals. Members of this family include: trypsin,
chymotrypsin and elastase. They are characterised by their active site which is the
catalytic triad of Asp-102, His-57 and Ser-195 (chymotrypsin numbering). The
overall tertiary conformation is two tightly-packed domains, symmetrically disposed
around a two-fold axis of symmetry (Neurath, 1989).
Members of the chymotrypsin archetype family are found in both the animal
and plant kingdoms, from prokaryotes to eukaryotes. Most of the serine proteinases
in higher mammals are translated as proenzymes. Cleavage is required in the NH2
region of the proenzyme (normally 220-260 residues from the COOH terminus) to
generate active proteinase.
The serine proteinases (bacterial) are exemplified by subtilisin with the
catalytic triad Asp-32, His-64 and Ser-221.
1.1.2. Mechanism of Action
The most important residues in the actual proteolysis reaction are the serine
and histidine residues. The nucleophilic attack by the serine hydroxyl group on the
carbonyl carbon atom of the substrate is catalysed by the histidine residue as a
general base. This leads to the formation of a tetrahedral intermediate, and an
imidazolium ion (addition reaction). The intermediate breaks down by general acid
catalysis to acyl-enzyme, imidazole base and amine product (elimination reaction).
As a result of this acylation step, the proton of the serine hydroxyl is transferred
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by the imidazole group to the amine leaving group. The acyl-enzyme is hydrolysed
through the reverse reaction pathway of acylation, but in this addition elimination
reaction a water molecule instead of the serine residue is the attacking nucleophile
(reviewed in Polgar, 1990). The members of the subtilisin family act in a similar
fashion, the result of convergent evolution (Barrett, 1986).
The specificities of serine proteinases are exceedingly diverse. The P residues
on the substrate protein which fit in to the S sites on the active site cleft, rather
than the P' residues are important in determining specificity (Barrett, 1986). Trypsin
has an overriding requirement that residue PI must be an arginine or lysine. Other
proteinases have evolved a high specificity for subsites S2 and S3, allowing SI a
more general requirement for basic residues (Barret, 1986).
1.1.3. Mast Cell Proteinases.
The presence of high concentrations of serine proteinases in secretion
granules is a characteristic feature of mast cells (Miller et al, 1990). Recent work has
shown that individual mast cells may express genes for several proteinases: in man
the presence of a multi-gene family encoding tryptases (proteinases with trypsin-like
substrate profile) was reported (Vanderslice et al., 1990) and in mouse at least six
distinct serine proteinases that can be expressed in different combinations in
different mast cell populations, have been identified (Reynolds et al., 1990).
1.1.4. Rat Mast Cell Proteinases
Chymotrypsin-like activity was first detected histochemically in rat mast cells
(Benditt and Arase, 1959), and the chymase, rat mast cell proteinase I (RMCP I) was
subsequently isolated from peritoneal mast cells (Lagunoff and Pritzl, 1976).
Woodbury et al. (1978) found that a second similar, yet distinct, proteinase (RMCP
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II) first isolated by Katunuma et al. (1975) was present in mucosal mast cells
(MMC). Recent work by Benfey et al., (1987) has indicated that a third serine
proteinase may be expressed in the rat.
RMCP I and II share a high degree of sequence homology (> 70%) but
differ in their net charge (LeTrong et al., 1987a) which may reflect different
properties and physiological functions. RMCP I is a relatively insoluble protein,
requiring a high concentration of salt for extraction and purification (Lagunoff and
Pritzl, 1976), whilst RMCP II is readily soluble in physiological conditions
(Woodbury and Neurath, 1978). The two rat mast cell proteinases, when isolated,
show similarity in their substrate profiles (Yoshida et al., 1980), and exhibit catalytic
activity similar to that of cathepsin G. The substrate profile of RMCP I bound to
secretory granules is limited to smaller molecules (Le Trong et al., 1987b).
RMCPII is homologous to bovine chymotrypsin A with 33% identity
(Woodbury and Neurath, 1978). A Ser(197)-Tyr(198)-Gly(199) sequence corresponds
to the Ser(214)-Trp(215)-Gly(216) sequence of chymotrypsin, indicating conservation
of the extended substrate binding site in RMCPII. There are, however, a number
of changes in the substrate binding site of RMCPII. Asn(86) is substituted for the
Ile(99) found in chymotrypsin. In addition, a disulphide bond (Cys(191) to Cys(220))
found in chymotrypsin and all other known serine proteinases (Yoshida et al, 1980)
is replaced by Phe(178) and by a five residue deletion immediately following
Ser(197)-Tyr(198)-Gly(199) in RMCPI. This indicates the possibility of a significant
change in the extended substrate binding site of RMCPI, particularly in the site of
S3, and may explain the unusual ability of the proteinase to accept a P3 prolyl
residue in substrates (Yoshida et al, 1980).
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The two best artificial substrates used in a study performed by Yoshida et
al (1978) had a Phe residue in the P3 position. This indicates the presence of an
hydrophobic S3 subsite. Although the natural substrate of RMCPII is unknown at
present, data would suggest that it has an aromatic residue at P3 and an acidic
residue at P4.
RMCPI is more likely to hydrolyze peptide bonds that have hydrophobic
or non-polar residues at the P2 and P'l positions, in addition to an hydrophobic
residue at PI (LeTrong et al, 1987b).
1.2. Mast Cells
1.2.1. History
The mast cell, first recognised over 100 years ago (Ehrlich, 1878; reviewed
in Galli, 1990), participates in a variety of pathological processes including allergic
reactions, and probably plays a fundamental role in the host defence against parasite
infection.
The first clear description of the mast cell was made by Paul Ehrlich while
he was a medical student. The mast cell was noted to be a deeply staining
metachromatic cell which Ehrlich considered to be overfed. Therefore the use of the
word mast derived from the German "Mastung", which means feeding or fatness.
The search for a physiologic function for the mast cell was stimulated by the
observation, made by Webb in 1931 (reviewed in Metcalfe et al, 1981) that the
intraperitoneal injection of various irritants, including india ink and egg white,
induced mast cell degranulation. At the same time Jorpes et al (1937; reviewed in
Metcalfe et al, 1981) discovered that heparin was the constituent which imparted the
metachromatic staining property to the mast cell.
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1.2.2. Morphology and Distribution.
In tissues the mammalian mast cell is generally ovoid and is found in the
vicinity of small blood vessels and lymphatic channels. Isolated rat peritoneal mast
cells in suspension average 12.6/xM in diameter (Benditt and Lagunoff, 1964;
reviewed in Metcalfe et al, 1981). The characteristic feature of these cells is the
presence of dense cytoplasmic granules which occupy the cytoplasm to such a
degree as to obscure the nucleus. In most mammals the granules are 0.2-0A/jM. in
diameter. In warm blooded vertebrates the cells predominate in the loose connective
tissue surrounding blood vessels, nerves, glandular ducts and under epithelial, serous
and synovial membranes (Compton, 1952; reviewed in Metcalfe et al, 1981). In
human tissues the mast cell is relatively abundant in skin, thymus, lymphoid tissue,
uterus, urinary bladder, tongue, synovia, mesentery around large and small blood
vessels and in subserosal and submucosal layers of the digestive tract. In the lung,
mast cells are found in both the bronchial airway connective tissues and in
peripheral intraalveolar spaces.
1.2.3. Heterogeneity of Mast Cells
The extent to which a given cell type can exhibit different characteristics or
functions before being considered to be heterogeneous is perhaps debatable, since
some diversity may be regarded as normal. However, mast cells show considerable
variation in their histochemical and biochemical properties, as well as in their
functional response to a variety of stimuli. Hardy and Wesbrook are usually
credited with the first observation that certain mast cells in the rat intestinal mucosa
were "atypical" in their histochemical staining properties in (see Galli, 1990).
Beginning in the 1960's, Enerback (1981) greatly extended the early observations of
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mast cell heterogeneity and defined in detail the conditions of fixation and
histochemical staining which discriminated between the "atypical" or mucosal mast
cell observed in the intestinal lamina propria and the connective tissue type mast
cell phenotype of the skin, peritoneal cavity and other sites in the rat. The
heterogeneity of mast cell populations has been further studied by the biochemical
analysis of their granule constituents. The granule proteoglycans consist of a protein
core with covalently linked glycosaminoglycan side chains which are highly
negatively charged due to the large numbers of sulphate and carboxylic groups (Yurt
and Austen, 1977). That there is proteoglycan heterogeneity amongst
sub-populations of rat mast cells was confirmed when 35S labelled proteoglycan was
purified from isolated rat intestinal mast cells (Stevens et al, 1986). The
glycosaminoglycan side-chains were typical of chondroitin sulphate di-B and
chondroitin sulphate A, which are not present in the glycosaminoglycans of heparin
in serosal mast cells; the latter are considered to be analogous to connective tissue
mast cells (Stevens et al, 1986). However the distinction between rat mucosal and
serosal mast cells as determined by proteoglycan content is not absolute, since trace
amounts of chondroitin sulphate E are present in isolated rat mucosal mast cells
(Stevens et al, 1986).
Perhaps the most convincing evidence for the presence of different mast cell
populations has come from studies on their granule proteinases. In the rat, two
chymotrypsin-like mast cell proteinases have been isolated and termed rat mast cell
proteinase I (RMCPI) and RMCPII (Woodbury and Neurath, 1980; Katunuma et
al, 1975, Woodbury et al, 1978). The two serine proteinases can be distinguished on
the basis of physical, chemical, structural and immunological properties (Woodbury
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and Neurath, 1978a;Woodbury et al, 1978). More recently, the gene encoding
RMCPII has been cloned and sequenced (Benfey et al, 1987) and sequence analysis
together with studies on the cellular distribution of RMCPII mRNA has indicated
that RMCPI and RMCPII are likely to be coded by separate, highly homologous
genes in separate cell populations. Further immuno- histochemical analysis indicated
that mast cells from connective tissue and from mucosa represented two major
non-overlapping populations of mast cells, which contained RMCPI and RMCPII
respectively (Gibson et al, 1987). However, tissue site may not be a reliable
indicator of mast cell sub-types, since significant quantities of RMCPII and
RMCPII-containing cells have been demonstrated in several non-mucosal tissues
including liver and thymus (Huntley et al 1990a). Moreover, a minor population of
mast cells expressing both RMCPI and RMCPII have been demonstrated in lung
and liver, indicating further heterogeneity in mast cell phenotypes (Huntley et al,
1990a).
Mast cell proteinases have also been characterised in other species including
man (Schechter et al 1986), sheep (Huntley et al, 1986) and mouse (Newlands et al,
1987). In addition to chymases, mast cell trypsin-like enzymes have been isolated
from rat serosal mast cells (Kido et al, 1984), dog skin and mastocytoma tissues
(Schechter et al, 1988; Caughey et al, 1988) and from human lung (Schwartz et al,
1981). Heterogeneity amongst human mast cell sub-populations has been defined
according to the distribution of chymase and tryptase (Schwartz, 1989), where the
majority of the mast cells in the submucosa of the small intestine and skin contain
both tryptase and chymase, and the majority of the mast cells in the mucosa of the
14
small intestine, bronchial epithelium and lung alveoli contain tryptase alone
(Schwartz, 1989).
1.2.4. Origin.
Mammalian mast cells are derived from precursors which originate in the
bone marrow. This point was established by Kitamura et al (1978) in a series of
papers describing experiments exploiting mutant mice genetically deficient of mast
cells, and their congenic normal (+/+) litter mates (reviewed in Galli, 1990). A
double dose of mutant genes at either the W or Si locus of the mouse produces the
pleiotropic effects of macrocytic anaemia, sterility and lack of hair pigmentation.
Evidence (see Galli, 1990) indicated that WBB6Fr W/Wv and WCB6FrSl/Sld mice
also expressed a deficiency of mast cells. However, WBB6Fr W/Wv mice can
develop mast cell populations if they receive bone marrow cells derived from their
normal littermates or from "beige" mice. The mast cells of "beige" mice are easily
distinguishable, because of the presence of giant cytoplasmic granules allowing
identification of the cells as of donor origin. The deficiency of the WCB6FrSl/Sld
is to due to an abnormality of tissue factors regulating mast cell development, as an
injection of WCBbF^Sl/SF bone marrow cells cures the deficiency of WBB6Fr
W/Wv mice. Recent evidence has shown that Sl/Sld mice are deficient in stem cell
factor, whereas W/Wv mice lack a functional c-kit receptor for the ligand, stem cell
factor (Geissler et al, 1988).
Mouse bone marrow cells, cultured for 2-6 weeks in a source of conditioned
medium rich in interleukin-3 (IL-3), a 25,000 Mr glycoprotein of helper T-cell
origin, develop into an apparently homogeneous population of non-transformed
mast cells (Razin et al, 1984). Recombinant IL-3, given to mice in vivo induces
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proliferation of multiple haematopoietic lineages, including certain populations of
cells similar to mucosal mast cells (Metcalf et al, 1986). Administration of IL-3 to
nude mice confers on these animals the ability to exhibit mucosal mast cell
proliferation in the absence of parasite infection (Abe et al, 1988).
The generation of mucosal mast cells is stimulated in vitro by factors derived
from T-cells of helminth-infected rats (Haig et al, 1982). Conditioned media capable
of causing the proliferation of mast cells were derived from cultures of antigen-
stimulated mesenteric lymph nodes of rats infected with the nematode
Nippostrongylus brasiliensis (Haig et al, 1982).
While the effects of T-cell products on mast cell recruitment and
proliferation so far have been in terms of mucosal mast cells, there are also recorded
effects on connective tissue mast cells, albeit of a more modest nature. IL-4 favours
the in vitro growth and maturation of mouse mast cells with properties of
connective tissue mast cells and augments the effects of IL-3 with regard to mucosal
mast cells (see Galli, 1990).
The mRNA levels of a number of cytokines have been reported to be
increased in mouse mast cells after IgE receptor-antigen cross linking events . These
include IL-1. IL-3, IL-4, IL-5, IL-6, and TNF-o; (see Gurish et al, 1991). TNF-a is
constitutively produced by mouse mast cells but increased expression is obtained
after activation (Gordon and Galli, 1990). The levels of TNF-o: mRNA and IL-6
mRNA increase > 20-fold 1 hour after activation (Gurish et al, 1991). Stem cell
factor also appears to have a role to play in the recruitment and proliferation of
mast cells, given the crucial role of the receptor for this ligand in some strains of
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mice {vide supra). Other cytokines implicated in recruitment and growth of mast
cells include IL-9, IL-10 and nerve growth factor (Woodbury et al, 1984).
1.2.5. Mast Cells and Mast cell Proteinases during parasite infection.
Among the events associated with the expulsion of nematode parasites from
the gastrointestinal tract, is the extensive accumulation of mast cells in the infected
tissues (Askenase, 1980; Jarrett and Miller, 1982). This phenomenon was first
examined in detail by Taliaferro and Sarles in 1939 (see Miller et al, 1986). They
noted the massive accumulation in the intestinal lamina propria of what they called
connective tissue basophils which arose by differentiation and division from a
stromal cell population. They also described the appearance of a cell type containing
eosinophilic granules, the globule leucocyte. The populations of these cells increased
even more rapidly after a second infection, with cell division occurring in both cell
types.
Further studies of the histochemistry and ultrastructure of parasitized
intestine led to the conclusion that the globule leucocytes were in fact mast cells;
they contained proteoglycan, monoamines and basic protein (see Miller et al, 1986).
In the 1960's these observations were confirmed and extended. Miller and
Jarrett (1971) revealed that the population of enteric mast cells expanded
exponentially during primary infection with N. brasiliensis (see Miller et al, 1986),
and at the same time their granules became depleted of proteoglycan (Miller and
Walshaw, 1972).
Nawa and Miller (1977) described an accelerated intestinal mast cell response in
infected rats adoptively immunized with putative T-cells separated from immune
thoracic duct lymphocytes. The role of recirculating T-lymphocyte in mast cell
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hyperplasia in parasitized gut was further confirmed in adult thymectomized,
irradiated rats to which bone marrow had been restored (Mayrhoffer, 1979).
1.2.6. Function of Mast Cells
Mast cells reside in most of the major organs and in view of this ubiquity
and their heterogeneity it is likely that they play important but diverse roles in the
biological processes of the host.
In man perhaps the most widely known and striking activity involving these
cells is their participation in inflammatory reactions,where release of potent
mediators may give rise to immediate hypersensitivity reactions (Huntley, 1990).
The evidence for a role in hypersensitivity reactions exists (Galli et al, 1990), the
precise nature of the role is obscure.
1.2.7. The mast cell and IgE
The fundamental immunologic component of allergy (immediate
hypersensitivity) is the production of an immunoglobulin of the s class. IgE is a
typical monomeric immunoglobulin consisting of two heavy and two light chains,
the light chains are of either the x or A type. The heavy chains of IgE contain
specific antigenic determinants which clearly distinguish IgE from other
immunoglobulins. In addition IgE has a higher Mr than other monomeric
immunoglobulins.
The IgE molecule, like all antibodies, has two regions; Fc and Fab. The Fc
region of IgE molecules binds with unusually high affinity (Ka= 1010 litres/mole) to
a class of Fc receptors located on the surface of mast cells. The receptors are large
molecules, composed of three types of domains or sub-units; a (Mr 37,000), |3 (Mr
33,000) and y (Mr 7,000) (see Metzger and Kinet, 1988). The sub-units are in a 1
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(o:):l (j8):2 (7) ratio. The a sub-unit is solely responsible for the binding of the IgE
Fc region. Analysis of the cDNA for the a sub-unit shows a 227 residue molecule,
with a 27 residue transmembrane segment and an anchoring cytoplasmic tail (Kinet
et al, 1987). There are 7 potential glycosylation sites, and the a sub-unit is known
to be 30% carbohydrate. The carbohydrate is not thought to play a part in the
binding.
The reaction of binding is a simple bimolecular one
ki
IgE(Fc) + Receptor ^ IgE (Fc) : Receptor
k-i
with kj= l-2xl05 M4 s4 and k, < lxlO"5 s4. No co-factors are required for this
interaction (Metzger et al, 1986).
The bound IgE molecules serve in their turn as receptors for antigens. The
binding of the IgE alone is not a sufficient requirement for degranulation, a
multivalent antigen must bind to more than one IgE bound to receptors, causing
cross-linking and aggregation of receptors (see Metzger and Kinet, 1988). Dimer
aggregates are sufficient to stimulate degranulation, although greater aggregations
will provide a better stimulus for degranulation. Thus the IgE molecule determines
which antigen can stimulate the mast cell, but plays no mechanistic role in
degranulation. Degranulation releases a variety of biologically active amines such as
serotonin and histamine. These amines are vaso-active and are implicated in the
clinical manifestations of allergic reactions such as asthma and hay fever. It is
believed that these vaso-active molecules assist blood components gaining access to
sites of infection.
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1.2.8. Anaphylactic release of Mucosal Mast Cell Proteinase and its relationship
to Gut permeability in rat primed with N. brasiliensis.
A major consequence of helminth infection is the development of high titres
of parasite specific, and non-specific IgE (Jarrett and Miller, 1982), although little
parasite specific IgE is detectable in the early stages of infection with N. brasiliensis.
The precise role of IgE in the general phenomenon of mast cell recruitment and
proteinase release during helminth infection is as yet unclear. However, rats
sensitized to egg albumin develop an IgE mediated reaction to subsequent
intraluminal challenge, which results in abnormalities of water and electrolyte
absorbtion (Perdue et al, 1984).
Experiments have indicated that the proliferation of mucosal mast cells was
co-incident with the systemic release of RMCPII (Woodbury et al, 1984). Immune
rats injected i.v. with soluble worm antigen had a 5-fold increase in serum RMCPII
levels between 5 and 60 minutes after challenge (King and Miller, 1984). The
secretory response in primed rats was both time and dose dependent, whereas no
RMCPII was detected in naive rats. RMCPII was found in large amounts in the gut
lumen in these experiments and the release of RMCPII was associated with very
substantial changes in gut permeability. Immune rats that are challenged with
soluble worm antigen show an accumulation of Evans blue in the gut lumen (King
and Miller, 1984), this dye is bound to albumin and thus provides a measure of
protein leakage into the gut from the epithelial and vascular systems (Rawson, 1949;
see King and Miller, 1984).
Studies by Patrick et al (1988) have demonstrated that RMCPII is associated
with the changes in the ultrastructure of the intestinal mucosa. These changes were
20
most noticeable in the basement membrane and underlying collagenous matrix of
the intestinal mucosa.
Analysis of the distribution of RMCPII in rat infected with TV. brasiliensis
has shown that the vast bulk of this proteinase is of intestinal origin (upto 22mg/g
in the proximal jejunum, Miller et al, 1986). Other notable sources of RMCPII are
the gastric, ileal, and colonic mucosae and the immune lung.
It has also been demonstrated that the proliferation of mucosal mast cells and
the release of RMCPII is co-incident with the expulsion of nematode parasites such
as TV. brasiliensis and T. spiralis, confirming that mucosal mast cells are functionally
active during the elimination of primary nematode infections (Woodbury et al,
1984). The high concentrations of RMCPII found in intestinal perfusates of rats
primed with TV. brasiliensis after challenge intravenously with worm antigen (King
et al, 1985), again indicates the potential activity of the mucosal mast cell in
helminth infection.
Systemic release of mast cell proteinases also occurs in sheep following
nematode infection (Huntley et al, 1987). Increased concentrations of sheep mast cell
proteinase (SMCP) were detected in the gut mucosa of animals infected with the
parasite Haemonchus contortus. Detection of SMCP in serum was frustrated, possibly
due to the presence of proteinase inhibitors which interfere with the ELISA
developed to assay sheep tissues and serum for the enzyme. Huntley et al (1990)
have also demonstrated the systemic release of mouse mast cell proteinase I (MMCP-
I) in mice infected with T. spiralis.
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1.2.9. Biological Functions of Rat Mast Cell Proteinases.
There appear to be two principal roles for mast cell proteinases: regulation
of mast cell secretion and proteolysis within the granule matrix and in the
surrounding milieu after degranulation.
Non-serpin serine proteinase inhibitors, and substrates of chymases inhibit
phospholipid methylation and inhibit Ca2+ influx into mast cells and histamine
release by mast cells (see Katunuma and Kido, 1988). These findings suggest that
serine proteinases in mast cells are activated by IgE- receptor bridging and play
some role in triggering the process of degranulation. Mast cell granule proteinase
may be involved in the process of IgE-mediated degranulation before a step of
calcium entry (see Katunuma and Kido, 1988). The release of histamine from mast
cells can also be prevented by inhibitors of metallo-proteinases, such as 1
10-o-phenanthroline; these results suggest that another proteinase, a
metallo-proteinase, may be implicated in the degranulation process but after a
calcium entry step (see Katunuma and Kido, 1988). Thus, histamine release induced
by a calcium ionophore (A23187) is blocked by inhibitors of metallo-proteinase but
not by F(ab')2 of antichymase. Histamine release can be inhibited ex vivo by
inhibitors of mast cell proteinase (Dietze et al, 1990). The conclusion is that serine
proteinases and metallo-proteinases play some common role in exocytosis.
Exogenous addition of purified RMCPI results in the degranulation of
connective tissue mast cells (CTMC) (Schick, 1990); experiments involving
radio-labelling of mast cell membrane components showed that a molecule (Mr
90,000) disappeared as RMCPI was added to mast cells (Schick, 1990). Loss of this
band due to trypsin pre-treatment resulted in de-sensitization to subsequent
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activation by mast cell proteinase, suggesting that this membrane component is
involved in degranulation of CTMC by mast cell proteinases.
Little is known about the function of the mast cell proteinases released from
rat mast cells in vivo. It has been demonstrated that they degrade type IV collagen
and fibronectin, but not types I, II, or III collagen in vitro (Sage et al, 1979;
Katunuma and Kido, 1988). The products of digestion of IgG by rat mast cell
proteinase have potent chemotactic activity on neutrophil leucocytes in vitro and
in vivo, whereas IgG itself has little chemotactic activity (Katunuma et al, 1986)
suggesting that released mast cell proteinase may cause limited hydrolysis of IgG and
produce the chemotactic factors.
RMCPII may be involved in the events leading to changes in gut
permeability. By degrading the collagen in basement membrane, the mast cell
proteinase may have a direct role to play in mediating permeability changes (Patrick
et al, 1988; King and Miller, 1984). RMCPI may have a role in activating matrix
metallo-proteinases (MMP) such as collagenase and stromelysin (David Woolley,
personal communication). These metallo-proteinases are present in the form of





The plasma proteinase inhibitors constitute by weight the third largest group
of proteins in plasma, after albumin and the immunoglobulins (Travis and Salvesen,
1983). Representing nearly 10% of total protein in plasma, they control a variety
of critical events associated with connective tissue turnover, fibrinolysis,
complement activation, and inflammatory reactions.
The existence of proteinase inhibitor activity in human plasma was
apparently first noted by Fermi and Pernossi in 1897. Since that time a host of
investigations has been made to determine the various inhibitory activities in
plasma, primarily by adding proteinases of varying specificities and catalytic
mechanisms to plasma and plasma fractions.
Apart from a-2-macroglobulin, which seems to function as a back-up
proteinase inhibitor (Travis and Salvesen, 1983) and inhibits proteinases from several
families, the most rigorously studied of the proteinase inhibitors is a-l-Proteinase
Inhibitor (a-l-PI, also known as a-l-antitrypsin in man) which is the archetypal
SERine Proteinase INhibitor (serpin). This is a name given to one class of proteins
which inhibit serine proteinases specifically. This class of proteinase inhibitors
includes antithrombin III, a-l-antichymotrypsin, a-2-antiplasmin and Cl-inhibitor.
These molecules all share a similarity in structure which determines their similarity
in function as will be outlined below. Some other proteins are also known to have
structural analogies to the serpins, although they have no known inhibitory
function. Proteins such as ovalbumin (Stein et al, 1990), hormone binding proteins
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(Pemberton et al, 1988) and beta-glucuronidase (Li et al, 1990) belong to the serpin
superfamily (Hunt and Dayhoff, 1980).
The serpins all have the same mechanism of inhibition: they form 1:1 molar
complexes with their target proteinase involving a reaction between the reactive site
loop of the serpin and the active site cleft of the serine proteinase. A peptide bond
in the reactive site loop is cleaved and typically the bond is X-Ser. This bond is
found between the methionine at position 358 and the serine at position 359 in ct-1-
PI and these residues are termed the PI and PI' residues respectively. The exact
nature of the association between the serpin and proteinase is unclear (Travis and
Salvesen, 1983).
There are other proteinase inhibitors which are class-specific, such as metallo-
proteinase inhibitors, and cysteine proteinase inhibitors. No class specific plasma
inhibitor of the aspartic proteinases is known.
1.3.2. Structure and Function
1.3.2.1. Primary Sequence and conformation.
Serpins contain approximately 400 amino acids residues (Travis and Salvesen,
1983). Attempts to crystallize native serpins in order to elucidate structure/function
relationships have been
unsuccessful. However, cleaved
serpin has been crystallized
(Loebermann et al, 1984). The
overall dimensions of cleaved
human ct-l-PI delineate an
asymmetrical molecule, 67A x 32A
x 32A, and the cleaved molecule is composed of three (3-pleated sheets and 8 a-
helices; the helices are formed by the first 150 residues (Loebermann et al, 1984).
Analysis of the crystal structure of cleaved a-l-PI reveals that the two generated
termini (Met 358 and Ser 359) are 70A apart (Loebermann et al, 1984) indicating a
major structural rearrangement of the molecule on cleavage. This observation has
led to the hypothesis that native serpin is in a "stressed " form, whilst cleaved serpin
is in a "relaxed" form (Carrell et al, 1987). To reconstruct the native inhibitor by
re-forming the Met-Ser bond, it is necessary to withdraw a central strand from the
major pleated sheet of the molecule to form a stretched loop of some 16 residues.
This exposed and stretched loop places the reactive centre in an accessible position
with probable distortion of the Met-Ser bond. It is likely that in this way the target
proteinase of a serpin is presented with an ideal substrate that fits precisely into its
active site cleft to give stable complex formation between enzyme and inhibitor (
Carrell et al, 1987; see Fig 1). The structural rearrangement may well have
implications for further functional activity of the complex.
Ovalbumin, although devoid of inhibitory properties, has structural
similarities to the serpins which suggest that it may be part of the superfamily of
serpins. Stein et al (1990), using crystallised ovalbumin as a model, have suggested
that the protruding loop takes the form of an cn-helix. This structure has 3 turns,
and the putative reactive centre (Ala 358-Ser 359) is exposed on the final turn. The
loop protrudes from the main body of the protein on two stalks, each 4 residues
in length. The loop appears to have a measure of mobility, which may be important
if it is to present itself as a substrate to a proteinase. The mobility is due to the
sequence of the stalk leading from the (8-sheet to the a-helix of the loop. The
26
primary sequence of the residues leading up to PI and away from PI' seems to be
important for the correct functioning of the serpin, and changes to these residues
can have pathological implications (section 1.3.5). Evidence to support this
hypothesis comes from the work of Lawrence et al (1990) who replaced the wild
type loop Plasminogen Activator Inhibitor-1 (PAI-1) with a 19 residue region from
PAI-2, AT-III, or an artificial serpin consensus loop. The chimeric proteins inhibited
urokinase type plasminogen activator with ka„'s similar to that of PAI-1, even
though native PAI-2 has a specific activity 200-fold higher for this proteinase,
indicating that structures outside the stressed loop are responsible for the major
differences in specificity between PAI-1 and PAI-2.
Although there is not much doubt that the reactive site loop plays a vital
role in the inhibition of serine proteinases, there may be a much more fundamental
level of interaction between the serpin and proteinase. Tissue plasminogen activator
(t-PA) contains an insertion of seven amino-acids (residues 296-302) that are
predicted to form a loop adjacent to the active site of the enzyme. The basic and
charged nature of the amino-acids in this loop (Lys-His-Arg-Arg-Ser-Pro-Gly)
suggests that electrostatic interactions could contribute to the interaction between
t-PA and PAI-1. Deletion of the entire loop or replacement of Arg 304, which is
predicted to be located at the edge of the active site of t-PA, yield variants that are
resistant to inhibition by PAI-1 and whose ability to catalyse the activation of
plasminogen is essentially undiminished (Madison et al, 1990). These mutants are
also resistant to inhibition by the complex mixture of serpins present in human
plasma (Madison et al, 1989).
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1.3.2.2. Interaction of serpins with factors other than proteinases.
PAI-1 binds to the extracellular matrix of cultured bovine aortic endothelial
cells (Mimuro and Loskutoff, 1989). Bovine plasma and lung extract contain
protein(s) that bind to PAI-1 and prevent this interaction. One of these proteins was
purified and was found to be vitronectin, suggesting that native PAI-1 circulates in
complex with vitronectin, a suggestion supported by the observation that all
detectable active PAI-1 in plasma migrates in complex with another molecule, when
analysed by gel filtration under non-dissociating conditions (Erickson et al, 1986).
It has been suggested that this interaction stabilizes the serpin (Mimuro and
Loskutoff, 1989), or localises and concentrates the PAI-1 in tissues where it is
required.
Interaction betwen PAI-1 and vitronectin can change the specificity of the
serpin (Ehrlich et al, 1990) and increases the efficiency of inhibition of thrombin by
PAI-1. Fibrinogen and heparin also enhance the rate of inhibition of t-PA by PAI-1
(Edelberg et al, 1991) Kinetic studies indicate that both fibrinogen and heparin
increase the second order inhibition rate constant by a maximum of four fold,
whereas vitronectin increases the constant by six fold. The data suggest that heparin
and fibrinogen may enhance the rate of inhibition by interacting with the
proteinase and that vitronectin may enhance the inhibition by an interaction with
the serpin. However there is evidence that a group of serpins are heparin dependant;
this group includes antithrombin III, heparin cofactor II and protease nexin I
(Ehrlich et al, 1991).
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1.3.2.3. Glycosylation.
Members of the serpin superfamily have molecular masses ranging from
45,000 to 70,000. Much of the variation in mass can be explained by post-
translational events such as glycosylation. It must also be remembered that SDS-
PAGE over-estimates the Mr of glycoproteins. Several investigators examined the
polymorphism in glycosylation of human a-l-PI responsible for 12% of the mass
of the inhibitor. It was first reported that the protein contained two distinct sets of
oligosaccharide chains attached as two sets to four positions in the protein (Chan,
S. K., et al, 1976). However others disputed this and suggested that the inhibitor
contained four attachment sites for three or four types of oligosaccharide chain
(Roll et al, 1978). Later two types of carbohydrate chain were discovered in human
G!-1-PI (Hodges et al, 1979). The original hypothesis of four oligosaccharide chains
was re-examined (Mega et al, 1980a; Mega et al, 1980b) and three carbohydrate side
chains in a-l-PI in positions 46, 83 and 247, numbering from the amino-terminus
of the polypeptide were found. However the heterogeneity associated with
individual forms of a-l-PI was later found to be the result of variations in the
quantity of each of the two forms of chain (Mega et al, 1980b). Vaughn et al (1982)
showed three classes of a-l-PI: class 1 had 3 biantennary oligosaccharide chains, class
II had 2 biantennary and one triantennary oligosaccharide chains and class II had
one bi- and two triantennary chains. The carbohydrate side chains of the major
plasma serpins of the horse have been characterised by lectin analyses of protein
blots from two-dimensional gels using the major plasma serpin, oi-l-PI as a control
(Patterson and Bell, 1990). Equine proteins seem to consist of partially sialylated
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biantennary side chains, except for the most acidic proteins which have triantennary
side chains.
The role of the carbohydrate in inhibitor function has not been
unequivocally established, although all plasma serpins are exported from their source
tissue, and glycosylation is very important in regulating secretion of proteins (West,
1986). It may also have a role to play in stability of the serpins in plasma; the half
life of recombinant ct-l-PI (unglycosylated) is much lower than the native
glycosylated form (Mast et al, 1990).
1.3.3. Genetics
In the human genome there are single genes for both ct-l-PI and a-1-
antichymotrypsin. There is a putative pseudogene down stream from the ct-l-PI
gene, no transcripts from the pseudogene have been found. The a-l-PI and a-\-
antichymotrypsin genes reside on chromosome 14 and are linked to the
immunoglobulin heavy chain region (Inglis and Hill, 1990). These two serpin gene
loci are within 120kb of each other. The a-l-PI gene has 5 exons dispersed over
12.2kb (Crystal, 1989), exons II-V code for the protein. Exon I has 3 components,
which are responsible for the tissue-specific expression of the protein (see figure 2).
Most hepatocyte mRNA transcripts begin in the middle of exon Ic, while
macrophage transcripts begin at exon la
(Long et al, 1984; Perlino et al, 1987).
Two of the three glycosylation sites are
encoded in exon II, the other is on
exon III, and the reactive site loop is
encoded on exon V. Exon II contains a Figure 2
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signal peptide of 24 residues (Brantly et al, 1988) to allow transport across the
endoplasmic reticulum, followed by subsequent processing in the Golgi prior to
secretion into the bloodstream. The gene structure for a-l-antichymotrypsin is
similar to that for a-l-PI. The gene spans lOkb and contains four exons, exon II is
extremely similar to exon II of a-l-PI, both contain the AUG initiation codon.
However exons III and IV of the ol-PI gene are represented by exon III of the ct-1-
antichymotrypsin gene. The intron structure of the two genes is radically dissimilar
(Kidd and Woo, 1986).
In the mouse genome the primordial a-l-PI and a-l-antichymotrypsin genes
have undergone an extensive series of duplication events (Hill et al, 1985).
Approximately 12 closely related genes whose proteins have a-l-antichymotrypsin
as their closest human relative have been identified. By the same token the a-l-PI
gene has multiplied in the mouse and there appear to be 6-8 genes (Inglis and Hill,
1990). These genes are found in two clusters,the SPI-1 and -II loci. SPI-1 contains
genes whose products are structurally homologous to human a-l-PI, and SPI-II
contains genes which code for proteins which are the structural homologues of a-1-
antichymotrypsin. The presence of antichymotrypsin activity in the mouse has yet
to be shown, and gene products from the SPI-II locus (known as contrapsins) are
known to have antitryptic activity (Inglis and Hill, 1990). The ct-l-PI genes in the
mouse are lOkb long (Krauter et al, 1986) and contain 5 exons.
The rat genome also contains multiple copies of genes on both the SPI-1 and
-II loci (Inglis and Hill, 1990). There are 4-5 genes on each cluster in the rat, the
overall picture being less clear than in the mouse genome.
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1.3.4. Evolution
The serpins provide an intriguing model of the way in which evolution can
provide a range of functions within one superfamily. The serpins exhibit a high
degree of homology (>95%, Borriello and Krauter, 1991) within gene clusters, and
to a lesser extent between clusters. Related members such as a-l-antichymotrypsin
and antithrombin III have >40% homology at the nucleotide level (Kidd and Woo,
1986). Dot matrix analysis of the two sequences has shown that there is greater
homology between the amino-terminal than between the carboxyl terminal portions
of the proteins (Kidd and Woo, 1986). Murine a-l-PI and contrapsin share 59% and
44% homology at the genomic and amino acid level respectively (Hill et al, 1984),
suggesting that the two proteins diverged from a common ancestral gene 200-300
million years ago.
The similarity between serpins extends across the species barrier. Hill et al
(1984) showed that, over the region of the gene analyzed, primate and murine a-l-PI
shared 70% homology at the genomic level and 60% at the amino acid level. Thus
serpins are highly related to each other. It should be noted however that when
serpins do diverge, it is most noticeable in the reactive site loop of the molecule.
This, as discussed, is the region of the protein which confers specificity for target
proteinase. However a common feature to all serpins is the stressed conformation
of the native molecule, necessitated by the requirement for the loop to be extruded
from the main body of the serpin. Thus the loop structure is preserved even though
the PI and PT residues have diverged considerably even between genes on the same
cluster (Borriello and Krauter, 1991).
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Further examples of polymorphism were demonstrated by Potempa et al,
(1991) in the horse. Three structurally related but functionally different serpins from
horse plasma were isolated and characterised. In spite of similarities in N-terminal
sequences, the reactive site loops of these proteins showed extensive variation. Only
what they have termed Inhibitor I, with a PI methionine residue, resembles human
a-l-PI with regard to specificity and reactive site loop sequence. Inhibitors II and
III are reported to have an arginine and alanine residue respectively at the PI site,
markedly altering specificity, susceptibility to oxidation and k,ss.
When comparing reactive site loop sequences of serpins within and across
species (Hill and Hastie, 1987; Carrell et al, 1987), and also noting the chromosomal
arrangement of the relevant genes (Inglis and Hill, 1990) it is compelling to
hypothesise a series of duplication and divergence events. Such an hypothesis has
been postulated (Inglis and Hill, 1990). Duplication events, arising from unequal
crossing-over, would relieve the selection pressure on a single copy of a gene,
allowing the duplicate to diverge, randomly, to an alternative form of the protein,
which may or may not have a role to play in the physiology of the animal. The
presence of pseudogenes at the serpin loci in man, and the abundant polymorphism
exhibited by lower mammals (Potempa et al, 1991; Pirie-Shepherd et al, 1991; Inglis
and Hill, 1990; Borriello and Krauter, 1990) bears witness to the validity of this
hypothesis. Hill and Hastie (1987) have suggested that the selection pressure behind
such evolution is the presence of extrinsic proteinases, namely those used by
parasites to facilitate their spread through the host. However this hypothesis,
although attractive in many ways, does not explain the lack of variety in man. As
a species man is just as susceptible to a wide range of parasites as all lower
33
mammals. However, parasites may have a tangential role in the rapid evolution of
serpins. It is known that parasites elicit a response in the host which includes the
increased concentration of free mast cell serine proteinases in a variety of tissues and
plasma, while many of the proteinases ar normally at extremely low concentrations
normally (Miller et al, 1983; Huntley et al, 1987; Miller et al, 1986; Gustowska et
al, 1983). The need to modulate the increased concentrations of mast cell serine
proteinases found in plasma and tissues (Miller et al, 1986) which could potentially
damage the host may be a sufficient selection pressure to drive evolution in the
direction of diversity. The resulting variation would be partly dependent on the
nature of the host response, as each species adapts to its own intrinsic response.
However at the present time there is not enough evidence to support either
hypothesis.
1.3.5. Pathology
Although there are only single known actively-transcribed genes for ct-l-PI
and cn-l-antichymotrpsin in man there are a number of allelic variations present
within the population which can give rise to a plethora of pathological conditions.
1.3.5.1. ct-l-PI deficiency.
The most obvious causes of disease are deficiency states of the anti-elastase
function of a-l-PI. The types of deficiency fall into 3 subgroups; "at risk", "null"
and "change of function". Deficiency of ai-l-PI is one of the most common lethal
hereditary disorders of Caucasians of European descent (Crystal, 1989). In normal
individuals more than 2g of a-l-PI are produced daily, the protein has an half-life
of 4-5 days in blood and serum levels are 25-30uM (Cox, 1989). Concentrations in
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the lung are approximately 10-20uM and in the alveolar epithelial lining are 2-5uM
(Wewers, 1987; Gadek et al, 1981).
The normal lung is constantly exposed to foreign particles which may
stimulate neutrophils to release elastase. When concentrations of a-l-PI are normal,
the amount of a-l-PI in the lower respiratory tract is in excess of this neutrophil
elastase burden, so protecting the lung. In contrast, in ce-l-PI deficiency, the reduced
concentration in plasma, and hence the lung, do not provide an adequate shield
against neutrophil elastase, exposing the alveolar walls to chronic proteolytic attack
(Crystal, 1989). If the individual with o-l-PI deficiency smokes, the defences of the
alveoli are further compromised because the Met-358 residue at the PI site is
vulnerable to oxidation by free radicals in cigarette smoke and also by those released
by inflammatory cells recruited to the lung in response to the smoke (Janoff, 1985).
When the Met-358 is oxidised, the inhibitory capacity of a-l-PI is decreased
markedly (Travis and Salvesen, 1983), so smoking exaggerates the deficiency of a-1-
PI by reducing the number of functional molecules available to protect the lung.
The association between a deficiency of a-l-PI and human disease was first
observed by Laurell and Eriksson in 1963. Emphysema, the most common
manifestation of gi-1-PI deficiency becomes evident by the third or fourth decade.
Smoking cigarettes accelerates the disease, hastening death from respiratory failure
by 10-15 years.
The a-l-PI gene is pleiomorphic, with approximately 75 alleles identified
(Cox, 1989). The allelic nomenclature is based on letter assignments corresponding
to the position of migration of the protein on iso-electric focusing. Approximately
90-95% of all a-l-PI alleles evaluated in a given population are "normal" in that
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functionality and serum concentration are unaffected. Of the 45 known normal
alleles, 10 have been sequenced (Crystal, 1989). The alleles designated Ml(Ala-213),
Ml(Val-213), M2 and M3 represent 95% of normal alleles in US Caucasians. The
coding exons of the four common normal alleles differ by sequential single base
changes, suggesting a pattern of evolution with Ml(Ala-213) probably being the
oldest human a-l-PI allele.
There is a subgroup of 12 "at risk" alleles, 9 of which have been sequenced
(Cox, 1989). Most mutations causing a-l-PI deficiency appear to modify the
intracellular processing of cn-l-PI in its path from the rough endoplasmic reticulum
(RER) to the Golgi, resulting in reduced secretion and hence reduced serum levels.
The most common mutations are Z and S. The Z mutation is a single base
substitution in exon V of the normal Ml(Ala-213) allele causing a Glu to Lys change
at position 342 in the protein (Brantly et al, 1988). The allele frequency is 1-2% in
affected populations. Typically only 10-15% of normal levels of a-l-PI are found in
serum (Brantly et al, 1988) although what is present is fully active. The defective
molecule aggregates in the RER of the affected individual (Crystal, 1989). The S
allele results from a mis-sense mutation causing replacement of Glu-264 by Val in
exon III of the normal Ml (Val-213) allele; of the two mutations S is the more
common. SS individuals are not at increased risk for emphysema, but SZ and ZZ
individuals are (Wewers et al, 1987). The problem with the S form of the protein
seems to be related to intracellular stability, catabolism being rapid in the lysosome
(Curiel et al, 1989). All other mutations belonging to the "at risk" group cause
deficiency because of intracellular aggregation or degradation of a-l-PI. Very recent
evidence had shown that the aggregation of a-l-PI in RER is caused by
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polymerisation of the molecules (Lomas et al, 1992). The polymerisation is caused
by the reactive loop of one molecule inserting into a gap in the A sheet of an
adjacent molecule resulting in concatenation of cc-l-PI (Mast et al, 1992).
There are six known mutations causing the null state. All are rare except for
nullproc;da. which is associated with the deletion of all four coding exons of the a-l-PI
gene (Crystal, 1989). The other null alleles include a variety of substitution, deletion
and insertion mutations which introduce stop codons into exons.
Some mutations result in altered function for the serpin, eg a-l-PIpittsburgh is
caused by Met-358 changing to Arg-358 resulting in the decrease of anti-elastase
activity and an increase in anti-thrombin activity. This mutation can lead to
bleeding disorders, a direct consequence of the heparin independent anti-thrombin
activity of the Pittsburgh variant (Owen et al, 1983).
A diagrammatic
summary of the risk of
emphysema deriving
from possession of
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Figure 3
1.3.5.2. a-1-antichymotrypsin.
The above mutations of ce-l-PI manifest themselves as liver, lung (Poller et
al, 1990) or blood disorders (Crystal, 1989). Recently it has been shown that the
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proteins forming the amyloid plaques in the brains of Alzheimer's disease patients
are the serpins proteinase nexin II and a-l-antichymotrypsin (Abraham et al, 1988).
The serpins are produced in the brain, particularly in areas that develop Alzheimer's
lesions. Whether the protein accumulation is a cause or result of the disease is not
at present understood.
1.3.5.3. Antithrombin III
Antithrombin is a major plasma protein inhibitor of the proteinases
generated during blood coagulation; it plays an important role in the regulation of
thrombin in the blood. Inherited deficiency of antithrombin is associated with
familial thromboembolism (Lane and Caso, 1989).
1.3.5.4. Cl-inhibitor
CI is the only plasma inhibitor of activated Clr and Cls, the serine
proteinase subcomponents of the first component of complement (Davis, 1989).
Absence or impaired function of the protein results in angioneurotic oedema. The
condition can be genetic in nature although the symptoms can be acquired in
individuals with B-cell lymphoproliferative disorders.
1.3.6. Clearance of the complex
The physiological fate of the complex formed between serpins and their
cognate proteinases is of importance, as the fate of the complex is essentially the fate
of the proteinase.
Studies directed towards an understanding of the fate of the complex revealed
that it had a shorter half-life in vivo than the corresponding serpin, eg 1-125 labelled
a-l-antichymotrypsin had a plasma half-life of 85 minutes, whilst complex formed
between this serpin and either chymotrypsin or cathepsin G had a half-life of 12
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minutes (Pizzo et al, 1988). It was found that clearance of this complex could be
blocked by a large molar excess of complexes formed from proteinases and a-l-PI,
or a-l-antichymotrypsin. Studies have demonstrated that the pathway responsible
for this clearance is also responsible for the catabolism of complexes formed from
heparin cofactor II and antithrombin III (Pizzo et al, 1988; Pratt et al, 1988). Thus
there appears to be a common receptor -mediated pathway for the plasma clearance
of serpimproteinase complexes, but this pathway does not seem to be involved in
the catabolism of serpins or proteinases. This receptor has been dubbed serpin
receptor I (Pizzo, 1989).
Several recent studies suggest that the complexes formed between serpins and
proteinases have intrinsic functional activities such as stimulating neutrophil
chemotaxis (Banda et al, 1988), and mediating increases in expression of the a-l-PI
gene in macrophages (Perlmutter et al, 1988). It is known that during complex
formation there is a structural rearrangement of the inhibitor, involving hydrolysis
of the serpin at the carboxyl-terminal portion of the protein. It is not known
whether this hydrolysis goes to completion, but the current hypothesis is that a
new domain on the serpin is exposed. This domain is recognised by the serpin
receptor, allowing clearance (Perlmutter et al, 1990). Recently a pentapeptide
domain (residues 370-374 of a-l-PI, FVFLM) has been shown to be sufficient for
binding to the receptor, this sequence is exposed during complex formation and is
conserved across a variety of serpins (Joslin et al, 1991).
The receptor seems to be responsible for the internalisation of the complex
and it also would appear to play a role in subsequent catabolism of the complex
intracellularly. Binding and internalisation is saturable and time dependent. SDS-
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PAGE analysis of intracellular radioactivity demonstrated that intact complexes (Mr
75,000 and 66,000) were internalised. Kinetic analysis showed that a single cohort
of 125I-a!-l-PI complexes were accumulated within 5-15 minutes of binding to the
cell surface. Evidence indicates that the subsequent degradation is lysosomal. Thus
the receptor mediates internalisation and delivery of the complex to the lysosomes
(Perlmutter et al, 1990).
It has been long known that macrophages produce ce-l-PI (Remold-O'Donnel
and Lewandrowski, 1983) and another serpin termed MPI (macrophage proteinase
inhibitor). Using RNA blot and dot hybridisation techniques, a-l-PI mRNA has
been detected in human peripheral blood monocytes, bronchalveolar and breast
milk macrophages but not in lymphocytes (Perlmutter et al, 1985).
Expression of cc-l-PI in macrophages may not be regulated by complex
binding alone (Perlmutter et al, 1985). There is evidence to suggest that elastase and
endotoxin have regulatory effects on the expression of this serpin (Perlmutter et al,
1988;. Barbey-Morel et al, 1987) in peripheral bloodmonocytes and bronchoalveolar
macrophages. These effects have been shown to be additive, the regulatory effect of
each molecule can be inhibited independently (Perlmutter and Punsal, 1988),
Diisopropyl fluorophosphate inhibits the effect of elastase and a monoclonal
antibody against the lipid A moiety of lipopolysaccharide inhibits the effect of
endotoxin. The effect of elastase results from a specific increase in steady state levels
of Qj-l-PI mRNA whereas endotoxin mediates a 5-9 fold increase in synthesis of a-1-
PI with minimal, or no change, in cc-l-PI mRNA levels.
40
1.4. Aims of the Project.
The concentrations of RMCP II in peripheral blood are greatly increased
during systemic and local intestinal anaphylaxis (King and Miller, 1984; Patrick
et al., 1988) and secretion of RMCP II into blood is associated with expulsion of
nematode worms in rats (Miller et al., 1983). The phenomenon of increased
concentrations of circulating soluble mast cell proteinase associated with worm
expulsion has also been observed in mouse (Huntley et al., 1990) and sheep
(Huntley et al., 1987). A physiological role for mast cell proteinases has not
yet been unequivocally demonstrated. However, several lines of evidence
suggest that human mast cell proteinases modulate the biological effect of
neuropeptides in the airway, resulting in airway hypersensitivity in man (Tarn
and Caughey, 1990; Caughey, 1990) and dog (Nadel, 1989). Exogenous RMCP
I has also been implicated in mast cell degranulation (Schick, 1990; Kido et al.,
1988), and in the processing of matrix metalloproteinases (Sopata et al, 19??).
Many serine proteinases which function in plasma or tissue during
inflammation appear to be regulated by a superfamily of serine proteinase inhibitors
(serpins) (Travis and Salvesen, 1983). This suggests that serine proteinases derived
from mast cells also will be regulated by the serpin superfamily. For example
human skin mast cell chymase is inhibited by at least two serpins (Schechter et al.,
1989). Work in this laboratory has shown that mouse serum has the ability to
interact with mouse intestinal mast cell proteinase, resulting in the formation of
higher molecular mass (c. 75kDa) complexes (Irvine et al., 1990) a characteristic
of the interaction of serpins with susceptible proteinases.
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At least 5 plasma proteins in the rat belong to the serpin superfamily and
function as serpins (Kuehn et al., 1984). The purpose of this present study was to
determine which, if any, of the rat serpins can regulate the activities of RMCP I and
II, in an attempt to elucidate the physiological fate of these mast cell proteinases in
an homologous system.
Antibodies specific for the rat serpins will be raised and used to investigate
the acute phase response involving serpins during nematode infection. Attempts to
correlate these data to data pertaining to rat mast cell proteinase concentrations will
be made.
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Chapter 2: Materials and Methods.
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2. Materials and Methods.
2.1.Animals
The rat strain was randomly bred male Wistars. Average body weight was
300-400g. All rats were killed under halothane anaesthesia by cervical dislocation.
The rabbit was an half-lop. This animal was killed under halothane anaesthesia and
exsanguinated. The sheep was a Blackface ewe that had grazed pastures at Moredun
Research Institute. All animals were obtained from the colonies maintained at the
Moredun Research Institute in Edinburgh. Laboratory animals were maintained in
a dark/light cycle of 12 hours and were allowed access to food and water ad libitum.
2.2. Parasitological Techniques
The strain of Nippostrongylus brasiliensis in these experiments was originally
established and maintained in the Department of Experimental Parasitology,
University of Glasgow and is now maintained in the Moredun institute by passage
in Wistar rats. The culture and maintenance of N. brasiliensis was essentially as
described by Nawa and Miller (1978). Briefly, seven days after infection faeces were
collected into water, washed and mixed to form a thick paste. Previously washed
granular charcoal (10-18 mesh, BDH Chemical Co.) was added to the faeces, and the
mixture incubated at 28°C in a humidified plastic box. Seven to 14 days after
incubation the infective stage larvae (L3) were collected into water at 37°C and then
transferred to a steel mesh covered with rice paper through which they migrated.
After washing the larvae in sterile saline, suspensions of larvae were counted under
a dissecting microscope, the concentration of the larval suspension was normally
adjusted to an infective dose of 3000 L3 in 0.5mL which was inoculated
subcutaneously into the flank of anaesthetized rats.
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2.3. Perfusion of animals
Animals were killed under halothane anaesthesia by cervical dislocation. The
thoracic cavity of the animal was exposed and the animal was perfused with 300mL
of PBS via the left ventricle of the heart. The exit point of the perfusate was the
right atrium. The animal was then perfused via the right ventricle with lOOmL PBS
to ensure a good perfusion of pulmonary tissues. A 16 gauge needle was used.
Perfusion was performed under gravity.
2.4. Preparation of serum and tissues.
2.4.1 Serum
Serum was obtained by collecting blood from the right atrium prior to any
perfusion, or from the right carotid artery. Blood was allowed to clot at room
temperature and serum was aspirated using a pastette. The serum was centrifuged
at 800g for 15 minutes in order to pellet erythrocytes. Serum was removed from the
pellet and stored at -20°C in lmL aliquots until used.
2.4.2 Tissues
Tissues were removed from a perfused animal, trimmed to remove excess fat
and stored in lg quantities at -20°C.
Small intestine was taken 12-15cm distal to the pylorus. The 5cm of large
intestine immediately distal to the caecum was removed. All other tissues were
removed whole and trimmed prior to storage.
Tissues were homogenised (10%w/v) in phosphate buffered saline (PBS),
using a Silverson sealed unit heavy duty laboratory Emulsifier. Gastrointestinal
tissues were homogenised in the presence of ImM phenylmethyl sulphonylfluoride
to prevent proteolysis by endogenous serine proteinases. The homogenates were
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centrifuged at 10,000g for 15 minutes and the supernatant was further centrifuged
at 50,000g for 30 minutes. All analysis was performed on the supernatant fraction




Protein concentration was determined using the bicinchoninic protein assay
system (Pierce and Warner, Chester, UK) modified for use with microtitre plates.
The standard curve was prepared using bovine serum albumin (BSA, from Sigma
chemical Co., Poole, Dorset, UK) in the range 10-50^tg. Absorbance at 540nm was
measured. A typical standard curve can be seen in Figure 2.1.
Protein concentration was also determined by measuring the absorbence of
a solution at 260nm and 280nm. Protein concentration was determined using the
following equation
[P] = (1.55x Abs 280) - (0.77xAbs 260)
2.5.2 Proteinase
The standard assay for monitoring enzyme activity during the purification
using the esterase substrate, benzyloxy-carbonyl-L-tyrosine-4-nitrophenyl ester
(CBZ-L-Tyr-4NPE, from Sigma chemical Co. Poole, Dorset, UK) was as follows:
10/zl of enzyme preparation was added to 100/d of 20mM Tris-HCl, pH 7.5. 10 /d
of substrate (lOmM in DMSO) was added to initiate the reaction and after 3
minutes at room temperature the formation of product was monitored at 405nm.
Figure 2.1
BSA (micrograms)
Standard curve for Pierce protein assay.
The assay was performed according to the manufacturers
instructions. The assay was read in a microtitre plate on a
titretek plate reader, with the filter wheel set at 540nm.
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2.6. Preparation of antibodies
2.6.1. Polyclonal antibodies
The procedure for rabbit and sheep polyclonal antisera preparation was as
follows. Equal volumes (200/xL) of antigen solution (100 /xg total protein) and
Freund's complete adjuvant (Sigma Chemical Co., Polle, Dorset) were emulsified
by drawing the mixture up a 19G needle 10-20 times. A solution of PBS/Tween-80
(2%v/v) equivalent to twice the volume of the original antigen solution was added
to the mixture. This final solution was also emulsified prior to injection
intramuscularly into the animal.
Subsequent immunisations were performed as above, except that the antigen
was emulsified in Freund's incomplete adjuvant. Secondary immunizations were
generally performed 4 weeks after the primary immunisation.
2.6.2. Monoclonal antibodies.
Mice were immunised as described in 2.6.1 and the animals were bled from
the tail after 4 weeks. The serum derived from tail bleeds was assayed by enzyme
linked immunoabsorbant assay ELISA, with Rat Serpin II-Mouse Mast Cell
Proteinase le as the coating antigen. Animals which tested positive were given a
secondary immunisation as described is 2.6.1. The spleen from an immune mouse
was removed and washed in medium (RPMI/10% FCS/ PenStrep [50/xg/mL
streptomycin, lOOU/mL penicillin]). The cells were liberated from the spleen using
26G needles and aspirated into a 50mL tube. This procedure was repeated with a
control spleen to provide feeder cells. The fusion partner (NSO derived from a
mouse myeloma cell line) was suspended in medium and all three sets of cells were
centrifuged for 5 minutes at 400g. The pellet of immune spleen cells was
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resuspended in lOmL of RPMI/PenStrep (serum free) and washed once in this
medium. The control spleen cells were resuspended in 5mL of
RPMI/PenStrep/HAT (O.lOmM hypoxanthine/0.4nM aminopterin/O.OlmM
Thymidine) and washed once in this medium. The fusion partner (NSO) cell pellet
was resuspended in lOmL RPMI/PenStrep. Immunised spleen cells were added to
fusion partner cells in a ratio of 10:1, and the suspension centrifuged for 5 minutes
at 400g. The supernatent was removed, lmL of fresh medium (serum free) was
added to the pellet and the cell pellet resuspended carefully by tapping the tube.
lmL of polyethylene glycol (PEG) 1500 (Boehringer, Mannheim) was added over
the course of 1 minute, the tube was in constant gentle motion. lOmL
RPMI/PenStrep was slowly added and the suspension centrifuged at 300g for 5
minutes. The pellet was resuspended in 1 mL of serum free medium and
RPMI/PenStrep/HAT. The cells were counted in a haemocytometer and the
concentration of fused cells adjusted to 1 x 106/mL. Feeder cells (control spleen
cells, 2 x 105/mL) were added to the fused cells (1 x 106/mL). The mixture was
plated out onto 96 well polystyrene plates and cultured in RMPI/10%
FCS/Penstrep/HAT/Glutamine (0.03%) at 37°C in 5% C02.
2.6.3. Selection of viable clones
Wells containing healthy colonies of growing hybridoma cells were assayed
by ELISA, using RSILMIMCP Ie bound to the plates as antigen. Colonies which
tested positive were plated out in a limiting dilution, in order to generate one clone
per well. Clones were re-assayed by ELISA. Positive clones were subcloned (see
chapter 5 for specific details) in RPMI/10% FCS/PenStrep/HT (no
aminopterin)/Glutamine.
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2.6.4. Conjugation of antibodies
Antibodies were conjugated essentially as described in Wilson and Nakane
(1978), with minor modifications. Horse radish peroxidase (HRPO) (4mg,
Boehringer Mannheim) was dissolved in lmL dH20. Freshly prepared 0.1M NaI04
(0.2mL)was added to the HRPO and the solution was stirred for 20 minutes at
room temperature. The HRPO-aldehyde solution was dialysed against ImM sodium
acetate pH 4.4 overnight at 4°C. The pH of the HRPO-aldehyde solution was raised
to 9-9.5 by the addition of 20^iL of 0.2M sodium carbonate buffer, pH 9.5 and
immediately 8mg IgG in lmL lOmM sodium carbonate buffer, pH 9.5 was added.
The reaction mixture was stirred for 2 hours at room temperature. Freshly prepared
sodium borohydride (0.1M) was added to the mixture (4mg/mL) and the solution
left for two hours at 4°C. The conjugate mixture was chromatographed on Sephadex
G-100 (15 x 950mm) equilibrated in PBS. The conjugated antibody was detected by
reading absorbance at 280nm and 403nm. Bovine serum albumin (fraction V) was
added to a concentration of lOmg/mL and aliquots were stored in 50% glycerol at -
20°C.
2.7. Preparation of affinity columns
CNBr-Sepharose 4b (Pharmacia) was washed and swollen in ImM HCl
(200mL/g). The protein to be coupled was dissolved in 0.1M sodium carbonate
buffer/0.5M NaCl, pH 8.3. The protein solution was added to the swollen
Sepharose 4B and the mixture was placed on a carousel for 2 hours at room
temperature. The gel was then transferred to a solution of 0.2M glycine, pH 8.0 and
allowed to mix for 2 hours at room temperature in order to block unreacted
coupling sites. The gel was then packed under gravity into a C-16 (16 x 100mm)
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type column (Pharmacia). 0.5mL of Sephadex G-25 was poured onto the top of the
settled matrix and the gel was subjected to a high-low-high pH regime to remove
excess blocking glycine. The column was stored at 4°C.
2.8. Column Chromatography
All column chromatography was performed using the FPLC system
(Pharmacia). Proteins were routinely detected by continuously monitoring
absorbance at 280nm. Columns used were all of the C-16 type (Pharmacia), or were
prepacked mono-columns (HR5/5, Pharmacia).
2.9. Purification of proteins
2.9.1 Antibodies
Antibodies were purified from antiserum by affinity chromatography with,
as ligand, the antigen used to raise the antiserum. Antiserum (200/xL) was applied
serially to a column (3mL) of ligand-Sepharose4B (0.25-0.5mg/g matrix) equilibrated
with PBS. Bound material was eluted with 2mL of 0.1M citric acid/0.5M NaCl, pH
2.2. Antibody solutions (2-3mL) were immediately titrated back to neutral pH by
addition of 200/rL of 1M Tris, pH 10. Antibody solutions were concentrated by
applying the protein solution (in 75mM Tris pH 10.00) to a MonoQ column
previously equilibrated in this buffer. 95% of the antibodies in solution bound to
the column under these conditions. The antibodies were eluted from the column
using 2mL of 75mM Tris/IM NaCl, pH 10.00. The final volume obtained was
typically l-2mL with a protein concentration of 2-4mg/mL.
2.9.2 RMCPII
RMCPII was purified from small intestines of rats previously infected with
N.brasiliensis. The tissue (lOg) was homogenised (20% w/v) in 20mM Tris-HCl, pH
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7.5, and centrifuged at 10,000g for 15 minutes, the supernatant was further
centrifuged at 50,000g for 30 minutes and the supernatant from this procedure was
applied to a CM-Sepharose column (16mm x 200mm) previously equilibrated in
20mM Tris-HCl, pH 7.5. The column was washed in lOOmL of 20mM Tris-HCl,
pH 7.5, and eluted protein was discarded. Protein bound to the column was eluted
with lOmL of 20mM Tris-HCl/lM NaCl, pH 7.5, and immediately applied to a
Sephadex G-25 column previously equilibrated in 20mM Tris-HCl, pH 7.5. The
protein eluting from this column was applied to a MonoS (Pharmacia, Milton
Keynes, Bucks, UK) column equilibrated in the same buffer. The MonoS column
was washed with 20mL of 20mM Tris-HCL and a continuous salt gradient (NaCl
0-0.3M) was applied at a rate of lOmM/mL. RMCPII was eluted at 80mM NaCl. To
ensure maximum purity, RMCPII was reapplied to the MonoS column three times.
This was necessary as an active fragment of the proteinase was sometimes generated
during the purification. The identity of the fragment was determined by
amino-terminal sequence analysis. A chromatogram from the monoS column can
be seen in Figure 2.2.
2.9.3 Mouse Intestinal Mast Cell Proteinase Ie
Purified Mouse Intestinal Mast Cell Proteinase Ie was a kind gift from
George Newlands.
RMCPII purification: monoS column profile
The buffer system is 20mM Tris-HCl, pH 7.5. The peak is RMCPII which








0.4% SDS -titrated to pH 8.8
UT- 0.5M Tris-HCl
0.4% SDS -titrated to pH 6.8
Reservoir buffer- 0.3% Tris
1.44% Glycine
0.1% SDS
AP- 2% ammonium persulphate
The solutions were mixed according to the table below to provide gels of
varying properties.
Running gel
solution 7.5% 10% 12.5% 15%
H20 (mL) 14.5 12.1 9.5 7
A/B (mL) 7.5 10 12.5 15
LT (mL) 7.5 7.5 7.5 7.5
AP (mL) 0.45 0.45 0.45 0.45






Ammonium Persulphate (mL) 0.3
TEMED (/xL) 20
All gels were cast using the Bio-Rad Protean II system or the Bio-Rad
Mini-Protean II system. Sample preparation was as outlined below.
Pre-treatment buffer (PTB)




Samples were diluted to the appropriate concentration in PBS, if required,
to 66% of the final volume required. The sample volume was then made up using
PTB. Samples were heated to 100°C for 3 minutes before loading onto the gel. Gels
were run at 25mA initially. When protein had entered the resolving gel the current
was increased to 35mA. Electrophoresis was stopped when the dye front was within
2cm of the bottom of the gel.
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3M Tris/0.3% SDS, pH 8.45 3.33mL
H20 4.56mL







3M Tris/0.3% SDS pH, 8.45 l.OmL
h2o 2.8mL
Ammonium persulphate (10%) 100/zL
TEMED 10/zL
Tank buffers
Upper tank buffer- O.lMTris/O.lM Tricine/0.1% SDS
Lower tank buffer-0.2M Tris-HCl, pH 8.9
All gels were cast using the Bio-Rad Protean II system or the Bio-Rad
Mini-Protean II system. Sample preparation was as outlined below.
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Pre-treatment buffer (PTB)




Samples were diluted to the appropriate concentration in PBS, if required,
to 66% of the final volume required. The sample volume was then made up using
PTB. Samples were heated to 100°C for 3 minutes before loading onto the gel. The
gel was run at 110V until the dye front was within 1cm of the bottom of the gel.
2.10.3 Non-reducing native gel system.
Buffers
A/B- 30% acrylamide/0.8% bis-acrylamide
Gel buffer- 25mL 1.5M Tris
75/j.L B-mercaptoethanol
0.5mL TEMED
-add water to about 70mL
-titrate to pH 7.8 with H2S04
-make upto lOOmL with water.
AP- 0.2% in H20
Tank buffer 65mM Tris-borate, pH 9.0
7.87g Tris
lg Boric Acid
-make upto lOOmL with H20
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For an 11.2% gel these components were mixed as follows.
Solution Stack Resolving Gel
A/B (mL) 0.5 4.48
Gel
Buffer (mL) 1 3
AP (mL) 1 3
H20 (mL) 1.5 1.52
These gels were cast using the Mini-Protean II gel system and run at 250V
for 50 minutes or until the dye front had reached the bottom 1cm of the gel.
2.10.4 Blotting procedures
Proteins were transferred to inert supports using the semi-dry method of
blotting (Khyse-Anderson, 1984). The transfer buffer was lOmM
3-[Cyclohexylamino]-propane-sulphonic acid (CAPS, Sigma Chemical Co., Poole,
Dorset) according to the method of Matsudaira (1987). Transfer was achieved in 1
hour with a current of 2mA/cm2 of gel.
Protein was transferred either to polyvinylenedifluoride (Immobilon-P,
Millipore, Watford, Herts, UK) or nitrocellulose (Schleicher & Schuell, Anderman
& Co., Kingston upon Thames, Surrey, UK) for subsequent analysis.
2.10.5 Staining procedures.
Coomassie Brilliant Blue.
Gels were fixed and stained in 0.5% Coomassie brilliant blue (R-250, Sigma
Chemical Co. Poole, Dorset, UK) dissolved in 25% methanol/10% acetic acid for
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15 minutes. Gels were destained in 25% methanol/10% acetic acid for 1-2 hours,
with 2-3 changes of destain solution.
Silver Stain (Morrisey, 1981)
Gels were fixed and stained in 50% methanol/10% acetic acid for 15
minutes. They were washed twice in 5% methanol/7% acetic acid for 5 minutes.
After incubation in 5/xg/mL dithiothreitol in HzO for 15 minutes gels were washed
3 times in distilled H20. They were incubated in 0.1% silver nitrate for 20 minutes,
rinsed in water for 30 seconds and developed in lOOmL of 3% Na2C03 with 50/rL
of 40% formaldehyde. Development was stopped with the addition of 10% citric
acid.
2.11. Protein sequencing.
Proteins were sequenced either by the Wellmet facility in the Department
of Biochemistry, University of Edinburgh, Edinburgh or by the microchemistry
department at the AFRC Institute of Animal Physiology and Genetics Research,
Cambridge Research Station, Babraham, Cambridgeshire. Protein was presented for
sequence either in solution (25mM bis-tris, pH 6.7) or bound to Immobilon (see
section 2.10.4) after electrophoresis. Protein bound to Immobilon was visualised
with Coomassie Brilliant Blue (see section 2.10.5), and excised from the support
with a clean scalpel.
2.12. Immunological Procedures
2.12.1 Ouchterlony
A solution of 1% (w/v) of fine agarose was made up in PBS and heated to
100°C. The solution was then poured (20mL) onto a 1850-102 Gelbond film (LKB)
and allowed to set at room temperature. Wells with a diameter of 5mm were then
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cut in the gel. The wells followed a standard pattern of 1 central well surrounded
by 6 peripheral wells in a hexagonal arrangement. Antigen solution was pipetted
(5/rL) into the central well and a series of descending serial dilutions of anti-serum
was pipetted into the peripheral wells. The gel was incubated overnight at 4°C in
a moist atmosphere, allowing sufficient time for diffusion of the anti-serum and
antigens leading to precipitate formation.
Excess fluid was removed from the gel by placing lint free tissue and paper
towels on the gel and compressing this "sandwich" with a lead weight (2Kg). The
gel was washed in PBS 2-3 times to remove excess protein from the anti-serum, in
between each wash the gel was compressed. Finally the gel was dried in a rapid air
flow at 37°C. Precipitates were visualised by staining the gel in 1% Coomassie Blue
(R-250) (w/v in 20% methanol/15% acetic acid) and destaining in 20%
methanol/15% acetic acid.
2.12.2 ELISA
Polystyrene plates (96 well) were coated with ligand or capture antibody
dissolved in 0.1M sodium carbonate buffer, pH 9.6. The standard concentration of
capture antibody or ligand was lpig/mL (50juL per well). After 1 hour at room
temperature, the plates were washed with PBS/0.05% Tween-20 (Sigma Chemical
Co, Poole Dorset) and incubated with a solution of 4% BSA/PBS/Tween-20, for 15
minutes at room temperature (50/xL per well). Serially descending dilutions of the
antigen or antibody to be detected were then added to the plates and left for an
hour (50 /aL per well). The plates were then washed 2-3 times in PBS/Tween-20
solution and an antibody, conjugated to horseradish peroxidase and specific for the
antigen/antibody of interest was added to the wells (50/jlL per well). After one hour
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the conjugate was removed and the plates washed in PBS/Tween-20. The
chromogenic substrate was then added to the wells, the recipe is below.
Chromogenic Substrate:
25mL 0.1M citric acid/25mL 0.2M Na di-hydrogen phosphate/50mL dH20,pH =
5.00.
Add 40mg OPD, 5/xL H202 (33% w/v) and use immediately (50/zL per well).
The colour-generating reaction was stopped by the addition of 25juL of
H2S04 (2.5M). Plates were read using a Titretek plate reader with the filter wheel
set at 405nm.
2.12.3 Western blotting
After transferring proteins (see section 2.10.4), the blot was washed in
PBS/0.5% Tween-80 for 20 minutes in order to "block" any remaining reactive sites.
After incubation for 1 hour at room temperature in antibody solution (made up in
PBS/Tween-80). the blot was washed 4-5 times in PBS/Tween-80. If the primary
antibody was conjugated directly to horse radish peroxidase, the blot was incubated
in a solution of diaminobenzidine (20mL)/H2O2 (50juL). If the primary antibody
was unconjugated the blot was incubated for another hour in a solution of
conjugated anti-primary antibody before the addition of the DAB
(0.4mg/mL)/H202 (50/xL/20mL) solution. Blots were finally rinsed in distilled water
and blotted dry using 3mm filter paper. They were stored at room temperature in
the dark.
2.13. Deglycosylation of serpins.
Serpin molecules were deglycosylated as follows. An aliquot of serpin (20/xL
containing 1-2/xg of protein) in solution was pipetted into an Eppendorf tube
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(1.5mL). Deglycoslyation buffer (lOOmM potassium phosphate/lOOmM EDTA/5%
jS-mercaptoethanol/0.1% SDS, pH 7.5) was added to the protein solution. One unit
of glycopeptidase F (PNGaseF, Boehringer Mannheim) was added to each sample.
The mixture was incubated at room temperature for 18 hours. Analysis of Mr
change was by SDS-10%PAGE (Schagger and von Jagow, 1987).
2.14. Statistical Analysis
All analysis of variance was performed by the Minitab program. Linear
regression was performed by Excell version 4. All non-linear regression analysis was
performed by the DNRP53 program written by R.G. Duggelby, University of
Queensland.
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Chapter 3: Purification and Characterisation of rat
serpins
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3. Purification and Characterisation of rat serpins.
3.1.Introduction
3.1.1. Serpins in Rodents.
At least five plasma proteins in the rat belong to the serpin superfamily and
function as serpins (Kuehn et al, 1984). Studies on the genetics of rodents have
shown that there are at least two loci in the rat and mouse that contain genes
coding for serpins (Inglis and Hill, 1990). The primordial genes for a-l-PI and
ct-l-antichymotrypsin have undergone an extensive series of duplication events,
followed by genetic divergence. In the mouse, where more work has been done, the
two loci are called SPI-1 and SPI-2 (Serine Proteinase Inhibitors-1 and -2). Each locus
contains 8-12 genes. Sequence analysis of SPI-1 genes shows that their overall
structure is very similar to that of human a-l-PI (Inglis and Hill,1990). The gene
products of this locus are known to function as inhibitors of serine proteinases. The
SPI-2 locus contains genes which resemble that of human a-1 antichymotrypsin,
although no true rodent antichymotrypsin activity has been discovered to date.
More recently it has been shown that there are 5 different species of mRNA
from mouse that encode members of the ct-l-PI family (Borriello and Krauter, 1990).
These 5 species share between them 3 distinct reactive site residues at the PI
position: methionine, tyrosine and leucine. The changes govern the proteinase
specificity of these serpins.
The rat also has two loci with homologous genes (Inglis and Hill, 1990),
again broadly resembling human a-l-PI and human a-\ antichymotrypsin, although
there are only 4-5 genes at each locus.
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Attempts to purify serpin molecules from both mice (Takahara and Sinohara,
1982) and rats (Kuehn et al, 1984) have yielded interesting results. Concentrations
of a-l-PI are 4-5 mg/ml in mouse serum, and it is a monomeric glycoprotein (Mr
53,000) with inhibitory activity against trypsin, chymotrypsin and elastase.
Contrapsin (Mr 55,000), a product of the SPI-2 locus, is a murine serpin which
inhibits trypsin but has no activity against elastase or chymotrypsin. It is present
at slightly lower concentrations (2.8mg/ml) in serum, and is immunologically
distinct from a-l-PI.
In the rat, purification of serpins has yielded 3 polypeptides . These were
designated ct-l-PI, Rat proteinase Inhibitor I and Rat Proteinase Inhibitor II (RPI-1
and RPI-2). The Mr of a-l-PI was 55,000, and of RPI-1 and -2, 66,000 and 65,000,
respectively. The inhibitory spectrum of the three molecules was different: a-l-PI
inhibited trypsin, chymotrypsin and elastase, whereas RPI-1 inhibited trypsin and
chymotrypsin and RPI-2 inhibited trypsin only (Kuehn et al, 1984) .
Mouse serum will also inhibit mouse mast cell proteinases (Irvine et al, 1990).
Gel analysis in conjunction with Western blot analysis indicated the formation of
complexes in mouse serum (Mr 73,000) in the presence of mouse intestinal mast cell
proteinase. Serum also blocked the binding of 3H-DFP to mouse mast cell
proteinases, further indicating that the higher molecular weight components
detected by western blotting were formed by the interaction of proteinase and
serpin.
Such evidence indicated that the best way to obtain a preparation of rat serpin
which would inhibit RMCPI or II would be to use the proteinase as a "bait", allow
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a complex to form, and by purifying the proteinase, co-purify the serpin involved
in the formation of the complex.
Serpins account for 10%, by weight, of human serum protein (Travis and
Salvesen, 1983). Their solubility at physiological salt concentrations, relative
abundance and acidic pi, would suggest that they are relatively easy to purify.
However, there could be as many as 10-12 proteins expressed within the SPI loci
(vida supra). Furthermore rat serum albumin (50% of soluble serum protein) could
pose a serious problem for any purification schedule as it has a similar Mr and pi,
and could constitute a major contaminant in any preparation of purified serpins.
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3.2. Results
3.2.1. Purification of Serpins
3.2.1.1. Detection of serpins and of RMCPII-Serpin complex in Rat Serum Q
of the characteristics of serpins is the ability to form essentially irreversible
complexes with a target proteinase (Travis and Salvesen, 1983). Thus it should be
possible to detect a complex by discerning the proteinase component of the
complex. By an obvious extension of this thinking, the presence of complexes
containing proteinases indicates the presence of serpins with the ability to form
detectable complexes with the proteinases.
Because the proteinase of interest in this work was RMCPII, and it was by
no means certain that there were serpins capable of inhibiting this enzyme, it was
decided to titrate RMCPII into rat serum, and try to detect any complex formed
by immuno- staining of RMCPII.
Purified RMCPII (see Materials and Methods, Chapter 2) was titrated into
rat serum over a range of 0-1 mg/ml. After incubation for 60 min at 37°C an
aliquot (equivalent to 30/xg protein) of each sample was removed and subjected
to SDS-7.5% PAGE. The protein was transferred to nitrocellulose after
electrophoresis, and the blot was probed with anti-RMCPII antibody. In the
presence of serum, RMCPII formed multiple complexes which were visualised by
Western blotting (Figure 3.1); the most abundant serpin-enzyme complex
(RMCPII-serpin complex) had an approximate Mr of 79,000 suggesting that a








Titration of RMCPII into rat serum and detection of RMCPll-serpin
complex.
Lane A, rat serum. Lanes B-G, RMCPII titrated into rat serum at 100 , 200,
300 , 400 , 500, lOOOpg proteinase/ mL serum. Lane H, 250ng RMCPII.
Samples were electrophoresed on 10%SDS-PAGE (Laemmli, 1970),
transferred to nitrocellulose sheets as described (see Materials and
Methods, Chapter 2) and probed with anti-RMCPII antibody conjugated to
horse radish peroxidase. The band visualised at Mr 79,000 is RMCPII-
serpin complex. RMCPII migrates at 28,000.
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3.2.1.2. Purification of complex
The strategy adopted was to purify the complex, raise an antibody to it and
use this antibody to affinity purify free serpin from serum.
RMCPII (500 /xg) was added to 1 ml rat serum and incubated for 1 hr at
37°C. The serum was then applied to a Sepharose 4B anti-RMCPII affinity
column (see Materials and Methods). The bound fraction, eluted with 0.1 M citric
acid, and the buffer was exchanged on a PD-10 column (Pharmacia) equilibrated
with 20 mM Tris-HCl, pH 7.5 (buffer A). The protein fraction was applied to a
monoQ column equilibrated in buffer A and a major peak was eluted at 50 mM
NaCl using a continuous gradient of 0-0.3 M NaCl (figure 3.2).
This pH (7.5) was chosen because, in theory, the complex would have a pi
between that of the serpin (pI = 4-5), and the proteinase (pi >9.6, demonstrated by
chromatofocussing, data not shown). At pH 7.5 the complex should bind to
monoQ, but not too tightly.
This peak contained 95% pure RMCPILserpin complex (as estimated by
SDS-PAGE, Figure 3.3a) and could be visualised on Western blots using
anti-RMCPII antibody (figure 3.3b). RMCPILserpin complex was used to raise
polyclonal antibodies in rabbits.
3.2.1.3. Raising a polyclonal antibody to serpin
Polyclonal antibodies against complexes were prepared as described (see
Materials and Methods, Chapter 2). The titre of the antibody was assessed by
Ouchterlony double diffusion (Figure 3.4). Antiserum was stored at -20°C until
used. The characterisation of this antibody is in chapter 5.
Figure 3.2
Purification of RMCPII-serpin complex by ion-exchange
chromatography.
The affinity purified complex was further purified on a monoQ
column. The eguilibrating buffer was 20mM Tris-HCl, pH 7.5. A










Electrophoresis of purified complex.
Lane A, molecular weight standards (Bio-rad). Lane B, RMCPII-serpin
complex, purified as outlined in the text. Electrophoresis on 10%SDS-PAGE
was performed according to the method of Schagger and von Jagow (1987).
Proteins were visualised using Coomassie Blue.
Figure 3.3b
A
Western blot of purified complex.
Lane A, RMCPII-serpin complex, purified and electrophoresed as
described (see Materials and Methods, Chapter 2), was transferred
to Immobilon using the method of Matsudaira (1987). The blot was
probed with anti-RMCPII antibody conjugated to horse radish
peroxidase. The complex migrates at Mr 79,000.
Figure 3.4
Double diffusion assay of rabbit antiserum.
The central well (1) contains 5 pL RMCPll-serpin complex
(lOOpg/mL), and wells 2-7 contain 5pL of rabbit anti-complex
antiserum diluted 1/2-1/32. Precipitates were visualised with
Coomassie Blue.
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3.2.1.4. Affinity purification of anti-(serpin-RMCPII)-complex
antibodies
The polyclonal antiserum was applied to a RMCPII affinity column (12 mg
ligand/g matrix) to remove antibody specific to this enzyme. The unbound fraction
was eluted using PBS and applied to a column (5 ml, 2 mg ligand/g matrix) of
RMCPII-serpin complex-sepharose. The column was then washed with 2 column
volumes of PBS and bound antibodies were eluted with 1 ml of 0.1 M citrate buffer
(pH 2.2) were immediately neutralised by the addition of 1M Tris base (200 /til/ml).
The eluted antibody (Rabl a-RSI/11) was used to make an "anti-serpin"-sepharose
column (1.4 mg ligand/g matrix) as outlined in Materials and Methods.
3.2.1.5. Purification of serpins
From preliminary investigations it was apparent that the protein most likely
to bind to any affinity column was albumin. Subsequent experiments (data not
shown) demonstrated a pi of 4.5- 4.9 for rat serum albumin. Rat serum albumin has
a Mr of 55,000- 60,000. These two chemical characteristics were very similar to the
expected values for rat serpins and initial chromatographic steps would have to
remove a large proportion of the albumin.
A comprehensive study by Gianazza and Arnaud (1982) had shown that the
dye Cibacron blue could be used as an affinity ligand to bind serum albumin,
moreover, a variety of serum proteins were fractionated on a column composed of
Cibacron blue covalently attached to a weak anion exchange matrix. Such a material
was commercially available as Affi-Gel blue (Bio-rad).
Rat serum (0.5 ml) was applied to an Affi-Gel blue column (16 mm x 50
mm) equilibrated in 25 mM bis-Tris-HCl, pH 6.7 (buffer B) and the column was
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washed with this buffer in order to elute a-l-PI (Gianazza and Arnaud, 1982). The
protein eluted in the wash was then applied to a sepharose 4B affinity column (16
mm x 50 mm) with, as ligand, the cross-absorbed, affinity-purified rabbit
anti-rat serpin polyclonal (Rabl a-RSI/II). The latter was obtained from a rabbit
immunized with serpin-RMCPII complex. The bound serpin was eluted with 1 ml
0.1 M citric acid pH 2.2 and applied immediately to a G-25 sephadex column
previously equilibrated with buffer B. The eluted protein was applied to a monoQ
column equilibrated in buffer B and a continuous gradient of 0-0.3 M NaCl (10
mM/ml) was established (Figure 3.5), the eluted peaks 1 and 2 contained proteins
with Mr of 52,000 and 54,500, respectively (determined on Tricine SDS-10% PAGE,
Schagger and von Jagow, 1987) (Figure 3.6), which were respectively labelled rat
serpin I (RSI) and rat serpin II (RSII) (Figure 3.7).
3.2.2. Complex formation between rat serpins and rat mast cell proteinases.
Equimolar concentrations of serpin (20/xl x 150/rg/ml) and rat mast cell
proteinase (4/d x 400/^1/ml) (based on protein concentrations, see Materials and
Methods, Chapter 2) were incubated together for 5 min in an Eppendorf tube at
room temperature. The samples were then analysed by SDS-10%PAGE as described
(see Materials and Methods, Chapter 2) and the gel stained with Coomassie blue.
The experiment in which RMCPII was added to RSI or II showed the expected
staining of a novel band at Mr 75,000 indicating formation of complex which
remained stable in SDS (Figures 3.8). However, the effect of adding RSI or II to
RMCPI was unexpected, in that no higher molecular weight complex was formed
but instead two fragments could be detected (approx Mr 25,000 and 37,000, Figures
3.9).
Purification of RSI and RSII by ion-exchange chromatography.
Affinity purified rat serpin was applied to a monoQ column
previously equilibrated in 25mM bis-Tris-HCl, pH 6.7. A continuous
NaCl gradient was generated. The peak eluting at 80mM NaCl is RSI;
the peak eluting at 150mM NaCl is RSII.
Figure 3.6
mm migrated
Estimation of relatative molecular mass of RSI and RSII.
The Mrs of known standards were plotted against the distance migrated
from the top of the resolving gel (10%, SchSgger and von Jagow, 1987).
The distances migrated by RSI and RSII were measured and the Mr









Electrophoresis of purified rat serpins.
Lane A, molecular weight standards. Lane B, RSI (2pg). Lane C,
RSII (2pg). Proteins were visualised using Coomassie Blue.
Electrophoresis was performed according to the method of Schagger









Electrophoresis of rat serpins and RMCPH-serpin complex.
LaneA, molecularweight standards (Bio-rad). LaneB, purified RSI
(5pg). Lane C, purified RSII (5pg). Lane D purified RSI (5pg) +
purified RMCPII (2.5pg). Lane E, purified RSII (5pg) + purified
RMCPII (2.5pg). Note that Lanes D and E contain complex formed
between rat serpin and RMCPII. proteins were visualised using
Coomassie Blue. Electrophoresis was performed according to the
method of chagger and von Jagow (1987).
Figure 3.9





Electrophoresis of purified serpins and serpins cleaved by RMCPI.
Lane A, molecular weight standards (Bio-rad). Lane B, purified RSI
(2pg). Lane C, purified RSI (2pg) + RMCPI (200ng). Lane D,
purified RSII (2pg). Lane E, purified RSII (2pg) + purified RMCPI
(200ng). Note that the rat serpins are cleaved to two major
fragments with approximate Mr 25,000 and 37,000. RMCPI can be
seen in lanes C and E migrating at Mr 29,000. Protein was visualised
using silver stain.
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In order to extend these findings, RMCPI was titrated into rat serum and the
samples were electrophoresed on SDS-10%PAGE. The proteins were then
transferred onto Immobilon and the blot probed with anti-RMCPI antibody. As can
be seen (Figure 3.10) there are no higher molecular weight proteins detectable as
there are when serum is titrated with RMCPII (Figure 3.3). This demonstrates that
not only is RMCPI not inhibited by RSI or II, there does not seem to be a serpin
in serum capable of inhibiting RMCPI.
3.2.3. Sequencing of serpins
Sequencing of the two serpin molecules was an essential step in determining
the identity of both molecules. Were they the same molecule, the differences in Mr
being due to post translational modification, or were the two molecules distinct
products of separate genes?
Sequencing was performed on an Applied Biosystems pulsed liquid phase
machine (ABI477a). Samples were prepared for sequence analysis by
chromatography of 50/tg of protein on C-18 HPLC column, the largest peak was
subsequently sequenced. The Amino-terminal sequence data for RSI and II is
presented in Figure 3.11 where it is compared to the predicted amino-terminal
sequence data for rat a-l-PI derived from nucleotide sequencing (Chao et al, 1990).
RSI is identical to rat o-l-PI over the first 17 residues, whilst RSII differs
from RSI at the first residue only, where glutamic acid is replaced by threonine.
3.2.4. Glycosylation of serpins
Samples (2/xg) of purified RSI and RSII were incubated for 18 hours at room
temperature with 1 unit of PNGaseF (Boehringer Mannheim and see Materials and




Western blot of RMCPI titrated into rat serum.
Lanes A contains rat serum. Lanes B-G RMCPI titrated into rat
serum at lOOpg, 200pg, 300pg, 400pg, 500pg, and lmg
proteinase/mL rat serum. Lane H contains 250ng RMCPI. Proteins
were electrophoresed as described (Schagger and von Jagow, 1987)
and transfered to Immobilon. The blot was probed with ant-RMCPI
























































































Amino-terminal sequence of RSI, RSII and rat a-l-PI (Chao et al. 1990)
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Materials and Methods, Chapter 2) and the gel fixed and stained as described (see
Materials and Methods, Chapter 2). From the result (Figure 3.12) it is obvious that
both serpins are heavily glycosylated as both experience an apparent loss in Mr of
33%.
Figure 3.12







Deglycosylation of RSI and RSII
LaneA, Molecular weight standards (Bio-Rad). LaneB, RSI (500ng). Lane
C, RSI (500ng) after incubation with PNGaseF (see Materials and Methods,
Chapter 2). Lane D, RSII (500ng). Lane E, RSII (500ng) after incunation
with PNGaseF (see Materials and Methods, Chapter 2). Samples were




The work outlined above shows the presence of at least two members of the
rat serpin superfamily which will inhibit RMCPII by forming essentially irreversible
complexes.
The observation that no stable complex is formed between RMCPI and RSI
or II, but that RMCPI degrades both the serpins is surprising given the level of
homology between RMCPI and II. The inference from this observation is that the
activity of RMCPI must be modulated in a different way from that of RMCPII.
From the amino-acid sequence analysis it can be seen that the two serpin
molecules isolated are both likely to be transcripts of the SPI-1 locus in rats. This
finding is verified by the genetic evidence (Inglis and Hill, 1990; Borriello and
Krauter, 1990). RSI is most likely to be a-l-PI, whilst RSII is a variant of a-l-PI
(a-l-PIb). These divergent forms of the same protein are most likely to have arisen
as a result of a duplication/divergence event at the chromosomal level leading to a
family of genes, each member encoding a serpin with a different target proteinase
due to minor alterations in the region of the gene encoding the reactive site loop
portion of the protein and at the N-terminus.
Neither of the molecules purified seem, from the amino-acid sequence
analysis, to be a rat contrapsin, based on a comparison with the structure of mouse
contrapsin (Inglis and Hill, 1990; Takahara and Sinohara, 1982). Nor do they appear
to be RPI-1 or -2 (Kuehn et al, 1984). RPI-1 and -2 have Mr's of 66,000 and 65,000,
much larger than RSI and II, a discrepancy that is too large to be explained by
differences in SDS-PAGE. Also, RPI-2 is reported as inhibiting only trypsin out of
the proteinases tested (Kuehn et al, 1984); the inability of RPI-2 to inhibit
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chymotrypsin further discounts the possibility of it being RS-I or -II. It seems
unlikely that RPI-1 and -2 are products from the same gene family as RSI and II as
no protein in the correct range of Mr (65,000-66,000) was found to bind to the
affinity column used to purify RSI and II. No evidence of any proteinase inhibitory
activity except RSI and II was found to bind to the affinity column. The possibility
that low level mRNA transcripts encoding other members of the genes from the rat
SPI-1 locus may be translated cannot be ignored, but no significant concentrations
of other molecules were detected in this study.
There is a difference in the Mr of RSI and II of about 2,500. If this difference
is due to primary sequence then RSII is c.25 amino acids longer than RSI, but this
cannot be verified until complete amino-acid sequence is available. The difference
in Mr could be due to differences in glycosylation: serpins are glycosylated in
general and RSI and II are no exception (see Figure 3.11).
The presence of two forms of a-l-PI in rat serum gives rise to speculation
about the translation of other gene products from the SPI-1 locus. Are there low
levels of 4-5 ce-l-PI's in serum each with slightly different specificities? Or is there
a developmental role for serpins? In the mouse it is known that foetal levels of
serpins are 15% of adult levels, and it requires 25-30 days before adult levels are
reached in the neonate (Lamontagne et al, 1981). Is one of the products from the
SPI-1 locus a juvenile (in developmental terms) form of the inhibitor? Are some of
the genes translated only as acute phase proteins? It is hoped to provide answers to
these questions in the following chapters.
72
Chapter 4: General Thermodynamic and Kinetic
Considerations
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4. General Thermodynamic and Kinetic Considerations
4.1. Introduction
The kinetics which govern the interaction of a serpin and its target
proteinase determine whether the serpin is likely to be a good inhibitor in vivo
(Bieth, 1974; Boudier and Bieth, 1989, Smith and Johnson, 1985). Thus a serpin
might inhibit a proteinase in vitro but the rate of reaction may be deplorably slow,
rendering the serpin all but useless in vivo. Alternatively the dissociation rate
constant may be high resulting in an unstable complex with rapid inactivation of
available serpin as the proteinase complexes with the serpin, cleaves the Pl-Pl,'
bond and dissociates leaving a non-functioning serpin.
The minimal scheme describing the interaction of serpins and proteinase is:
k-ass
E + I - E: I
]s~
diss
Where E and I stand for proteinase and serpin respectively and kass and kdiss are the
association and dissocation rate constants respectively. The rate of association of E
with I is given by equation 1:
^f~=kass[E] [J] -kdlss[EI] (1)
If no significant dissociation of EI occurs during the association process, ie if the
association reaction is measured over a time period considerably shorter than the
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dissociation half life of the EI complex being studied, the second term of equation
1 can be neglected:
t-n (2)
Integration of equation 2 for [E]0 = [I]0 yields
m- o)
The concentration of E,[E], at any time can be found from the initial rates
of substrate hydrolysis. The association rate constant, kass, can be calculated by
non-linear regression analysis (using the DNRP53 program of R.G. Duggleby,
University of Queensland, Australia which fits experimental data to equation 3).
The K; of the reaction between E and I is defined as kdiss/kass, which is
equivalent to:
v _ IE] [J] mK'—mr ' 1
Where the concentrations are those at equilibrium. By substituting for [EI]
aild'"1"1'
[EI] = ( [E] a-[E] ) (5)
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[I] = [I]0-([E]0-[E]) (6)
(where [E]0 is initial enzyme concentration and [I]G is initial inhibitor concentration)
and re-arranging we get equation 7 (Bieth, 1974):
[.E]2 + (Ki+ll] a-[E] a) [£■] - K± -0 (7)
which can be solved:
[E] ( [E] 0-K±- [J] 0) + ( ( [E] 0-K±- [J] Q) 2+AKi . [E] a) 1/2
TeT0 2TWZ <8)
The constant K; can thus be determined experimentally by reacting E with
increasing amounts of I for 30 mins, followed by addition of substrate and the
measurement of residual proteinase activity. The rate of steady state substrate
hydrolysis is used to determined [E] for a given [I]Q. The fractional activity,
([E]/[E]0), can then be used to determine the substrate-dependent K; by fitting the
data to equation 8 using non-linear regression analysis.
The rate constant which applies to the dissociation of the SEC, kdiss, can be




4.2.1. Titration of proteinases and serpins
RMCP II, RMCP I and chymotrypsin were active-site titrated as described
(Kezdy and Kaiser, 1970) using Cbz-L-Tyr-ONp as titrant, and trypsin was titrated
with p-nitrophenyl-p'-guanidinobenzoate HCl as titrant (Chase and Shaw, 1970) .
All serpins were back-titrated against RMCP II as follows; RMCP II (36 nM) was
incubated with various amounts of purified serpin. After 5 min the residual activity
of the proteinase was measured using Cbz-L-Tyr-ONp as substrate, absorbances at
410 nm were measured. Fractional proteinase activity ([E]/[E]0) was plotted against
I (mL) and the concentration of the serpin determined from the x-axis intercept of
the extrapolated line through the experimental data.
4.2.2. of RSI and RSII
Equimolar amounts of proteinase and serpin (both active-site-titrated) were
incubated in a test-tube. After a period of time (0-3 min), 50 fil aliquots were
removed and added to a cuvette containing 950 yu.1 of substrate in PBS (12.5 yuM
Cbz-L-Tyr-ONp for chymases, 125 /iM BAPNA for trypsin) to measure the
residual activity of the proteinase. This experiment was performed with two
molarities of RMCP II: 9nM and 24nM. Molarity of chymotrypsin was 9.5 nM and
molarity of trypsin was 6.25 nM. No inhibition of RMCPI was observed, therefore
kass and K; could not be derived.
To derive an estimate of the k^,., the values of [E] obtained were plotted as
1/[E] against time. This plot allows a line with the equation
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to be drawn. The estimate of k^ derived from this manipulation was used in the
DNRP53 program to derive a value of kass from non-linear regression analysis. Plots
of typical experiments are shown (Figure 4.1), the theoretical curve (equation 3)
fitted to experimental data can be seen in figure 4.2.
4.2.3. K; of RSI and RSII with RMCPII
A standard concentration ofRMCP II (36 nM) was incubated with increasing
concentrations of serpin for 30 min at room temperature. The incubation mixture
was then analysed for residual proteolytic activity using Cbz-L-Tyr-ONp (final
molarity 100 /iM). All measurements were made in a centrifugal analyser with a





allowed a straight line to be drawn, the equation of the line is given by
^ .Ju[£]
1-a a
The gradient of this line can be used as an estimate for the K^, which can
then be used to derive a more accurate value of from the DNRP53 program. An
example of this linear plot is shown in figure 4.3.
Figure 4.4 shows an example of an experiment in which the
substrate-dependent Kj was determined in this way and a theoretical curve (equation
8 ) drawn through experimental data for the reaction between RMCP II and RSI
Figure 4.1
Time (seconds)
Plot of 1/[E] (enzyme activity) as a function of time.
The proteinase (RMCPII) is incubated with a serpin, in this case RSII, and
aliquots are assayed at the times specified on the x-axis. The slope of this
line, derived by linear regression, provides an estimate of kass. This
estimate was used in the DNRP53 program of Duggleby (see text) which
derives more reliable estimates of kinetic constants by an iterative, non¬
linear process (see text and Figure 4.2).
Figure 4.2a
0 60 120 180 240 300
TIME (seconds)
Determination of kasii between RSI and RMCPII.
RMCPII was incubated with equimolar concentrations of RSI and residual
enzyme activity (•) was assayed at times specified on the x-axis. The
theoretical line (-) was fitted by non-linear regression using the DNRP53
program. Derived values are tabulated (Table 4.1a).
Figure 4.2b
0 60 120 180 240 300
TIME (seconds)
Determination of kass between RSII and RMCPII.
RMCPII was incubated with equimolar concentrations of RSII and residual
enzyme activity (•) was assayed at times specified on the x-axis. The
theoretical line (-) was fitted by non-linear regression using the DNRP53









24 48 72 96 120
TIME (seconds)
Determination of k„8 between RSI and chymotrypsin.
Chymotrypsin was incubated with equimolar concentrations of RSI and
residual enzyme activity (•) was assayed at times specified on the x-axis.
The theoretical line (-) was fitted by non-linear regression using the
DNRP53 program. Derived values are tabulated (Table 4.1a).
Figure 4.2d
Determination of kas, between RSII and chymotrypsin.
Chymotrypsin was incubated with equimolar concentrations of RSII and
residual enzyme activity (•) was assayed at times specified on the x-axis.
The theoretical line (-) was fitted by non-linear regression using the
DNRP53 program. Derived values are tabulated (Table 4.1b).
Figure 4.2e
0 60 120 180 240 300
TIME (seconds)
Determination of kasE between RSI and trypsin.
Trypsin was incubated with equimolar concentrations of RSI and residual
enzyme activity (•) was assayed at times specified on the x-axis. The
theoretical line (-) was fitted by non-linear regression using the DNRP53




0 60 120 180 240 300
TIME (seconds)
Determination of kass between RSII and trypsin.
Trypsin was incubated with equimolar concentrations of RSII and residual
enzyme activity (•) was assayed at times specified on the x-axis. The
theoretical line (-) was fitted by non-linear regression using the DNRP53
program. Derived values are tabulated (Table 4.1b).
Figure 4.3
Plot of I/(l-a) as a function of 1/a.
The proteinase (RMCPII) was incubated with increasing concentrations of
serpin (I) and fractional enzyme activity (a) measured (see text). The
slope of this line, derived by linear regression, provides an estimate of Ks.
This estimate was used in the DNRP53 program of Duggleby (see text)
which derives more reliable estimates of thermodynamic constants by an













Determination of K1app between RSI and RMCPII.
RMCPII was incubated with increasing concentrations of RSI [I] and
residual enzyme activity (•) was plotted as a function of [I]. The
theoretical line (-) was fitted by non-linear regression using the DNRP53




















Determination of Kiapp between RSII and RMCPII.
RMCPII was incubated with increasing concentrations of RSII [I] and
residual enzyme activity (•) was plotted as a function of [I]. The
theoretical line (-) was fitted by non-linear regression using the DNRP53
program (see text). Derived values are tabulated (Table 4.1b).
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and RSII. The substrate-dependent K; (K;app) can be converted to the true K; by using
equation 10:
gaPP
The Km for the RMCP II/Cbz-L-Tyr-ONp system was measured
independently by classical means ( Hanes plot) and found to be 2.46 /*M in the
buffer conditions used for all experiments described. All values of K; are tabulated
(Table 4.1).
4.2.4. kdiss RSI and II in complex with RMCPII




As can be seen from table 4.1, RSI and II are efficient inhibitors of RMCPII,
trypsin and chymotrypsin. The values of kass derived are _>_105 M4s4; this is typical
of serpin-proteinase interactions (see Table 4.2). It should be noted that these
association constants are 100-fold less than the figures expected of a serpin and its
target proteinase such as o-l-PI and elastase (6.5 x 107M4s4), or a-1-
antichymotrypsin and cathepsin G (5xl07M4s4 ,Beatty et al, 1980) . Therefore it is
unlikely that either of the serpins isolated here have RMCPII as a specific target
proteinase.
However, it can be seen that the association constant between RSII and
bovine chymotrypsin is of the order of 106 M4s4. This is a particularly intriguing
finding given that a specific rat antichymotrypsin has yet to be described, although
it should be noted that this figure is similar to the constant derived for the
interacton of bovine chymotrypsin and human a-l-PI (5.9 x 106, Beatty et al,
1980).Nonetheless the kass between RSII and chymotrypsin is 5 fold greater than the
constant between RSI and chymotrypsin, suggesting the possibility of different PI
residues. Studies (Rubin et al, 1990) have shown the marked differences in
association constants that arise as a result of changes to the PI residue. Changing
the leucine at residue 358 on a-l-antichymotrypsin to arginine results in a 1000-fold
increase in the association constant for trypsin and a 20-fold decrease in the
association constant for bovine chymotrypsin. The structural homologue of human
antichymotrypsin in rodents is contrapsin which exhibits inhibitory capacity
towards trypsin alone (Takahara and Sinohara, 1982) . Rodent serpins from the a-\-
PI locus (SPI-1) have at least three reactive site PI residues between them (Krauter
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and Boriello, 1990) ; methionine, the classic antitrypsin PI residue; leucine, the
classic antichymotrypsin PI residue; and tyrosine. This suggests that gene products
from the SPI-1 locus have diverged thus allowing a range of proteinases to be
targeted by proteins translated from the same gene cluster. However, given the
range of serine proteinases that individual serpins can inhibit it would be foolish to
speculate on the nature of the PI residues in the rat serpins isolated based on kinetic
data alone.
The nanomolar K; of RSI and RSII for RMCPII indicates their efficiency as
inhibitors in vitro (Smith and Johnson, 1985). Obviously the efficiency of RSI and
II as inhibitors in vivo depends on the concentrations of these molecules in body
fluids and tissues. Complexes formed between RSI and RMCPII have a half life of
2.4 hours, whilst the figure for RSII and RMCPII is 1 hour. Evidence (Pizzo et al,
1988) exists to suggest that the clearance time of complexes from the body is of the
order of 1-2 hours. From the kinetic data presented here it would seem that RSI,
when compared to RSII is the better inhibitor of RMCPII . There might be an
inhibitor which has a better inhibition constant for RMCPII ( RSI-RMCPII = 3.6 x
10"10M) but it is obviously not present in concentrations great enough to have an
effect on the level of RMCPII in serum. Certainly it is not present in quantities
which allow its purification. This is not to deny the importance of low level potent
inhibitors of serine proteinases. From the data presented here, RSI would seem to
have the most important role in the inhibition of RMCPII. High levels of RSI in
serum during anaphylactic shock may be enough to compensate for the average
association constant discussed (vida supra). Levels of RSI and II in rat tissues will be
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discussed below, as will the effect of parasitic infection on the levels of these acute-
phase proteins.
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Table 4.1a Kinetic data for RSI
Enzyme V^ass ^diss K, ti/2d
M'V1 s"1 M hr
RMPCI NI NI NI NI
RMCPII 2.2 x 105 7.92 x 10"5 3.6 x 10"10 2.4
chymotrypsin 6 x 105 ND ND ND
trypsin 4.13 x 105 ND ND ND
Table 4.1b Kinetic data for RSII
Enzyme Kss ^diss K; ti/2d
M'V1 s"1 M hr
RMPCI NI NI NI NI
RMCPII 1.65 x 105 1.65 x 10"4 1.0 x 10"9 1.2
chymotrypsin 3.17 x 106 ND ND ND
trypsin 6.68 x 105 ND ND ND
S[D- not determined, NT not inhibited
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Table 4.2
Values for kass between various serine proteinases and serpins















human antichymotrypsin2 6 x 104
human chymotrypsin human antichymotrypsin2 1 x 104
human cathepsin G human antichymotrypsin2 5 x 107
'Rubin, iRubin, H., Zhi, M. W.,Nickbarg, E., McLarney,
3. , Naidoo, N. , Scheonberger, 0. L. , Johnson, J. L., and
Copperman, B. S. (1990) Journal of Biological Chemistry 265 1199-
1207.
aBeatty, iBcatty, K., Bieth, J., and Travis, J. (1980)
Journal of Biological Chemistry 255 3931-3934
84
Chapter 5: Generation and Characterisation of
Antibodies.
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5. Generation and Characterisation of Antibodies.
5.1 Introduction
When studying the biochemical and physiological properties of a protein, it
is of paramount importance to have an assay method which will allow detection of
the protein in a variety of circumstances. Many proteins, especially enzymes, can
be detected by monitoring a chemical reaction and other, such as serpins by
monitoring the decreased activity of a target proteinase. However many enzyme
families can display overlapping substrate specificities and most serpins will inhibit
more than their "target" proteinase. More specific techniques are, therefore, required
to identify and quantify serpins in complex biological samples such as plasma or
tissue homogenates.
Antibodies can surmount many of the aforementioned problems. An
antibody can detect a protein in a variety of tissue sources. Polyclonal antibodies
allow detection of antigenically similar proteins. The specificity can be improved
by affinity purifying antibody preparations using a specific antigen as ligand.
Monoclonal antibodies, although highly specific, must be used in conjunction with
another antibody if quantification of antigen by sandwich ELISA is the aim. A
single monoclonal antibody can be used in a competition ELISA, but one needs a
ready supply of antigen. The multivalent nature of polyclonal antibodies can lead
to the formation of lattices of antigen and antibody, leading to precipitation of the
antibody-antigen complex. This property of polyclonal antibody preparations allows
for the development of Radial ImmunoDiffusion assays (RID). Directly labeled
antibody preparations can be used to probe Western blots, or it can be used to
localise antigens in immunocytological studies.
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Antibodies can also be used to affinity purify antigen rapidly and efficiently.
Antibodies can also prove useful in the screening of expression libraries, leading to
the elucidation of gene sequence data.
Many antibody preparations raised against one member of a family of related
proteins will cross react with all members of the family, or even structurally similar
but functionally dissimilar proteins (Lafferty et al, 1991). This very cross reactivity
can, however, be extremely useful in the elucidation of phylogenetic relationships.
Selection of a unique peptide as antigen can increase to specificity of the antibody
preparation.
Antibodies have been employed extensively in the study of serpins. The
localisation of protease nexin-I, a potent inhibitor of urinary plasminogen activator
(u-PA) and thrombin, to the amyloid plaques found in Alzheimers patients was
achieved with antibodies specific for protease nexin-I. Western blotting studies
subsequently localised this serpin in the cerebro-spinal fluid of normal individuals
(Festoff et al, 1989). Further immunocytochemical studies showed that an
antigenically similar molecule was found in mouse skeletal muscle. The molecule
co-localised with acetylcholine receptor clusters at synaptic neuro-muscular
junctions, implicating protease nexin-I in the remodeling events that occur in
synapse formation and elimination (Festoff et al, 1991).
Antibodies have also been employed in the quantitation of serpins in a
variety of species. Electro-immunoassay was utilised to determine the concentrations
of a-l-PI and contrapsin in mice (Takahara and Sinohara, 1981), the antibody
prepartion was whole antiserum raised against mouse ct-l-PI. LaMontagne et al,
(1981) implemented rocket immuno- -electrophoresis and ELISA to determine
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concentrations of ctl-PI in mouse serum and a variety of other biological fluids. The
ELISA, based on a sheep polyclonal antibody raised against purified mouse a-l-PI
was used to assay bronchoalveolar lavage, and a concentration of 65/rg a-l-PI/lung
was reported. Detectable concentrations of a-l-PI were reported in amniotic fluid,
bile, breast milk and gastrointestinal washings. The ontogeny of a-l-PI in mice was
also monitored.
A monoclonal antibody against a novel epitope of human a-l-PI has been
shown to detect certain disease conditions (Silvestrini etal, 1990). The concentration
of human cc-l-PI was estimated to be 0.4mg/mL using this antibody in ELISA.
Further evidence from the same group suggested that the epitope on a-l-PI
recognised by this monoclonal antibody is only present on 19% of cn-l-PI isoforms;
the true concentration of a-l-PI in serum is nearer to 2-3mg/mL. The effects of diet
on a-l-PI concentrations was investigated in rats using a radial immunodiffusion
assay (RID) with a rabbit anti-rat a-l-PI antiserum to quantify this serpin in control
and experimental animals (Lewis et al, 1985). This study reported concentrations of
1.9mg a-l-PI/mL in normal rats.
Antibodies have also been essential in the elucidation of tissue distribution
of mast cell proteinases (and by extension the distribution of mast cell populations)
in the rat, mouse and sheep (Woodbury and Neurath, 1978; Woodbury and Miller,
1981; King et al, 1986; Huntley et al, 1990b; Newlands et al, 1987; Huntley et al,
1987). Antibodies were instrumental in determining the effects of parasite infection
on concentrations of mast cell proteinases. In these latter studies the technique
utilised was ELISA analysis.
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In this present study the aim was to detect and quantify serpin
concentrations in a variety of rat tissues and in serum. A polyclonal antibody (Rabl
a-RSI/II) had been raised against RMCPII-serpin complex (see chapter 3). This
antibody preparation had been used as an affinity ligand in the subsequent
purification of RSI and II (see chapter 3). It was reasoned that the best approach to
developing a sandwich ELISA, to quantify serpin concentrations, would be to raise
monoclonal antibodies. In order to raise a panel of antibodies directed againstnative
and cleaved serpins mice were immunised with mouse mast cell proteinase Ie in
complex with RSII. Since mouse mast cell proteinase Ie would not be antigenic
antibodies would most probably be raised against epitopes unique to cleaved serpins
and against native serpin. Antibodies detecting cleaved serpin (ie serpin in complex
with proteinases), should not react with uncleaved serpin and vice versa. In this
way, it was hoped to quantify complexes and serpins in traumatised rats. Uncleaved
serpin was also used as antigen in the attempt to generate monoclonal antibodies.
For reasons which will be dealt with below it was also necessary to generate
further polyclonal antibody preparations. The following studies describe the
generation and characterisation of the polyclonal and monoclonal antibody
preparations utilised in Chapters 6 and 7 to detect and quantify serpin
concentrations in rat serum and tissues.
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5.2 Results
5.2.1. Rabbit Polyclonal anti—rat serpin:RMCPII complex antibody
A rabbit was immunized with RMCPII—serpin complex as described in
Materials and methods (see Chapter 2). By double diffusion, immuno-precipitation
occurred at dilutions of 1/32 (Figure 3.4) and following a further immunization the
rabbit was bled out fourteen days later, the anti—serum was collected in 5mL
aliquots and stored at —20°C. Antibody specific to RSI/II (Rabl a-RSI/II) was
purified as described in chapter 3.
5.2.2. Specificity of the rabbit polyclonal antibody.
Normal rat serum and serum from N. brasiliensis infected animals was
electrophoresed on polyacrylamide gels under reducing conditions (see Materials and
Methods, Chapter 2) and the resolved proteins transferred to Immobilon as
described (see Materials and Methods, Chapter 2). The blot was probed with Rabl
ct-RSI/II conjugated to horse radish peroxidase (Po) (see Materials and Methods,
Chapter 2). Rabl a-RSI/II-Po detects a protein(s) that co-migrates with uncleaved
rat serpins (Figure 5.1) in control rat serum.
5.2.3. Mouse Monoclonal anti—(cleaved rat serpin) antibody
To generate further probes, attempts were made to raise monoclonal
antibodies specific for RSI. Mice were immunized with RSI (100/zg) and after 4
weeks and a further immunization spleen cells were obtained and hybridomas were
generated (see Materials and Methods, Chapter 2). However, hybridomas did not
survive for more than 72 hours, and no successful fusion was detected. The fusion
partner, NS-0 cell line, may have been responsible for the failure of this experiment








Specificity of Rabl a-RSI/II
Normal rat serum was electrophoresed under reducing conditions (tridLne
buffer system) and protein was transferred to Immobilon as described (see
Materials and Methods, Chapter 2). The blot was probed with Rabl a-
RSI/H-po. The darkly staining band is rat serpin. Note the staining of
bands at apparent Mr 72,000 and 25,000.
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A fresh source of NS-0 cells was obtained and a second attempt to raise
monoclonal antibodies was made. The antigen was complex formed between RSII
and mouse mast cell proteinase-lE (MMCP-IE), an isoform of the soluble
chymotrypsin-like proteinase from murine intestinal mast cells (Newlands et al,
1993). Complex formation between RSII and MMCP-IE was shown by SDS-PAGE
after incubation of varying concentrations of RSII and MMCP-IE at room
temperature for 5 minutes (Figure 5.2). Since a structural rearrangement of the
serpin is believed to occur at complex formation, it was reasoned that this would
provide novel epitopes, and that MMCP-IE would not be immunogenic. Some
epitopes generated by complex formation would therefore be specific for complex,
and certain antibodies that recognised novel epitopes generated by complex
formation would bind to cleaved RSII but not to native serpin. This approach
would possibly allow development of a complex-specific ELISA.
Three Mice were immunised intra peritoneally with 100fig of RSILMMCP-
1E. The animals were further immunised with 100/xg of antigen at 3 and 5 week
intervals and spleen cells obtained as described (see Materials and Methods, Chapter
2). The hybridoma fusions were plated out in 96 well plates and assayed every 2—3
days by ELISA using RSII-MMCP IE as coating antigen (see Materials and
Methods, Chapter 2). Four hybridoma cultures tested positively for RSILMMCP-1E
reactivity, but only one clone retained reactivity with the antigen after 5 days. This
culture was sub—cloned 3 times and used to generate ascitic fluid in mice as









Formation of RSII-mouse mast cell proteinase Ie complex
Lane A,molecularmass standards (Bio-Rad). Lane B, purified RSII (1pg).
Lane C, RSII (lpg) + MMCP Ie (0.5pg). Proteins were electrophoresed
according to the method of Schagger and von Jagow, 1987. Note the
presence of RSH-MMCP Ie complex in lane C. MMCP Ie migrates at Mr
26,000. Proteins were visualised using Coomassie Brilliant Blue.
91
5.2.4. Specificity of the mouse monoclonal antibody
5.2.4.1. ELISA
Supernatant from the third sub—clone was tested for antigenic reactivity by
ELISA. The results of this assay (Figure 5.3) suggest that the monoclonal antibody
(MAbl) binds RSI and II only when they are complexed to a serine proteinase, in
this instance RMCPII. Uncleaved RSI and II do not bind to the antibody. The
antibody binds to RSII in complex with MMCP-1E, as the hybridoma cultures were
selected on this criterion.
5.2.4.2. . Western Blotting.
The specificity of the MAbl was further analyzed by Western blotting.
Normal rat serum was electrophoresed on a polyacrylamide gel under reducing
conditions (see Materials and Methods, Chapter 2). The proteins were transferred
to Immobilon as described (see Materials and Methods, Chapter 2) and the blot was
probed with MAbl-Po (Figure 5.4a). Under these conditions MAbl recognises
uncleaved serpin. The specificity of MAbl was also determined on Western blots
of non-reducing gels. Control serum, serum taken 14 days after infection with N.
brasiliensis and purified RMCPILserpin complex were electrophoresed under non
reducing conditions, and the subsequent blots probed with MAbl-po (Figure 5.4b).
This result demonstrates that MAbl-po can be used to detect, if not quantify,
complex under certain conditions.
5.2.5. Sheep polyclonal anti—rat serpin antibody.
Attempts to use a combination of Rabl a-RSI/II and the mouse monoclonal
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Dilution of Monoclonal antibody
Cross reactivity of MAbl
Antigen was bound to polystyrene plates as described (see Materials
and methods. Chapter 2). The supernatant from the 3rd subclone
was of the monoclonal antibody was then added to the wells in a
series of 10-fold dilutions as indicated on the x-axis. the colour
reaction was generated by adding a sheep anti-mouse antibody
conjugated to horse radish peroxidase, and the OPD substrate,
MAbl is cross reactive with RSI-RMCPII complexes (+-+) and RSII-
RMCPII complexes (x-x) under these conditions. It does not react
with uncomplexed RSI (■-■) or RSII (D-D). Reasons for the higher









Specificity of MAbl antibody
Normal rat serum was electrophoresed under reducing conditions (tricine
buffer system) and protein was transferred to Immobilon as described (see
Materials and Methods, Chapter 2). The blot was probed with MAbl-po.
The darkly staining band is rat serpin.
Figure 5.4b
A B C
Specificity of MAbl antibody.
Lane A, Normal rat serum. Lane B, Serum from a rat taken 14 days after
primary infection. Lane C, purified RS-RMCPII complex. Samples were
electrophoresed under nonreducing conditionsand theproteins transferred
to Immobilon as described (seeMaterials and Methods, Chapter 2). The blot
was probed with MAbl-po. Note the staining of complex in lane B.
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A second polyclonal antibody was raised. A sheep was immunised with RSI. After
4 weeks antiserum was tested by Ouchterlonie double diffusion, against a solution
of RSI. A precipitin arc was detected at an antiserum dilution of 1/2 (Figure 5.5a).
The animal was given a second immunisation and bled again 4 weeks later. The
antiserum was again assayed by double diffusion. A precipitin arc was visible at an
anti—serum dilution of 1/32 (Figure 5.5b). Antiserum (200mL) was drawn from
the animal and frozen in lOmL aliquots.
Sheep antibody was affinity purified against RSI/II-RMCPII complex as
described (see Materials and Methods, Chapter 2). Purified antibody (Shi a-RSI/II,
2mg/mL) was stored at —20°C in lOOptl aliquots.
5.2.6. Specificity of sheep polyclonal antibody by Western Blotting.
The specificity of Shi a-RSI/II was determined byWestern blot analysis. Rat
serum was transferred from a reducing gel to Immobilon and the blot was probed
with Shi a-RSI/II-po. The result (Figure 5.6) shows a protein(s) migrating at Mr
approximately 54,000.
5.2.7. Development of Capture ELISAs
The availability of 2 polyclonal antibodies and one monoclonal antibody
permitted a choice of 8 different capture ELISAs. As has already been mentioned
(vide supra) the assay wherein antigen was captured by Rab 1 a-RSI/II and detected
by MAbl was not successful. The likely reason is that Rabl cc-RSI/II and MAbl
recognise a common epitope.
Attempts to capture with MAbl were not successful, possibly because the
antibody was not affinity purified from the ascitic fluid. Thus, attempts to coat an
Figure 5.5a
Double diffusion assay of sheep anti-RSII antiserum.
The central well (1) contains 5pL of RSII (lOOpg/mL). Wells 2-7 contain 5pL
of sheep anti-RSII antiserum diluted 1/2-1/32.
Figure 5.5b
Double diffusion assay of sheep anti-RSII antiserum
The central well contains 5pL RSII (100pg/mL), and wells 2-7 contain 5 pL








Specificity of Shi a-RSI/II antibody
Normal rat serum was electrophoresed under reducing conditions (tricine
buffer system) and protein was transferred to Immobilon as described (see
Materials and Methods, Chapter 2). The blot was probed with Shi a-
RSI/II. The darkly staining band is rat serpin.
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ELISA plate with MAbl would not have resulted in a high enough concentration
of antibody to be effective as a capture antibody.
This left 5 antibody combinations, of which it was decided to investigate
further ELISA (1) with Shi a-RSI/II as the capture antibody andMAbl as detection
antibody, ELISA (2) with Shi a-RSI/II capture antibody and Rabl a-RSI/II for
detection, and ELISA (3) with Rabl a-RSI/II as the capture antibody and Shi a-
RSI/II for detection.
5.2.7.1. ELISA (1) employing Shi a-RSI/II as the antigen capture antibody and
MAbl as the antigen detection antibody.
Microtitre plates were coated with Shi a-RSI/II at a concentration of
1/xg/mL. A broad range of concentrations of RSI and II was used to generate a
standard curve. Captured antigen was detected with MAbl-Po. The results (Figure
5.7) suggest RSII is detected with a greater sensitivity than RSI. The apparent bias
is greater than 5-fold with respect to RSII detection.
5.2.7.2. ELISA (2) employing Shi a-RSI/II as the antigen capture antibody and
Rabl a-RSI/II as the antigen detection antibody.
Microtitre plates were coated with Shi a-RSI/II (1 /xg/mL). A broad range
of concentrations of RSI and II was used to generate a standard curve. Captured
antigen was detected with Rabl a-RSI/II-Po. This ELISA (Figure 5.8) is also biased
towards detection of RSII, although the sensitivity of detection is only 2.5-fold
greater for RSII. This is less than the > 5-fold sensitivity that ELISA (1) displays
(see Figure 5.7). The colour generation in this ELISA was lower than for ELISA (1)






















Detection of purified serpins by ELISA 1
Polystyrene plates were coated with Shi a—RSI/II polyclonal antibody
(lpg/mL) then washed and blocked as described (see Materials and
Methods, Chapter 2). Serial dilutions of RSI (■) and RSII (□) were
incubated in the wells for an hour. The plates were washed and captured
antigen was detected by MAbl conjugated to horse radish peroxidase and
reacted with OPD (a peroxidase substrate). Colour generation is plotted
as a function of serpin concentration. This assay is biased towards
detection of RSII.
Figure 5.8
Detection of purified serpins by ET .ISA 2
Polystyrene plates were coated with Shi a-RSI/H polyclonal antibody
(lpg/mL) then washed and blocked as described (see Materials and
Methods, Chapter 2). Serial dilutions of RSI (■) and RSII (□) were
incubated in the wells for an hour. The plates were washed and captured
antigen was detected by Rabl a-RSI/II-Po and reacted with OPD (a
peroxidase substrate). Colour generation is plotted as a function of serpin
concentration. This assay is biased towards detection of RSII.
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5.2.7.3. ELISA (3) employing Rabl a-RSI/II as the antigen capture antibody and
Shi a-RSI/II as the antigen detection antibody.
Microtitre plates were coated with Rabl a-RSI/II (1/rg/mL). The same
concentration range of RSI and II was used as in the previous experiments.
Captured antigen was detected with Shi a-RSI/II-Po. This ELISA was again biased
towards detection of RSII, the bias being approximately 10-fold in favour of RSII
(Figure 5.9).
5.2.7.4. Further purification of rabbit and sheep polyclonal antibodies.
All of the ELISAs investigated display a bias towards the detection of RSII.
From the purification studies of Chapter 3 it is known that RSI and II are present
in serum, but the ratios are unknown. Any assay system that shows greater
sensitivity towards one of the serpins in rats will give grossly incorrect results when
used to quantify serpin concentrations, particularly if RSI and II are not present in
approximately equal ratios.
An attempt was made to minimise the bias towards RSII seen in the ELISAs.
Antibodies from rabbit and sheep antisera were affinity purified using RSI-sepharose
4B or RSII-sepharose 4B. All sheep antibodies that bound to RSI-sepharose 4B
subsequently bound to RSII-sepharose 4B, suggesting that RSI and II have a similar
epitope that is recognised by the sheep antiserum. It was possible to obtain antibody
preparations from rabbit antiserum that bound to RSI-sepharose 4B but not to RSII-
sepharose 4B (Rab2a a-RSI) or vice-versa (Rab2b a-RSII).
5.2.7.5. ELISA 4
When Rab2a a-RSI and Rab2b a-RSII were used as antigen capture
antibodies in ELISA it became apparent these antibodies (Rab2a a-RSI and Rab2b
Figure 5.9
Detection of purified serpins by ELISA 3
Polystyrene plates were coated with Rabl a-RSI/II polyclonal antibody
(lpg/mL) then washed and blocked as described (see Materials and
Methods, Chapter 2). Serial dilutions of RSI (■) and RSII (□) were
incubated in the wells for an hour. The plates were washed and captured
antigen was detected by Shi a-RSI/H-Po and reacted with OPD (a
peroxidase substrate). Colour generation is plotted as a function of serpin
concentration. This assay is biased towards detection of RSII.
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a-RSII) were cross reactive with both RSI and RSII (data not shown). However
ELISA (4) employing Rab2a oRSI as the antigen capture antibody with Shi a-
RSI/II-Po for detection proved to recognise RSI and RSII with only a 2-fold bias
towards RSI (Figure 5.10). This was the lowest partiality observed to date. Rab2a
cc-RSII was not a good capture antibody; colour generation was very reduced with
Shi q:-RSI/II-Po for detection.
ELISA (4) was used to quantify serpin concentrations in rat serum and tissue
samples in control rats and helminth infected rats (see Chapter 6) because of this
low bias. Mabl was used to probe Western blots of samples electrophoresed on
nonreducing gels as it appeared to demonstrate the highest specificity.
Figure 5.10
Detection of purified serpins by ELISA 4
Polystyrene plates were coated with Rab2 a-RSI/II polyclonal antibody
(lpg/mL) then washed and blocked as described (see Materials and
Methods, Chapter 2). Serial dilutions of RSI (■) and RSII (□) were
incubated in the wells for an hour. The plates were washed and captured
antigen was detected by Shi a-RSI/II-Po and reacted with OPD (a
peroxidase substrate). Colour generation is plotted as a function of serpin
concentration. This assay is biased towards detection of RSI, however the
degree of bias is less than that evident in ELISA's 1,2, and 3.
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5.3 Discussion
Apart from Rabl a-RSI/II, which was raised to facilitate the purification of
rat serpins, the main purpose in generating the antibodies characterised in this study
was to expedite the detection and quantification of serpins and serpin complexes in
plasma and tissues. To this end it was imperative that the antibodies should be
highly specific for their target antigens. Only one antibody (Shi a-RSI/II) was
raised specifically against uncleaved serpin. This antibody was shown to be specific
for serpins by Western blotting (Figure 5.6). Rabl a-RSI/II was raised against
RMCPILserpin complexes and, by removing cross reactivity against RMCPII, it was
possible to obtain a preparation that was specific for serpins by Western blotting.
More importantly this antibody preparation was used to affinity purify RSI and
RSII. Thus two serpin-specific antibody preparations were available to develop
ELISA's.
The quantification and detection of serpins is complicated by the presence
of uncleaved serpin and serpin complexed to proteinases in biological samples. Many
workers are aware of the limitations of immunological techniques. In order to
quantify ATIILfactor IX complexes in human blood (Takahashi et al, 1991), it was
necessary to remove free ATII by absorbtion onto barium citrate. Complex was
then detected with a combination of ATIII antibodies and factor IX antibodies.
Further complications can arise if the epitope on the serpin or proteinase is
obscured when the molecule is in a complex. Kurokawa et al (1991) have described
a monoclonal antibody directed against tissue type plasminogen activator (tPA)
which will not bind to tPA complexed to plasminogen activator inhibitor 1 (PAI-1).
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An antibody with specific binding to a free proteinase can be used to quantify free
proteinase.
MAbl was generated against RSILMMCPIe with the goal of developing an
ELISA specific for complex, this approach was partially successful. Uncleaved serpin
bound to a plate is not detected by MAbl, complexed serpin is detected (Figure 5.3).
However, MAbl will detect uncleaved serpin when used to probe Western blots of
gels run under reducing conditions (Figure 5.4a), the antibody will also detect
uncleaved serpin and complexed serpin when used to probe Western blots made
from nonreducing gels (Figure 5.4b).
Uncleaved serpin captured in an ELISA (1) by Shi a-RSI/II was detectable
with MAbl. This was unexpected as MAbl was presumed to be complex specific,
detection of uncleaved serpin by Western blotting was conjectured to be a result of
the appropriate epitope being exposed by electrophoresis and blotting. The fact that
complex was undetected under reducing conditions was thought to be due to steric
hindrance by the proteinase component of the complex, hindrance that was not so
critical under nonreducing conditions. It may be that the conformation of the
serpimproteinase complex is subtly altered when bound by Shi a-RSI/II, and this
change is enough to allow MAbl access to its epitope.
An additional problem with ELISA (1), was the bias towards detection of
RSII. This bias was also noted when Rabl a-RSI/II was used to detect antigen
captured by Shi a-RSI/II (ELISA (2)). This suggests that the sheep antibody may
have a higher affinity for, and an inherent bias towards RSII. Using Rabl a-RSI/II
as capture antibody and Shi a-RSI/II as detection antibody further exacerbated this
bias. Further evidence of this inherent bias was found in radial immunodiffusion
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assays using sheep antiserum (data not shown). It was decided to try and isolate RSI
and RSII specific antibodies from the affinity purified rabbit (Rabl ct-RSI/II) and
sheep (Shi o-RSI/II) antibody preparations. This resulted in the production of
rabbit antibodies which bound to RSI-Sepharose 4B (Rab2 a-RSI) or RSII-Sepharose
4B (Rab2 a-RSII). Rab2 a-RSI antibodies were used as capture antibodies in ELISA
(4), with Shi a-RSI/II used as the detection antibody. Sheep antibodies that bound
to RSI-Sepharose 4B also bound to RSII-Sepharose 4B, indicating that RSI and RSII
had similar epitopes that would bind to Shi ct-RSI/II. ELISA (4) was deemed to be
the most suitable as there was good colour development, and minimal bias towards
RSI. The lack of bias was crucial to the choice of ELISA. Approximately equal
masses of RSI and II were obtained from each purification procedure and this is the
limit of the information regarding the ratios of RSI and II at present. ELISA (4)
would be used to quantify serpin concentrations in helminth infected rats. If the
serpins should be differentially expressed as a result of such an infection, a biased
assay would only distort the true picture.
ELISA (4) would quantify serpin and serpinrproteinase complexes in plasma
and tissue homogenates. Although detection of complex, distinct from serpin, was
possible by probing Western blots of nonreducing gels, it was not possible to
quantify serpin:proteinase complex unequivocally. It may be possible to develop a
specific ELISA for complex using anti-RMCPII antibody as a capture antibody, and
serpin antibody as a detection reagent, or vice versa. Such ELISA's have been
developed for the detection of neutrophil elastase and elastase:a-l-PI complexes
(Hamaguchi et al, 1991).
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The difference between concentrations determined by ELISA (4), and a
complex-specific ELISA would obviously provide a more accurate value for
uncleaved serpins. Such an ELISA would also be very useful in determining that
fraction of RMCPII which is inactive and bound to serpin, when used in
conjunction with a RMCPII specific ELISA.
In conclusion, three antibody preparations were successfully raised against
serpins. All of these were shown to be serpin specific by Western blotting analysis
of serum. MAbl was capable of detecting complex under certain conditions. ELISA
(4) was able to detect RSI and II with a slight bias towards detection of RSI, but this
was lower than the bias towards RSII apparent in ELISAs (1), (2), and (3). No assay
capable of quantifying complex alone was developed, although such an assay should
be possible by utilising antibodies specific for cognate proteinases in conjunction
with serpin specific antibodies. Equipped with such techniques it was decided to
investigate the distribution of serpins in a variety of tissues and in plasma (see
chapter 6).
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Chapter 6: Serpins as Acute Phase proteins in
Helminth Infection
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6. Serpins as acute phase proteins in Helminth infection
6.1. Introduction.
6.1.1 The acute phase response.
Inflammation comprises a series of cellular changes, which can facilitate
phagocytosis and elimination of microorganisms. This is followed by proliferation
of connective tissue cells and repair of the intracellular matrix. Both events require
the complex control of various cell types at a local level. The constellation of
systemic responses that accompany trauma and inflammation, regardless of cause,
is termed the acute phase response.
There are approximately 30 plasma proteins in the acute phase response.
They are all produced in increased amounts in the liver in inflammation. When
classified according to function it is clear that they all have roles to play in
inflammation or the healing process that follows (Kushner and Mackiewicz, 1987).
The serpins a-l-PI and a-l-antichymotrypsin are part of this response, with 2-4 fold
increases in production during the response (Kushner and Mackiewicz, 1987). There
are also negative acute phase proteins, which include albumin and prealbumin.
There is little evidence that these negative acute phase proteins play an active part
in inflammation and the reduced concentrations may simply reflect redistribution
in the extravascular space (Ballantyne et al, 1973).
The serpins involved in the acute phase response are primarily concerned
with modulating the activity of the cellular proteinases released during infection. In
man, a-l-PI inhibits leucocyte elastase and a-antichymotrypsin inhibits granule
derived cathepsin G.
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6.1.2. The Acute Phase Protein Response in Helminth Infection in Rodents.
In a study to determine the effects of infection with Trichinella spiralis on
the hepatic responses it was discovered that this parasite does not elicit the acute
phase response (Stadnyk et al, 1990). Similarly, intestinal infection with N.
brasiliensis, did not elicit a response although infection via the cutaneous route,
which involves a stage in the lung, did elicit the acute phase response. This and the
results with T. spiralis suggest that intestinal helminth infections do not invoke
systemic hepatic responses.
6.1.3. Mast Cell Proteinases in the Gut during parasite infection.
Rat Serpins I and II inhibit RMCPII and mouse intestinal mast cell
proteinase, but not RMCPI (see chapters 3, 4 and 5). If these serpins have a
physiological role to play in modulating the activity of mast cell proteinases, then
it might be a beneficial evolutionary trend to have both serpins and proteinases
expressed in the same tissues.
There are detectable concentrations of serpins in liver, lung and serum
(Travis and Salvesen, 1983). The concentrations ofRMCPII in liver (8.27/rg/g tissue)
and lung (ll^ig/g tissue) have been quantified (Huntley et al, 1990b) but most
RMCPII is located in the gastrointestinal tissues (Table 6.1).
Enteric RMCPII is within mast cells of the mucosal and submucosal layers
of the tissue (Gibson et al, 1987). In fact >98% of enteric mast cells stain
exclusively for RMCPII. As a result RMCPII is almost the exclusive mast cell
proteinase in the gut from the duodenum to the colon (Gibson et al, 1987). There
are also substantial concentrations of RMCPII in the gastric and rectal mucosae
(Gibson et al, 1987).
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During intestinal nematodiasis there is recruitment of mast cells in the
gastrointestinal mucosa, as discussed (see chapter 1). This recruitment is coincident
with the presence of increased concentrations of RMCPII in serum in the rat and
the expulsion of the parasite from the host (see chapter 1). Similar events also occur
in mice after infection with the parasite T. spiralis (Huntley et al. 1990a). The
distribution ofMMCP-I, like RMCPII, is predominantly in the gastrointestinal tract
of normal mouse (Huntley et al, 1990a). After infection with the parasite T. spiralis,
the concentrations of MMCP-1 (at day 10) increase 30-fold in the stomach, 4,000-
fold in the duodenum, 2,000-fold in the jejunum, 2,000-fold in the ileum and 1,000-
fold in the colon (Huntley et al, 1990a) when compared with values in uninfected
controls.
6.1.4. The effect of N. brasiliensis on the expression of rat serpins.
Although the modulation of concentrations of RMCPII by nematode
infection is well documented (see section 6.1.3) the specific effect of infection on the
serpin inhibitors of RMCPII is not. In this chapter the acute phase response was
investigated by measuring the concentration of rat serpins.
The strategy was to examine the concentrations of serpins in serum and then
to quantify serpins in tissues which had been extensively perfused to remove plasma
proteins. This approach would possibly detect tissue specific serpins, if they existed.
The techniques employed, Western blot analysis and ELISA with the antibody
preparations discussed in Chapter 5, would allow not only the quantification of
serpin concentrations in serum and perfused tissue, but would also render the
identification of distinct, yet antigenically similar proteins possible. Non denaturing
gel electrophoresis was used to analyse the serum and perfused tissue samples. This
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technique was chosen as MAbl would not detect complexed serpin under reducing
conditions (data not shown) but would detect complex in serum from rats infected
with N. brasiliensis (Figure 5.5).
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6.2 Results
6.2.1. Concentrations of Serpins in normal rat tissues and serum.
The first stage of this study involved determining the concentrations of
serpins in normal rats. The ELISA (4) employing Rab2a ct-RSI as the capture
antibody and Shi a-RSI/II as the detection antibody made no distinction between
RSI & II, (see chapter 5).
Serum samples were taken from control animals prior to whole body
vascular perfusion as outlined (see Materials and Methods, Chapter 2). Perfused
tissues were treated as described (see Materials and Methods, Chapter 2). All samples
were assayed by ELISA (4) using RSI as the standard protein. The results are
tabulated (table 6.1).
Table 6.1 Concentration of serpins in serum and perfused rat tissues.
Sample Mean (n = 5) Standard error
Serum 3 mg/mL 0.17mg/mL
Liver 76.9 /ig/g 12.5/xg/g
Lung 54 jig/g 7-5/xg/g
Stomach 69.5/xg/g 9.4/xg/g
Small intestine 48/rg/g 7.07/xg/g
Large intestine 14.1/tg/g 3.02/xg/g
The highest concentration ol serpin molecules is located in plasma. The liver
contains the highest concentration of serpins compared with the other perfused
tissues assayed.
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6.2.2. Effect of N. brasiliensis infection on the concentrations of serpins in
tissues and serum.
Animals were infected with TV. brasiliensis as described (see Materials and
Methods, Chapter 2) and were killed, and their vasculature perfused. Tissues were
removed and homogenised for analysis at 7,9 and 14 days after primary infection.
The tissues were assayed for serpins by ELISA (4) using RSI as the standard protein.
The data is tabulated (Table 6.2). The effect of TV. brasiliensis on each tissue is
displayed as a histogram in Figure 6.1.
Figure 6.1a
Concentration of serpins in rat serumat different times after infection with
N. brasiliensis.
Serum samples were assayed using ELISA 4. Boxes show the SEM.
Figure 6.1b
Day post-infection
Concentration of serpins in rat liver at different times after infection with
N. brasiliensis.
Hepatic homogenates were assayed using ELISA 4. Boxes show the SEM.
Figure 6.1c
Day post-infection
Concentration of serpins in rat lung at different times after infection with
N. brasUiensis.
Pulmonary homogenates were assayed using ELISA 4. Boxes show the SEM.
Figure 6.1 d
Day post-infection
Concentration of serpins in rat stomach at different times after infection
with N. brasiliensis.
Gastric homogenates were assayed using ELISA 4. Boxes show the SEM.
Figure 6.1 e
Day post-infection
Concentration of serpins in rat small intestine at different times after
infection with N. brasiliensis.
Intestinal homogenates were assayed using ELISA 4. Boxes show the SEM.
Figure 6.1f
Day post-infection
Concentration of serpins in rat large intestine at different times after
infection with N. brasiliensis.
Intestinal homogenates were assayed using ELISA 4. Boxes show the SEM.
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Table 6.2
Concentrations (mean _+ SE, n = 5) of serpins in Rat serum (mg/mL) and
tissues (/tg/g wet weight) following infection with N. brasiliensis.
Sample Day 0 Day 7 Day 9 Day 14
Serum1 3±0.17 7.7+.0.58*" 4.8 + 0.42" 3.8+.0.17
Liver2 76.SD12.5 96.5^20.2 29.5^4.4* 42.+11.44*
Lung2 54 + 7.5 280.+ 35*" 892.5^40.5*** 290^48*"
Stomach2 69.5j+9.4 50.25^+7.5 108±32.4 61+.5.5
Small
Intestine2
48^7.05 217.5^34.5*" 140+.11.5" 58.7+.16.5
Large
Intestine2
14.1+.3.02 95.5^27.5*** 97.5+:35.4*" 32±4.2"
1. mg/mL serum, 2./xg/g wet weight tissue, * significant difference p<0.05, **
significant difference p<0.01, *** significant difference p< 0.001. Significance is
measured in relation to control sample (day 0).
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There are significant increases in concentrations of serpins in serum 7
(p< 0.0001) and 9 (p< 0.001) days after infection (Table 6.2, Figure 6.1a) with a
return to normal values by day 14. The analyses of liver (Table 6.2, Figure 6.1b)
show a slight, but insignificant, rise in concentration by day 7 of infection, with a
significant decrease below control values on day 9 and 14. The response in lung
(Table 6.2, Figure 6.1c) involved a highly significant (p< 0.001) increase in serpin
concentration by day 7 and a further increase by day 9 of infection. At day 14
concentrations are returning to normal, although they are still significantly higher
than in controls. There is no significant change in the stomach (Table 6.2, Figure
6.Id), but increases occurred in small (Table 6.2, Figure 6.1e) and large intestine
(Table 6.2, Figure 6.If). In both organs, the concentrations increase by day 7 to
values significantly (p < 0.001) greater than those in control rats (450% and 700%
respectively), are maintained until day 9, and then return to control values by day
14 of infection. The % increase in concentrations in pulmonary and gastrointestinal
tissue is greater than the increase in plasma concentrations.
6.2.3. Analysis of samples by non-denaturing electrophoresis and Western
blotting.
In order to determine whether the serpins in these samples were all of the
same molecular weight, and whether complexed serpin was detectable, samples
were subjected to non denaturing electrophoresis (see Materials and Methods,




The blot of serum proteins (Figure 6.2a) probed with MAbl shows
distinctive changes in the profile of serpins. The sample taken from rats at day 7 of
infection shows a slight downward shift in Mr, although the intensity of the band
appears unaltered. It is possible to detect an immunoeactive polypeptide in the
higher Mr range (approximate Mr 75,000) at days 7, 9 and 14. This is likely to be
complexed serpin. There are high levels of RMCPII (a target proteinase for rat
serpins) in serum at this point in the infection (Miller et al, 1983) although
concentrations of RMCPII are measured in /xg/mL rather than mg/mL (Huntley
et al, 1992).
Liver
The analysis of hepatic homogenates (Figure 6.2b) shows the presence of
immunoreactive protein(s) that migrate at the same Mr as complex. There is not
sufficient free serpin to be detected by this method. The apparent concentrations
of complex appear to increase over the course of the infection. An additional band,
approximately 5000-10,000 Da. heavier than complex is immunoreactive in these
samples. The identity of this band is unknown, although it may be a serpin
(translated because of the infection) in complex with proteinase. The other
possibility is that the serpins in the liver undergo a modification in glycosylation,
accounting for the dissimilarity in Mr. In the samples from days 9 and 14 of
infection there are also immunoreactive bands at a Mr > 100,000.
Lung
Homogenates of lung (Figure 6.2c) also display increasing concentrations of





Detection of serpin and serpin proeinase complex in rat serum after
infection with N. brasiliensis
Lane A, normal serum. Lanes B-D, serum samples from days 7,9,and 14
after infection with N. brasiliensis. Proteins were elctrophoresed under
nonreducing conditions and transferred to to Immobilon as described (see
Materials and Methods, Chapter 2). The blots were probed with MAbl-po
antibody. Note the change in intensity and Mr of the serpin as the infection
proceeds. Note also the appearance of protein migrating with a similar Mr
to complexed serpin as the infection progresses.
Figure 6.2b
serpin
Detection by Western blotting of serpin and serpin proeinase complex in
hepatic homgenates after infection with N. brasiliensis.
Lane A, homogenate of control liver. Lanes B-D, hepatic homogenates from
days 7,9,and 14 after infection with N. brasiliensis. Proteins were
elctrophoresed under nonreducing conditions and transferred to to
Immobilon as described (see Materials and Methods, Chapter 2). The blots
were probed with MAbl-po antibody. Note the apparent absence of serpin
as the infection proceeds. Note also the appearance of two immunoreactive




Detection by Western blotting of serpin and serpin proteinase complex in
pulmonary homgenates after infection with N. brasiliensis.
Lane A, control pulmonary homogenate. LanesB-D, pulmonary homogenates
from days 7,9,and 14 after infection with N. brasiliensis. Proteins were
electrophoresed under nonreducing conditions and transferred to to
Immobilon as described (see Materials and Methods, Chapter 2). The blots
were probed with MAbl-po antibody. Note the presence of serpin-
proteinase complex in all samples analysed. An immunoreactive polypeptide
co-migrating with rat serpin is visible in all the samples. This protein
increases in intensity as the infection progresses.
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homogenates also contain the immunoreactive protein migrating with an apparent
Mr of > 100,000.
Stomach, small and large intestine.
Analysis of gastric and of small and large intestinal homogenates shows the
presence of protein(s) with the same mobility under non reducing conditions as
complex purified from rat serum titrated with RMCPII (Figure 6.2d). It is also
possible to see what may be a free serpin, particularly in homogenates from the
small intestine. The free serpin would appear to have a slightly higher Mr than RSI.
Concentrations of free serpin in stomach and large intestine, quantified by ELISA,
are such that they may be undetectable by blotting. There does not appear to be
any protein migrating with a Mr > 100,000 in these samples.
So as to further characterise the immunoreactive proteins with similar
mobility to RMCPII-serpin complex, serum and perfused thoracic tissue
homogenates were subjected to non reducing electrophoresis and the gels were
blotted. These blots were probed with anti-RMCPII antibody.
Pulmonary homogenates displayed an immunoreactive protein, with a similar
mobility to RMCPII-serpin complex (Figure 6.2e). Thus, some component of the
complex in lung at day 14 of infection is RMCPII-RSI/II complex. No
immunoreactive proteins were detectable in serum or liver homogenates (data not
shown), although this could be because the concentrations of these proteins are
below the limit of detection by this technique.
6.2.4, Albumin levels in homogenates.
In order to be sure that the serpins detected in various tissues were derived
from those tissue and were not residual plasma proteins following incomplete
Figure 6.2d
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Detection by Western blotting of serpin and serpin proteinase complex in
gastrointestinal homgenates after infection with N. brasiliensis.
Lane A, control gastric homogenate.Lanes B-D, gastric homogenates from
days 7,9,and 14 after infection with N. brasiliensis. Lane E, control small
intestinal homogenate. Lanes F-H, small intestinal homogenates from
7,9,and 14 days after infection with N. brasiliensis. Lane I, control large
intestinal homogenate. Lanes J-L, large intestinal homogenates 7,9, and
14 days after infection with N. brasiliensis. Proteins were electrophoresed
under nonreducing conditions and transferred to to Immobilon as described
(see Materials and Methods, Chapter 2). The blots were probed withMAbl-
po antibody. Note the presence of serpin-proteinase complex in all samples
analysed. In the small intestinal samples (Lanes E-H) the intensity of these
serpin bands appears to rise and decrease during the course of the
infection. An immunoreactive polypeptide migrating slightly above rat
serpin is visible in all the samples.
Figure 6.2e
A B
Detection by Western blotting of RMCPII-serpin complex in pulmonary
homgenates after infection with N. brasiliensis.
Lane A, purified RMCPII-serpin complex- Lane B, pulmonary homogenate
14 days after infection wityh N. brasiliensis. The proteins were
electrophoresed under nonreducing conditions and protein was transferred
to Immobilon as described (see Materials and Methods, Chapter 2). The blot
was probed with anti-RMCPII antibody, conjugated to horse radish
peroxidase.
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perfusion, albumin concentrations were compared in perfused tissue and in plasma
from control and infected rats. Bromophenol blue was added to all of the samples
and the difference in absorbance between 600nm and 575nm was measured. The
data are presented as percentage of serum albumin concentrations at the time of
infection. The serum dilution curves are shown in Figure 6.3, and the data are
presented in Figure 6.4.
The only organ that displays a notable change in albumin levels is the liver.






control -e- day 7 day 9 day 14
Binding of Bromophenol blue by rat serum albumin at different times after
infection with N. brasiliensis
Serum was diluted as indicated on the x-axis. Samples were taken from
control animals (■), 7 days after primary infection (□), 9 days after
primary infection (*) and 14 days after primary infection (as). Note the
decrease in binding of the dye in all infected samples, indicating a
decrewase in albumin concentration. This may be due to the negative acute


























V//A Liver B Lun9 •touch
| email intestine 1 1 large intestine
14
Albumin concentrations in tissues after whole body vascular perfusion
displayed as a percentage of serum albumin concentration.
The albumin concentration was determined as described in the text. Each




The results of this study indicate that the concentration of plasma serpins in
control rats is approximately 3mg/mL. This is in excellent agreement with the
values reported by other workers (Takahara and Sinohara, 1981; LaMontagne et al,
1981; Lewis et al, 1985). This value is also very similar to the serpin concentration
reported in human plasma (Silvestrini et al, 1991).
Previous studies (LaMontagne et al, 1981) have indicated the presence of
serpins in various fluids in the body, notably bile, breast milk, bronchiolavage fluid
and gastrointestinal washings. Although the serpins in these fluids were shown to
be electrophoretically heterogeneous, it was hypothesised that this was due to post-
translational modification. The source tissue of all the serpins quantified was
postulated to be the liver. The serpins in rodent gut were believed to have been
transported to that location in bile, secreted from the liver.
The present investigation of serpins aimed to eliminate plasma-, and, by
extension, liver-derived serpins by perfusing the vasculature. Although perfused liver
contained the greatest concentrations of serpins (as quantified by ELISA) of all the
perfused tissues assayed, there were appreciable serpin concentrations in all of the
other organs. The gastric and gastrointestinal homogenates contained over 100/xg
serpin/g wet weight tissue (Table 6.1).
Infection of rats with the helminth N.brasiliensis significantly alters the serpin
concentration in plasma (p< 0.001), lung (p< 0.001) and small and large intestine
(p < 0.001). Previous reports (Stadnyk et al, 1990) have shown that N.brasiliensis will
elicit an acute phase response in rats if allowed to follow its normal course of
infection. The sites that the parasite resides in all show significant increases in serpin
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concentration as a result of infection. The data presented here are in broad
agreement with the data of Stadnyk et al (1990), who reported a 200-500% rise in
a variety of serum proteins of hepatic origin by day 8 of N. brasiliensis infection,
with a return to normal protein concentrations by day 10-14 of infection.
Concentrations of serpins increase significantly in the sites where mast cell
recruitment and increases in concentrations of RMCPII occur following infection
with N. brasiliensis (see section 1.2.8 for references). Mast cell recruitment in
response to intestinal nematodiasis occurs principally in the intestinal mucosa, and
lung (Arizono et al, 1987; Mayrhofer et al, 1976; Taliaferro and Sarles, 1939).
Analysis of the Western blots of serum show the increase in staining
intensity of an immunoreactive protein that co-migrates with complex (Figure 6.2a)
as the infection proceeds. The appearance of this protein may correlate with
increased RMCPII concentrations, resulting in complex formation in plasma. The
blot also shows slight Mr shifts in the densely staining polypeptide that co-migrates
with serpin. This may be the result of altered glycosylation events (LaMontagne et
al, 1981).
Further analysis of the serpins in perfused organs, by Western blotting,
indicated that only pulmonary homogenates contained immunoreactive polypeptides
that migrated in SDS-PAGE in an identical fashion to plasma serpins (Figure 6.2c,
Lane b). It is known that alveolar macrophages will synthesise serpins (Downing et
al, 1985), and this might explain the relatively high concentration of serpin found
in lung. Both hepatic and pulmonary homogenates contained immunoreactive bands
that migrated more slowly than plasma serpins (Figure 6.2b, lane b and 6.2c, lane
b). These "heavier" bands had a similar mobility to proteinase-complexed serpin.
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Further analysis of the putative complex in pulmonary homogenates, by probing
blots with anti-RMCPII antibody, reveals that this protein does indeed contain
RMCPII. On both blots (Figure 6.2c, lane E and Figure 6.2e), this complex migrates
with an apparent Mr that is less than complex derived from plasma serpins,
implying that the serpin component of this complex is of a different Mr from
plasma serpins. This putative complex also appears to increase in density as the
infection proceeds. Concentrations of RMCPII in pulmonary tissue increase by
almost 2000% to > 100/xg/g on day 9 of infection (Huntley et al, 1992). The
concentrations of serpins in lung at this time would be sufficient to modulate
locally-released RMCPII and evidence presented here does suggest a RMCPII
component to at least some complexed serpin detected in lung by western blotting
(Figure 6.2e). Thus, rat serpins may have a role to play in the lung in the
modulation of mast cell proteinase activity.
Western blots of pulmonary and hepatic homogenates also showed the
presence of immunoreactive proteins migrating with apparent Mr in excess of
100,000. These proteins were absent in serum samples analysed in the same way.
The identity of these bands is unknown, but their absence from serum is intriguing.
The densest staining bands in gastric and intestinal homogenates exhibited
a reduced mobility on non-reducing PAGE. In figure 6.2d (lanes B, F and J) it is
possible to discern an immunoreactive protein that migrates more slowly than
plasma serpin as well as the more obvious band that migrates fractionally faster than
complex. It is tempting to classify these slow immunoreactive proteins as complexed
serpin of some form, and the faster bands as serpins, as they display antigenic
similarity to plasma serpins. There have been reports of altered electrophoretic
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mobility of serpins in rodents (Lewis et al, 1985). This phenomenon was shown to
be due to microheterogeneity in carbohydrate content, caused by protein deficiency.
The altered a-l-PI contained more sialic acid and consequently was more acidic.
The variation in Mr could also be due to local synthesis of serpins in the gut,
proteins translated from different genes on the serpin locus would not all have
identical masses. There is evidence that the a-l-PI gene is expressed in a human
intestinal epithelial cell line (Perlmutter et al, 1989). The tissues and organs
investigated were all perfused prior to homogenisation. The levels of albumin
present in the perfusates were less than 5% of serum albumin concentrations as
adjudged by the albumin assay (Figure 6.4), lending further credence to the
hypothesis that novel, locally synthesised, serpins are visualised in these
experiments.
Gastric and intestinal homogenates displayed a slight rise in albumin
concentrations by day 7 of infection. This may be a result of increased permeability
at these sites because of the increased concentration of RMCPII (see King and
Miller, 1984).
Western blot analysis of gastric and gastrointestinal homogenates also
indicates that the immunoreactive protein with the greater Mr is the predominant
immunoreactive band in these homogenates. This protein has a similar Mr to
RMCPII-serpin complex. It is possible to detect immunoreactive bands in small
intestinal homogenates that display a slightly slower mobility when compared to
serpin. The density of the immunoreactive proteins appears to vary with the
infection. This variation indicates a rise at day 7 and 9 with less densely staining
proteins at day 14 and in control animals. This pattern correlates well with the
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ELISA data presented in this work. However there is some doubt as to whether the
ELISA (which employs two polyclonal antibody preparations, affinity purified as
discusses in Chapter 5) detects these slower migrating immunoreactive proteins. The
patterns of intensity of staining in the Western blots do not correlate well with the
ELISA data, except the small intestinal homogenates. The apparent continual rise
in density of the RMCPII-serpin complex in pulmonary homogenates is not
reflected in the ELISA data. A possible explanation is that the apparent increase in
intensity of the detected proteins is due more to post translational modifications,
rather than increased synthesis of serpin alone. The Western blots are of
nonreducing gels, glycoproteins can migrate as a broad band under these conditions.
Increased glycosylation of a protein would appear as a broader band on a gel or
blot. The band width in each lane of each blot does appear to broaden as infection
time increases, possibly as a result of increased glycosylation.
In earlier studies of rodent infection with N. brasiliensis it has been shown
that the message to trigger the acute phase response arose from the site of
inflammation, in particular from alveolar macrophages (Lamontagne et al, 1984).
Alveolar macrophages from infected rats secrete increased amounts of IL-6 and IL-1
(Gauldie et al, 1987; Lamontagne et al, 1985). Whether the serpin acute phase
response is part of the general response as mediated by cytokines or is mediated by
the mast cell proteinase release or indeed by another factor derived from mast cells
is unknown at present. Stadnyk et al (1990) favours a dual response; one in skin and
lung mediated by cytokines from macrophages, and a separate intestinal response.
This theoretical intestinal response must either be induced as a result of the skin and
pulmonary response or be induced locally in the sites where the parasite resides. It
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is known that elevated concentrations of elastase will induce macrophages to
synthesise and secrete a-l-PI (Perlmutter et al, 1988). This induction of serpin
synthesis by a target proteinase is hypothesised to be mediated by the receptor
believed to bind serpin-proteinase complex. It is possible that RMCPII can also
mediate such a response in macrophages or other cell types, although no evidence
exists of such a phenomenon. The evidence of Stadnyk et al, (1990) for a dual
response is that intestinal only infection with N. brasiliensis does not elicit the
serum and lung response seen in this present study, although such an infection will
still immunize the recipient against a challenge infection (Ogilvie, 1965). Thus,
stimulation of intestinal macrophages alone is not enough to trigger the systemic
acute phase response.
The evidence presented in this work suggested that serpins located in the
lungs and small intestine had different Mrs compared to plasma serpins. It was
unknown whether these molecules were locally synthesised or whether the
differences in electrophoretic mobility were due to post-translational modification.
It was decided to purify these molecules in an attempt to resolve these issues. The
next chapter of this thesis deals with the preliminary results of these investigations.
118
Chapter 7: Preliminary studies of tissue specific
serpins
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7. Preliminary studies of tissue specific serpins in rat.
7.1 Introduction
The serpin molecules detected by Western blot analysis of hepatic and
pulmonary homogenates (Figure 6.2b and c) display a different electrophoretic
mobility to the serpin molecules detected in plasma (Figure 6.2a). A difference in
electrophoretic mobility is also apparent in gastrointestinal homogenates (Figure
6.2d). Although there are reports of electrophoretic differences due to variation in
glycosylation (Lewis et al, 1985) in traumatised rats, there are also differences in the
nature of the serpin response reported in this work (see Chapter 6). The increase
in concentration of serpins is not found in all the sites assayed, eg the intestinal
response is markedly different from that of the stomach. The timing of the increase
also varies from tissue to tissue. The increase in serpins in pulmonary homogenates
peaks 7 days after infection with N. brasiliensis, and then begins to return to
control values (Table 6.2 and Figure 6.1c). The increase in serpin concentrations
appears to be sustained in small and large intestine 7 to 9 days after primary
infection with the parasite (Table 6.2 and Figures 6.1e and f). As all assays were
performed on perfused tissue homogenates this evidence points to the existence of
locally synthesised serpins.
Although serpins are found predominantly in plasma (Travis and Salvesen,
1983; and this work, Chapter 6) and are synthesised in the liver, there is also
evidence that cells other than hepatocytes can and do synthesise serpins. Using
RNA blot and dot hybridisation, a-l-PI mRNA was detected in human peripheral
blood monocytes and in bronchoalveolar and breast milk macrophages, but not in
T or B lymphocytes (Perlmutter et al, 1985). The a-l-PI synthesised by these cells
120
is secreted in a functionally active form, as evinced by complex formation with
serine proteinases (Perlmutter et al, 1985).
Further evidence of a pulmonary source of a-l-PI was provided by Greening
et al (1985) suggesting that macrophages may modulate the proteinase/proteinase
inhibitor balance in the macrophage microenvironment.
Local synthesis of serpins may occur in other sites in man. For example a
single 1.6 kilobase a-l-PI-specific mRNA was found (Perlmutter et al, 1989) in
human jejunum and in a human colonic epithelial tumour cell line, Caco2. The
mRNA was identical in size to that found in human HepG2 cells, but smaller than
the message in macrophages in which an alternative upstream transcriptional start
site is used (Perlino et al, 1987). The synthesis and secretion of the peptide in Caco2
cells reveals a protein with Mr 52,000. Results of these experiments provide further
evidence for the hypothesis that expression of the a-l-PI gene in different cell types
is controlled by distinct regulatory factors.
As there is only one known gene encoding a-l-PI in man, it seems likely
that Kb differences in message and Mr differences in secreted peptide would be due
to alternative initiation of translation and splicing, and alternative post-translational
modification. In other species however, novel inhibitors have been discovered in
peritoneal macrophages. Remold-O'Donnell and Lewandrowski (1983) report the
presence of two inhibitors of serine proteinases in peritoneal macrophages of the
guinea pig. One of these proteins formed complexes with Mr 78,000 and was
subsequently shown to be a-l-PI by immunological criteria. The other protein was
termed MPI (Macrophage Proteinase Inhibitor). This second inhibitor formed
complexes with Mr 66,000, suggesting a smaller inhibitor than a-l-PI. As well as
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inhibiting elastase, this protein was secreted constitutively in cultured macrophages,
whereas a-l-PI was not.
It is known (Inglis and Hill, 1990) that there is more than one gene
encoding a-l-PI in the rat Spi-1 locus. The possibility exists that the serpins
synthesised in lung and intestine in the rat are transcribed/translated from genes
other than those expressed in hepatocytes.
To test this hypothesis it was decided to further characterise serpins from
lung and intestine. The first stage in this characterisation involved the attempted
purification of serpins from rat lung and small intestine. The purification protocol
was based on the affinity column, with Rabl a-RSI/II as the ligand, utilised in
Chapter 3. Purification of serpins would allow preliminary sequence data to be
obtained and hopefully a more positive indication of the inhibitory capacities of any
molecules isolated.
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7.2 Methods and Results
7.2.1 Perfusion of animals
Male wistar rats (6 months old, 250-300g body weight) were infected with
N.brasiliensis as described (see Materials and methods, Chapter 2) and killed 10 days
after the primary infection. The animals were perfused and the organs removed and
washed in PBS. Tissue was trimmed and stored at -20°C until processed.
7.2.2 Purification of serpins from rat pulmonary tissue
Putative serpins were purified using a combination of anion exchange
chromatography and affinity chromatography (see Materials and Methods, Chapter
2). Briefly, soluble proteins from pulmonary homogenates were fractionated on
DEAE-Sepharose. Proteins that bound to this column, previously equilibrated in
20mM Tris-HCl, pH 7.5, were eluted using 1M NaCl and applied to a Rabl a-
RSI/II-sepharose 4B column. Cross reactive protein eluting from this column was
applied to a monoQ column previously equilibrated in buffer B. Unbound protein
was washed off the column using 20mM Tris-HCl buffer, pH 7.5 and a continuous
salt gradient (0-0.3M NaCl) was generated. Two peaks were eluted from this
column, the first at 80mM NaCl and the second at lOOmM NaCl (Figure 7.1). The
eluted protein was concentrated by vacuum centrifugation and stored at-20°C prior
to analysis.
The two proteins isolated from pulmonary tissue were subjected to reducing
SDS-10%PAGE (tricine buffer system) and the proteins transferred to Immobilon
for Western blotting analysis. Both proteins are cross reactive with the MAbl
(Figure 7.2), the protein eluting from the monoQ column at 80mM NaCl migrated
in a similar fashion to RSI, whilst the protein eluting from the column at lOOmM
Figure 7.1
volume (mL)
Purification of pulmonary serpins by anion exchange chromatography.
Pulmonary protein affinity purified with Rabl a-RSI/RSH antibody was
applied to a monoQ column previously equilibrated in 25mM bis-tris-HCl,
pH 6.7. A continuous salt gradient was generated (0-0. 3M NaCl). Two main









Western blot of purified pulmonary serpins.
Pulmonary serpins were purified as described (see text) and
electrophoresed under reducing conditions (Tricine gel system). The
proteins were transferred to Immobilon sheets as described (see Materials
and Methods, Chapter 2) and the blots were probed with MAbl-po. Lane
A, pulmonary serpin eluting at 80mM NaCl. Lane B, pulmonary serpin
eluting at lOOmM NaCl. Mr standards are as indicated.
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NaCl migrated to a lower Mr. Both purified proteins had a similar Mr to the
uncleaved serpin detected in pulmonary homogenates (Figure 6.2c), indicating that
this protein had been successfully purified. Sequence analysis showed that the
protein eluting at 80mM NaCl had complete homology to RSI over the first 10
residues (Figure 7.3). The protein eluting at lOOmM NaCl has complete homology
to RSI over the first 10 residues, but then diverges with at least 4 changes of amino
acid in the next 10 residues (Figure 7.3). The protein eluting at lOOmM NaCl was
not detected in serum, the preliminary sequence presented here suggests that both
proteins purifed from pulmonary homogenates may be gene products of the Spi-1
locus. The protein eluting at lOOmM NaCl was tentatively named RSIa. An attempt
to confirm this sequence data was unsuccessful, due to technical difficulties.
To determine whether this new serpin (RSIa) has inhibitory properties, an
equimolar concentration (500nM) of RMCPII was added to RSIa and the results
analysed by SDS-10% PAGE. The result (Figure 7.4) shows the presence of a higher
molecular weight protein in samples containing RSIa and RMCPII, characteristic
of complex formation.
7.2.3 Purification of serpins from rat stomach.
The protocol was essentially that of section 7.2.2. The purified protein was
concentrated and analysed after the affinity chromatography stage. As protein
concentrations were very low, it was feared that a further fractionation step would
result in an unacceptable loss of protein.
Electrophoresis of this protein fraction followed byWestern blotting showed
the presence of two major bands when the blot was probed with MAbl-po, at
approximate Mr's of 60,000, and 50,000 (Figure 7.5). It is difficult to directly
Figure 7.3
Sequence of Lung Serpin I and Lung Serpin II
Compared to sequence data derived from RSI and RSII
purified from serum.
Position 1 2 3 4 5 6 7 8 9 10
LSI E D A Q E T D T S Q
LSI I E D A Q E T D T S Q
RSI E D A Q E T D T S Q
RSI I T D A Q E T D T S Q
Position 11 12 13 14 15 16 17 18 19 20
LSI
LSI I Q D R X G T S G K I
RSI Q D Q S P T Y R K I
RSI I Q D Q s P T Y R K I









Complex formation between purified pulmonary serpin (RSIa) and RMCPII.
Lane A, Mr standards. Lane B, Pulmonary serpin (500ng). Lane C,
Pulmonary serpin (500ng) + RMCPII (250ng). Sampleswereelectrophoresed
acording to the method of Schagger and von Jagow (1987). Protein was







Detection of purified gastric serpins
Lane A, RSI (lpg). Lane B, affinity purified gastric serpin (lpg).
Protein was electrophoresed under reducing conditions (Tricine buffer
system) and the protein was transferred to Immobilon. the blot was
probed with MAbl-po. Note the presence of two immunoreactive
polypeptides in the gastric sample.
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compare these purified proteins with the immunoreactive proteins detected in
gastric homogenates, as the gastric homogenates were analysed under non reducing
conditions (Figure 6.2d).
7.2.4. Partial purification of serpins from rat intestinal tissue
Intestinal serpins were purified as described in section 7.2.2. The protein
fraction was then concentrated by vacuum centrifugation and stored at -20°C prior
to analysis.
Reducing SDS-PAGE (tricine buffer system) analysis of this protein showed
3 main bands (Figure 7.6). The upper two proteins showed cross reactivity with
MAbl-po, under non-reducing conditions (Figure 7.7). These immunoreactive
proteins show similar electrophoretic mobility to the two immunoreactive bands









Detection of purified intestinal serpins
Lane A, Mr standards. Lane B, RSI (lpg),. Lane C, affinity purified
intestinal serpin (lpg). Protein was electrophoresed under reducing
conditions (Tricine buffer system). Note the presence of three




Detection of purified intestinal serpins
Lane A, purified intestinal serpins. Proteins were electrophoresed
under nonreducing conditions and transferred to Immobilon as described
(see Materials and Methods, Chapter 2). The blot was probed with
MAbl-po. The left edge of the blot shows the approximate migration of
purified RSI and RSI-RMCPH complex. Note that the upper band in the
intestinal sample co-migrates with complex, whilst the lower band
appears to have a slightly greater mass than RSI.
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7.3. Discussion.
The aim of these preliminary investigations was to partially characterise
serpin tissue derived serpins. Previous studies of perfused tissues (see Chapter 6,
Figure 6.2c and d) had indicated that there were electrophoretic differences between
tissue and plasma derived imunoreactive proteins detected by MAbl-po, under non
reducing conditions. Differences in the timing and duration of significant (p < 0.001)
changes in concentrations of serpins (Table 6.2) were also noted in the lung and
intestine.
Two molecules isolated from pulmonary homogenates were both cross
reactive withMAbl-po under reducing conditions. The Mrs of these molecules were
similar to those of RSI and RSII, and both proteins had a similar elution profile to
plasma serpins on anion exchange chromatography, implying similar pi's. The
proteins can both be classified as serpins, based on amino-terminal sequence data
(Figure 7.3). It is equivocal whether the pulmonary serpin with complete identity
to RSI over the first 10 residues is RSI. The pulmonary serpin which displays
incomplete homology to RSI and RSII also displays a slightly different pi, as
adjudged by its anion exchange elution characteristics. The pi would appear to be
approximately midway between the pi's of RSI and RSII (see Chapter 3). This
provides further indication, along with the preliminary sequence data, that a novel
pulmonary specific serpin exists in rats. The serpin band detected in pulmonary
homogenates (Figure 6.2c) is likely to be a tight doublet composed of the two
serpins purified and partially sequenced. Further confirmation of the inhibitory
capacity of the pulmonary serpin eluting at lOOmM NaCl is provided by the ability
of this protein to form an SDS stable complex (Figure 7.4). An immunoreactive
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polypeptide with similar electrophoretic mobility to complexed serpin and detected
with anti-RMCPII antibody was present in pulmonary homogenates (Figure 6.2e).
The synthesis of this novel serpin, which would appear to be translated from the
Spi-1 locus (Inglis and Hill, 1991) based on preliminary sequence data, may be
responsible for the significant increased concentrations of serpin detected in
pulmonary homogenates during the infection with N. brasiliensis (see Chapter 6).
However, no attempt was made to purify serpins from the lungs of control animals,
due to the limitations of time.
It was not possible to characterise putative gastrointestinal serpins with the
same degree of confidence. Immunoreactive proteins from stomach and small
intestine were partially purified and the two proteins isolated from gastric
homogenate both cross react with MAbl-po under reducing conditions. This
indicates that neither of these proteins is complexed with proteinase, as MAbl will
not detect complex under reducing conditions. This result, in conjunction with the
apparent molecular weight of the molecules (approximate Mrs 50,000 and 60,000)
may indicate that both molecules are serpins.
The partially purified preparation of intestinal protein exhibited 3 bands
under reducing SDS-PAGE (Figure 7.6), two of which were cross reactive with
MAbl under non reducing conditions (Figure 7.7). The lack of resolution in Figure
7.7 is probably because the protein was electrophoresed directly after affinity
chromatography, and was in a solution of 0.1M citric acid/0.5M NaCl, pH 2.2.
These preliminary investigations indicate that there are tissue specific serpins
in rat. Any hypothesis as to the regulation of synthesis of these molecules at the
moment would be speculative in the extreme. If time had allowed it was hoped to
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further purify the immunoreactive molecules from pulmonary and gastrointestinal
homogenates, and properly characterise them. Sequence analysis would provide
more proof of the identity of these proteins, and kinetic studies of the inhibitory
properties of these molecules would provide a basis for determining their role in the
modulation of RMCPII during helminth infection.
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Chapter 8: Concluding Remarks
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8. Concluding Remarks.
The purpose of this work was to determine which, if any, serpins in rat
would inhibit mast cell proteinases. By titrating RMCPII into rat serum it was
possible to purify complex formed between RMCPII and serpin(s) molecules.
Antibodies raised against this complex were used to affinity purify two plasma
serpins. Amino acid sequence analysis of these two molecules showed that they were
similar, but distinct, proteins. One of the two plasma serpins isolated (RSI) had
100% amino terminal sequence homology with the predicted amino acid sequence
of an G!-1-PI clone (Chao et al, 1990), the other molecule (RSII) exhibited incomplete
homology to this clone. This evidence suggests that both RSI and II are
transcribed/translated from the SPI-1 locus in rat, which encodes 4-5 genes for a-1-
PI (Inglis and Hill, 1990).
Before this work, only one a-l-PI molecule had been purified and partially
characterised from the rat (Kuehn et al, 1985). This protein had displayed inhibitory
capacities towards a variety of serine proteinases, but inhibition of mast cell
proteinases had not been investigated. Both RSI and RSII inhibit RMCPII, the Ki's
are sufficiently low (< 10 9M) to indicate efficient inhibition (Beatty et al, 1980). The
observation that RMCPI is not inhibited by RSI and II, and will in fact cleave the
serpins into two smaller fragments is unexpected. RMCPI is chemically and
enzymatically similar to RMCPII. The inference from this data is that RMCPI
activity will be modulated in some other way, possibly by the mast cell granule
(LeTrong et al, 1987b).
A variety of antibodies were raised against the purified rat serpins, and
complexes prepared from these serpins and mouse mast cell proteinases. All of the
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antibodies developed in the course of this work were shown to be specific for rat
serpins. Attempts to generate monoclonal antibodies against a cleaved form of rat
serpin were only partially succesful, however further attempts may prove to have
more success. These antibodies were used to develop ELISA's, which aided in the
quantification of serpin concentrations in plasma and in perfused tissues. The data
obtained suggest that tissue specific serpins exist in lung and gastrointestinal tissues.
The synthesis of serpins locally in these tissues has been described in man (Greening
et al, 1985; Perlmutter et al, 1989) and, in rats infected with N brasiliensis, the
changes in concentrations of serpins were indicative of an acute phase response. The
differenct tissue responses, in terms of timing and intensity, provided further
credence to the hypothesis that there were tissue specific serpins in the rat.
Electrophoresis followed byWestern blotting of perfused tissue homogenates
indicated subtle differences in molecular mass between plasma serpins and serpins
from lung, stomach and intestinal tract. An attempt to purify serpins from
pulmonary tissue suggested the presence of at least one serpin that was not found
in plasma. This serpin had inhibitory capacity against RMCPII and had a similar
pi to RSI and RSII. Preliminary sequence analysis also indicated that at least one of
the molecules found in lung was tissue specific. The maximal concentrations of
serpins were on day 7 of infection in serum and day 9 in the lung. In both cases the
serpin concentration is greater than the RMCPII concentration at this point in N.
brasiliensis infection (Miller et al, 1986). In serum the molar ratio of serpins to
RMCPII is about 2500 and in lung about 10. RSI and II, since they are involved in
the acute phase response, will doubtless inhibit other target proteinases such as
neutrophil elastase. It may be reasonable to hypothesise that RSI, RSIa and II have
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a role to play in the modulation and clearance of RMCPII although this will not
be their sole function. A Western blot of pulmonary homogenates probed with a-
RMCPII antibody suggests that at least some fraction of the serpin-proteinase
complex present has an RMCPII component.
There is an apparent abundance of serpin in gastrointestinal tissue, and this
increases during infection with kinetics which are distinct from those in plasma and
lung. There is a rise in concentration of protein recognised by antibodies specific
for serpins, but this rise is sustained from day 7 until day 9. Liver or bloodare
unlikely to be the source of these proteins since they were isolated from perfused
tissues, and were never co-purified in preparations of RSI and II derived from
serum. The elution characteristics of these proteins from the monoQ column allows
a tenative assignment of pi's in the 5-6 range. However as discussed in chapter 7,
a precise assignment of Mr was not feasible.
It is believed that the trigger for the acute phase response during N.
brasiliensis infection is the stimulation of alveolar macrophages to produce cytokines
(Lamontagne et al, 1984). If this is the case then the lung is stimulated to produce
pulmonary-specific serpins in addition to plasma-specific serpins, based on the
evidence presented here.
In a similar study to this present work, Stadnyk et al, (1989) reported two
peaks of plasma glycoprotein during the first 9 days of infection. However this
present study did not sample plasma until day 7 of infection so any early increase
resulting from an acute phase response was not measured.
Stadnyk et al (1984) noted that an N. brasiliensis infection when confined to
the intestine did not elicit the acute phase response, leading to speculation that
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intestinal macrophages lack the required mediators to trigger the systemic acute
phase response. This present study has demonstrated a response in gut by day 7 of
infection.
No attempt was made to show the presence of serpins in gut macrophages
nor in enterocytes, although such a study should be very interesting. It is known
that elastase can induce the expression of ot-l-PI in mononuclear phagocytes
(Perlmutter and Punsal, 1988), and the secretion of RMCPII by MMC in the gut
may, similarly, promote local synthesis of serpins. Studies on the clearance of
complexed elastase by macrophages have indicated that a biological feedback
mechanism may be in operation (Perlmutter et al, 1990) such that the endocytosis
of serpin-enzyme complex can stimulate the expression of serpins in macrophages.
Thus we can see how an excess of serine proteinase, forming complex in the
microenvironment of the macrophage with low levels of constitutively produced
serpin, could stimulate the expression of further serpins from macrophages.
The three ct-l-PI-like rat serpins will all form complexes with RMCPII.
Further, it is known that RSI and RSII will inhibit trypsin and chymotrypsin (see
chapter 4). The two plasma serpins have association constants of the order 105 M'V1
and inhibition constants of the order 10"9 M and below, indicating that they are
efficient inhibitors.
If we try to determine whether or not the serpins are physiologically
relevant inhibitors of RMCPII we have to make certain assumptions based on the
data presented in this thesis. The total concentration of serpin is 3mg/mL in plasma,
and assuming that RSI and II are present in equimolar concentrations (implied from
the amounts of each serpin obtained from the purification procedure) and with M,s
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of 50,000, the plasma concentration of each serpin is approximately 30/zM. We are
now in a position to calculate certain kinetic parameters as outlined by Bieth (1980).
The time needed for complete inhibition of a proteinase is given by the
equation
5
delay time = — ——
Kss* [Ho
This equation is based upon the time for the concentration of active enzyme
to fall to 1% of original values. This assumes that the [inhibitor] remains essentially
unchanged, ie the inhibitor is present in large excess. The molar ratio of serpin to
RMCPII is about 2500 in plasma. By using the assumed concentrations for RSI and
II (vide supra) we can calculate that complete inhibition of RMCPII occurs within
0.75 seconds (RSI) and 1 second (RSII) in control rats. The half-lives if dissociation
for complexes formed between RSI and RMCPII, or RSII and RMCPII are at least
1 hour (see table 4.1), the half-life for complex clearance has been shown to be 12-15
minutes (Pizzo et al, 1988). Thus the kinetic and thermodynamic constants
calculated in this present study, coupled with other evidence (from other
laboratories) pertaining to the clearance of complexed serine proteinases, suggests
that RSI and II may have a physiological role in the clearance of RMCPII.
The data presented indicate that RMCPII, a chymase, is inhibited by
members of the family of proteins that are a-l-PI-like (classically the anti-
elastase/trypsin serpins). The proteins translated from the Spi-2 locus (Inglis and
Hill, 1990) are homologous to the human o-l-antichymotrypsin proteins, but no
evidence has been found here of involvement of these proteins in inhibition of
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RMCPII. Interestingly, RSII displays a high kass for chymotrypsin, indicating that
the divergence of the genes on the Spi-1 locus (Inglis and Hill, 1990; Borriello and
Krauter, 1991) has resulted in an anti-elastase activity evolving into an anti-
chymotrypsin activity (possibly a mutation from methionine as pi' residue to
leucine). However, RSI appears to be the physiologically more relevant inhibitor
as far as RMCPII is concerned based on thermodynamic evidence.
Evidence presented here and elsewhere (Inglis and Hill, 1990) has indicated
the presence of multiple serpin genes as opposed to the single functional gene and
a pseudo gene coding for the homologous protein in man (Inglis and Hill, 1990).
Hill and Hastie (1987) have proposed that the diversity of serpins in rodents is a
result of parasitic infection. Recent evidence has shown that there are many more
genes for mast cell proteinases than had been thought (Reynolds et al, 1990;
Vanderslice et al, 1990). As mentioned in the Introduction to this work, it may be
that the diversity of serpins has evolved to inhibit the multitude of proteinases in
mast cells and other cells. There is evidence for a diversity of mast cell proteinases
in human mast cells (Vanderslice et al, 1990), but so far only one gene for human
o;-l-PI is known to be expressed, this does not exclude the possibility that other
genes are responsible for the production of human serpins which will modulate
mast cell proteinase expression. It is already known that a-l-antichymotrypsin, as
well as a-l-PI, will inhibit mast cell proteinases from human skin mast cells
(Schechter et al, 1989).
As shown in this thesis there are a multiplicity of Spi-1 serpins expressed in
the rat and their expression is affected dramatically by helminth infection. There
are several questioned raised by this work. Firstly, the known multiplicity of rodent
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serpins (Inglis and Hill, 1991) coupled with the present findings raises questions
regarding the tissue distribution of serpins. It is feasible that individual genes on the
SPI-1 cluster may be transcribed /translated in different tissues and, furthermore,
transcription of each gene may be controlled by a unique set of regulators. The data
in Chapter 6 and 7 which suggests differences in timing and intensity of response
may indicate that different physiological traumas are responsible for regulating the
synthesis of tissue specific serpins. The questions that need to be answered concern
the stimulus for increasing concentrations of serpins, especially in the gut. It is not
known if intestinal inoculation of adult N. brasiliensis induces local synthesis of
serpins, although it has been suggested that such an infection will not stimulate the
acute phase response (Stadnyk et al, 1990). If an increase does occur then further
investigation of the regulation of such an event would be worthwhile. For example
does circulating serpin-RMCPII complex provoke further synthesis in the gut. This
line of investigation is inextricably bound to the question of complex clearance in
helminth infection. Which cell types are responsible for complex clearance, and will
they be stimulated to synthesise serpin? The answers to such questions will require
the use of recombinant DNA technology. This will be necessary because of the need
for in situ hybridisation studies to determine the precise source of
transcription/translation of serpins in a variety of tissues. However the similarity
in primary sequence between serpins will require the utilisation of very specific
antibody preparations in addition to the above mentioned techniques. Development
of capture ELISAs, specific for RMCPII:RSI/II complexes, may be possible with the
judicious use of a-RMCPII antibodies in conjunction with the cx-serpins antibodies
generated in this work. Such an assay could provide information on the fate of
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RMCPII in helminth infection. Such an ELISA would also be very useful in
characterising the clearance of complex from rat plasma.
One very intriguing flight of fancy is that mast cells themselves may
synthesise serpins, and may themselves be stimulated to synthesise serpins by
helminth infection. In the course of this study, it was not possible to demonstrate
a serpin which would inhibit RMCPI. Tissue concentrations of RMCPI are known
to be affected by helminth infection (Huntley et al, 1992), and although it is
believed that the mast cell granule is responsible for the modulation of the activity
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Rat mast cell proteinase II (RMCP II) from mucosal
mast cells was titrated into rat serum, and the resulting
serine proteinase inhibitor (serpin)-enzyme complex
was purified by affinity chromatography on anti-
RMCP II-Sepharose 4B and by Mono-Q anion-ex-
change. The purified complex was used to raise poly¬
clonal antibodies which, after cross-absorption against
RMCP II-Sepharose 4B, were specific for serpin and
were used to affinity purify two rat serpin molecules
(RSI and RSII) that inhibit RMCP II in rat serum. The
kinetic constants characterizing the interaction be¬
tween RMCP II and RSI and RSII are k,„ 2.2 x 105 and
1.65 x 105 M_1 s~\ respectively; K„ 3.6 x 10_1° and
1.0 x 1(T9 m; and kd, 7.9 x 1(T5 and 1.65 x 1(T4 s"\
Amino-terminal sequence analysis indicated that RSI
and RSII are distinct, differing at the amino-terminal
residues, and are products of the rat Spi-1 locus. Rat
mast cell proteinase I (RMCP I) from connective tissue
mast cells cleaved both RSI and RSII and was not
inhibited.
The presence of high concentrations of serine proteinases
in secretion granules is a characteristic feature of mast cells.
Recent work has shown that individual mast cells may
express genes for several proteinases; in man the presence of
a multigene family encoding tryptases was reported (Van-
derslice et al., 1990), and in mouse at least six distinct serine
proteinases that can be expressed in different combinations
in different mast cell populations have been identified (Rey¬
nolds et al., 1990).
Chymotrypsin-like activity was first detected histochemi-
cally in rat mast cells (Benditt and Arase, 1959) and the
chymase, rat mast cell proteinase I (RMCP I),1 was subse¬
quently isolated from peritoneal mast cells (Lagunoff and
Pritzl, 1976). Woodbury et al. (1978) found that a second
similar, yet distinct, proteinase (RMCP II), first isolated by
Katunuma et al. (1975), was present in mucosal mast cells.
Recent work by Benfey et al. (1987) has indicated that a third
serine proteinase may be expressed in the rat.
RMCP I and II share a high degree of sequence homology
* The costs of publication of this article were defrayed in part by
the payment of page charges. This article must therefore be hereby
marked "advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
§ To whom correspondence should be addressed.
1 The abbreviations used are: RMCP, rat mast cell proteinase; RS,
rat serpin; SDS, sodium dodecyl sulfate; PAGE, polyacrylamide gel
electrophoresis; serpin, serine proteinase inhibitor; bis-Tris, 2-[bis-
(2-hydroxyethyl)amino]-2-(hydroxymethyl)-propane-l,3-diol; Tri-
cine, A-[2-hydroxy-l,l-bis(hydroxymethyl)ethyl]glycine.
(>70%) but differ in their net charge (LeTrong et al., 1987a),
which may reflect different properties and physiological func¬
tions. RMCP I is a relatively insoluble protein, requiring a
high concentration of salt for extraction and purification
(Lagunoff and Pritzl, 1976), whereas RMCP II is readily
soluble in physiological conditions (Woodbury and Neurath,
1978). The two rat mast cell proteinases, when isolated, show
similarity in their substrate profiles (Yoshida et al., 1980) and
exhibit catalytic activity similar to that of cathepsin G. The
substrate profile of RMCP I bound to secretory granules is
limited to smaller molecules (LeTrong et al., 1987b).
The concentrations of RMCP II in peripheral blood are
greatly increased during systemic and local intestinal anaphy¬
laxis (King and Miller, 1984; Patrick et al., 1988), and secre¬
tion of RMCP II into blood is associated with expulsion of
nematode worms in rats (Miller etal., 1983). The phenomenon
of increased concentrations of circulating soluble mast cell
proteinase associated with worm expulsion has also been
observed in mouse (Huntley et al., 1990) and sheep (Huntley
et al., 1987). A physiological role for mast cell proteinases has
not yet been unequivocally demonstrated. However, several
lines of evidence suggest that human mast cell proteinases
modulate the biological effect of neuropeptides in the airway,
resulting in airway hypersensitivity in man (Tarn and
Caughey, 1990; Caughey, 1989) and dog (Nadel, 1989). Exog¬
enous RMCP I has also been implicated in mast cell degran-
ulation (Schick, 1990; Kido et al., 1988) and in the processing
of matrix metalloproteinases (Sopata et al., 1988).
Many serine proteinases that function in plasma or tissue
during inflammation appear to be regulated by a superfamily
of serine proteinase inhibitors (serpins) (Travis and Salvesen,
1983).
This suggests that serine proteinases derived from mast
cells also will be regulated by the serpin superfamily. For
example, human skin mast cell chymase is inhibited by at
least two serpins (Schechter et al., 1989). Work in this labo¬
ratory has shown that mouse serum has the ability to interact
with mouse intestinal mast cell proteinase, resulting in the
formation of higher molecular mass (~75-kDa) complexes
(Irvine et al., 1990), a characteristic of the interaction of
serpins with susceptible proteinases.
At least five plasma proteins in the rat belong to the serpin
superfamily and function as serpins (Kuehn et al., 1984). The
purpose of the present study was to determine which, if any,
of the rat serpins can regulate the activities of RMCP I and
II, in an attempt to elucidate the physiological fate of these
mast cell proteinases in an homologous system.
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Fig. 1. Titration of RMCP II into rat serum and detection
of RMCP II-serpin complex. Lane A, 0.25 gl of rat serum; lane B,
0.25 gl of rat serum + 100 fig of RMCP Il/ml of serum; lane C, 0.25
nl of rat serum + 200 gg of RMCP Il/ml of rat serum; lane D, 0.25 gl
of rat serum + 300 fig RMCP Il/ml of rat serum; lane E, 0.25 ill of
rat serum + 400 fig of RMCP Il/ml of rat serum; lane F, 0.25 fi\ of
rat serum + 500 fig of RMCP Il/ml of rat serum; lane G, 0.25 gl of
rat serum + 1 mg of RMCP Il/ml of rat serum; lane H, 250 ng of
RMCP II. Samples were electrophoresed on 10% SDS-PAGE (Laem-
mli, 1970), transferred to nitrocellulose sheets as described in the
Miniprint, and probed with anti-RMCP II antibody conjugated to
horseradish peroxidase. The band visualized at 79 kDa is RMCP II-
serpin complex; RMCP II migrates at 28 kDa.
experimental procedures and results2
Titration of RMCP I and II into Rat Serum—Purified
RMCP I or II was titrated into rat serum over a range of 0-1
mg/ml. After incubation for 60 min at 37 °C, an aliquot of
each sample was removed and subjected to SDS-PAGE
(7.5%). The protein was transferred to nitrocellulose after
electrophoresis, and the blot was probed with anti-RMCP I
or II antibody. In the presence of serum, RMCP II formed
multiple complexes that were visualized by Western blotting
(Fig. 1); the most abundant serpin-enzyme complex had an
approximate molecular mass of 79 kDa, suggesting that a 50-
kDa protein(s) is involved with the 28-kDa RMCP II in this
reaction. At a titration of >500 fig of RMCP Il/ml of serum,
free protease could be observed (Fig. 1). RMCP I formed no
complexes that could be detected with anti-RMCP I antibody
(Fig. 2).
Purification of the Serpin-Enzyme Complex—RMCP II (500
fig) was added to 1 ml of rat serum and incubated for 1 h at
37 °C. The serum was then applied to a Sepharose 4B anti-
RMCP II affinity column. The bound fraction, eluted with
0.1 m citrate, was immediately desalted on a PD-10 column
(Pharmacia LKB Biotechology Inc.) equilibrated with 20 mm
Tris-HCl, pH 7.5 (buffer A). The protein fraction was applied
to a Mono-Q column equilibrated in buffer A, and a major
peak was eluted at 50 mm NaCl using a continuous gradient
of 0-0.3 m NaCl. This peak contained 95% pure serpin-
proteinase complex (by SDS-PAGE) and could be visualized
on Western blots using anti-RMCP II antibody. Serpin-pro-
teinase complex was used to raise polyclonal antibodies in
rabbits.
Purification of Serpins—Rabbit antibodies raised against
2 Portions of this paper (including "Experimental Procedures," part
of "Results," and Figs. 5-8) are presented in miniprint at the end of
this paper. Miniprint is easily read with the aid of a standard
magnifying glass. Full size photocopies are included in the microfilm
edition of the Journal that is available from Waverly Press.
Fig. 2. Titration of RMCP I into rat serum and the absence
of complex formation. Lane A, 0.25 fi\ of rat serum; lane B, 0.25 //I
of rat serum + 100 fig of RMCP I/ml of serum; lane C, 0.25 fi\ of rat
serum + 200 fig of RMCP I/ml of rat serum; lane D, 0.25 fi\ of rat
serum + 300 fig RMCP I/ml of rat serum; lane E, 0.25 gl of rat serum
+ 400 ng of RMCP I/ml of rat serum; lane F, 0.25 gl of rat serum +
500 fig of RMCP I/ml of rat serum; lane G, 0.25 gl of rat serum + 1
mg ofRMCP I/ml of rat serum; lane H, 250 ng ofRMCP I. Techniques
were as described for Fig. 1, except that anti-RMCP I antibody was
used to probe the blot. RMCP I migrates at 29 kDa. No RMCP I-
serpin complex was visualized.
0 8 16 24 32
volume (ml)
Fig. 3. Purification of RSI and RSII by ion-exchange chro¬
matography showing the Mono-Q column profile, 25 mm Bis-
tris-HCl, pH 6.7. The peak eluting at 80 mm NaCl is RSI; the peak






Fig. 4. Electrophoresis of purified rat serpins. Lane A, mo¬
lecular weight standards (Bio-Rad); lane B, RSI (2 gg); lane C, RSII
(2 fig). Proteins were visualized using Coomassie Blue. Electropho¬
resis was performed according to the method of Schagger and von
Jagow (1987).
serpin-proteinase complex were affinity-purified as outlined
under "Materials" and "Methods."
Rat serum (0.5-ml aliquot) was applied to an Affi-Gel Blue
column (16 x 50 mm) equilibrated in 25 mm bis-Tris-HCl,
pH 6.7 (buffer B), and the column was washed with this
buffer. This step was incorporated to remove most of the
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Table I
Kinetic Data for RS I and RS II
All data were determined as described in the Miniprint.
Enzyme ka ki kd t'/i d
M~l S~l M s~l h
RSI
RMCP I NI° NI NI NI
RMCP II 2.2 x 105 3.6 x 10-10 7.92 x 10"5 2.4
Chymotrypsin 6.0 x 105 ND ND ND
Trypsin 4.13 x 105 ND ND ND
RSII
RMCP I NI NI NI NI
RMCP II 1.65 x 105 1.0 x 10"9 1.65 X 10"4 1.0
Chymotrypsin 3.17 x 106 ND ND ND
Trypsin 6.68 x 105 ND ND ND
" NI, not inhibited; ND, not done.
position
I 2 3 4 5 6 7 8 9 10
alpha-l-PI E D A Q E T D T S Q
RSI E D A Q E T D T S Q
RSII T D A Q E T D T S Q
12 13 14 15 16 17 18 19 20 21
alpha-l-PI D Q S P T Y R K I S
RSI D Q S P T Y
RSII D Q S P T Y R K I S
Fig. 9. Sequence of RSI and RSII compared with rat a-1-
proteinase inhibitor (alpha-1-PI). The data is from Chao et al.
(1990) and this work.
albumin in the sample (Gianazzi and Arnaud, 1982). The
protein eluted in the wash was then applied to an anti-rat
serpin-RMCP II-complex Sepharose 4B column (16 X 50 mm)
with, as ligand, the cross-absorbed, affinity-purified poly¬
clonal antibody. The bound serpin was eluted with 1 ml of 0.1
M citrate, pH 2.2, and applied immediately to a Sephadex G-
25 column previously equilibrated with buffer B. The eluted
protein was applied to a Mono-Q column equilibrated in buffer
B and a continuous gradient of 0-0.3 M NaCl (10 mM/ml)
was established. The chromatogram of this column can be
seen in Fig. 3; the eluted peaks 1 and 2 contained proteins
with molecular masses of 52 and 54.5 kDa, respectively (de¬
termined on Tricine SDS-PAGE (10%), Schagger and von
Jagow (1987)), which were, respectively, labeled RSI and RSII
(Fig. 4).
Inhibition Kinetics of RSI and II with RMCP I and II—
The ka values of the reactions between RSI and II and RMCP
II, chymotrypsin, and trypsin were determined as outlined in
the Miniprint, and the inhibition constant, K„ of the inter¬
action between RSI and II and RMCP II was also determined
experimentally as outlined. All results are tabulated (Table
1).
Sequencing of RSI and RSII—RSI and II were sequenced
on an Applied Biosystems 477A pulsed-liquid phase Protein
Sequencer. The proteins were prepared for sequence analysis
by high pressure liquid chromatography on a C18 column and
eluted with an acetonitrile gradient. The amino-terminal se¬
quences are shown in Fig. 9, where they are compared with
the predicted sequence of the gene product of the rat a-1-
proteinase inhibitor gene (Chao et al., 1990). The partial
sequences of RSI and II are identical apart from the amino-
terminal residue.
DISCUSSION
Serpins act on their target proteinases by forming 1:1 molar
complexes with them. A short peptide loop on the surface of
the inhibitor is bound by the cognate proteinase and is cleaved
between the pi and pi' residues (Travis and Salvesen, 1983).
This results in the structural rearrangement of the serpin
such that the proteinase is covalently bound to the serpin,
resulting in inactivation of the proteinase. The pi residue is
crucial in determining the specificity of the serpin.
The data presented provide evidence that there are at least
two serpins in rat plasma that will inhibit RMCP II by
forming essentially irreversible complexes. The kinetic data
(Table I) show that the inhibition is of a similar order to
those of other proteinase-serpin interactions (Beatty et al.,
1980). However, RMCP II is unlikely to be the natural target
proteinase for RSI and II, as the ka values determined are
approximately 10-fold less than values obtained for a-1 -pro¬
teinase inhibitor and its target proteinase elastase or a-1-
antichymotrypsin and its target proteinase cathepsin G
(Beatty et al., 1980).
The observation that there is no complex formed between
equimolar concentrations of RMCP I and RSI or II is unex¬
pected. RMCP I, as has been discussed (see above), is chem¬
ically and enzymatically similar to RMCP II. The inference
from the data is that proteolysis by RMCP I must be modu¬
lated in a different way from RMCP II. The fact that no
serpin-RMCP I-complex is seen on Western blots of rat serum
titrated with RMCP I (Fig. 2), in conjunction with the obser¬
vation that RMCP I will cleave RSI and II under physiological
conditions (Fig. 6) supports the hypothesis that the mast cell
granule may be responsible for modulating RMCP I activity
(LeTrong et al., 1987b). Currently, investigations are under¬
way to determine the role of the rat a-2-macroglobulin-like
molecule, a-l-inhibitor3 (Enghild et al., 1989), in the modu¬
lation of RMCP I activity.
Sequence analysis of the amino terminus of RSI and II
indicated that both molecules are probably gene products of
the Spi-1 locus of the rat (Inglis and Hill, 1990). RSI is most
likely to be rat a-1-proteinase inhibitor, the serpin believed
to control elastase activity in vivo. RSII differs from RSI in
that it has threonine at the amino-terminal position, as op¬
posed to glutamate (Fig. 9). This is the first time that a
member of the rat Spi-1 protein family, other than a-1-
proteinase inhibitor (Kuehn et ai, 1964), has been purified
and identified.
Recent evidence (Borriello and Krauter, 1990) has shown
that at least five members of the Spi-1 multigene family are
expressed in the mouse. Analysis of the reactive site region of
the genes (generated by polymerase chain reaction) has shown
that there are three variant pi residues, methionine, tyrosine,
and leucine. The pi site residue determines effectiveness
against the various target proteinases, and a methionine res¬
idue would be expected at the pi site of a-l-proteinase inhib¬
itor. Leucine is the residue found at the pi site of human a-
1-antichymotrypsin (Morii and Travis, 1983). Interestingly,
the molecule designated RSII is more potent as an inhibitor
of chymotrypsin than of trypsin or chymase (see Table I).
In the mouse, this family of genes has less than 4% overall
predicted amino acid sequence divergence (Hill et al., 1984).
The presence of residues other than methionine at the pi site
has led to speculation (Borriello and Krauter, 1990) that
proteins encoded by the Spi-1 locus in mouse may not all
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have anti-elastase activity. The evidence (Table I) that RSII
inhibits chymotrypsin more efficiently than other proteinases
used in this work supports this hypothesis. Further investi¬
gations should reveal the extent of the polymorphism in the
rat Spi-1 locus.
Future work in this laboratory will determine whether any
proteins encoded by the Spi-2 (Inglis and Hill, 1990) locus
can form complexes with rat mast cell proteinases. The Spi-
2 locus encodes proteins that are the structural homologues
of human a-l-antichymotrypsin, although no evidence pre¬
vious to this has reported a rodent a-l-antichymotrypsin
activity.
It will also be of interest to determine the biochemistry of
RMCP II-serpin complexes in the rat, and to this end we have
initiated a series of experiments designed to investigate the
clearance of the proteinase-serpin complex from body tissues
and fluids, enabling us to understand more fully the physio¬
logical fate of rat mast cell proteinases after the events stim¬
ulating degranulation.
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EXPERIMENTAL
I. Materials
An I ma Is
istar rats were used in all experiments; the animals were kept
cycle and allowed access to food and water ad libitum. Animals i
by exsanguination under deep anaesthesia. Blood was allowed to
ature and serum, obtained by centrifugation. was stored in 5 ml
used.
Chemicals
The substrates, henzyloxy 1 carbony 1 -l.-tyrosine-parani trophenol ester (Cbz-L-Tyr-ONp) and
benzoyl-L-arginine-p-nitroanl1ide (BAPNAl were purchased from Sigma (Poole, Dorset I. The
proteinases RMCP I and RMCP 11 were purified In this laboratory as described (Gibson and
Miller, 19861, bovine pancreatic trypsin was purchased from Sigma and bovine pancreatic
rhymotrypsin from Boehringer Mannheim (Lewes, East Sussex, UK). Sephadex G-75 and affi-gel
blue were purchased from Bio-Rad, monoQ HR5/5 columns, CNBr sepharose 4B and all columns
(CI6 type l were purchased from Pharmacia. All columns were run on Pharmacia/LKB FPLC
equipment. Polyclonal and monoclonal antibodies against RMCP I and II were a kind gift fron
G. Newlands and J. Huntley (MR1, Edinburgh). AffIn1ty-1igands were coupled to CNBr-sepharos
as per manufacturer's Instructions. Triclne was purchased from Sigma. Proteins were blottec
onto nitrocellulose or lmmobilon for visualisation with antibodies. All other chemicals wer
lighesi pur; labU
ling the buffer systems of
ting was performed using tt
i of Matsudaira (1987).
?. Methods
Electrophorf
Electrophoresis was with the Blo-Rad mini Protean II system i
Laemml i (197(1) and Schagger and von Jagow ( 1987 >. Western bl<
semi-day method (Khyse-Anderson. 1984' using the buffer syst«
Production of antibody against serpin-RMCP I I-complex (SEC)
Polyclonal antibodies against complexes (see Results: purification of serpin-RMCP !l-complex
(SEC)) were prepared as follows: 100 ug of antigen in an emulsion of Kreund's complete
adjuvant was injected intramuscularly into a rabbit. The rabbit was bled from the ear after
two weeks and the tftre of the antibody assessed by Ouchterlony double diffusion.
When the titre began to decrease the animal was given a further intramuscular injection of
100 ug antigen in an emulsion containing Kreund's incomplete adjuvant. After a further test
bleed to ensure that the titre of the antibody was maximal the animal was killed and bled.
The blood was allowed to clot at room temperature, and antiserum was obtained by
centrifugation. Antiserum was stored at -?0°C until used.
Affinity purification of anti-(serpin-RMCP Il-complex) antibodies
I? mg ligandg matrix) to remove antibody specificity to this enzyme. The unbound fraction
was eluted using PBS and applied to a column < f> ml, 2 mg ligand'g malrix) of SEC-sepharose.
The column was then washed with 2 column volumes of PBS and bound antibodies, eluted with I
ml of 0.1 M citrate buffer Ipll ?.?>. were immediately neutralised by the addition of 1M Tris
base (200 uL ml). The eluted antibody was used to make an "antI-serpin"-sepharose column
(1.4 mg ligand'g matrix).
Titration of proteinases and serpins
RMCP II. RMCP I and rhymotrypsin were active-site titrated as described by Kezdy and Kaiser
(1970) using Cba-L-Tyr-ONp as titrant, trypsin was titrated as described by Chase and Shaw
( 1970 < using p-nl t ropheny I-p'-guan idi nobenzoa te liCI as titrant. All serpins were hack-
titrated against RMCP 11 as follows; RMCP II (16 n.M) was incubated with various amounts
of purified serpin. After '» min the residual activity of the proteinase was measured using
Cbz I-Tvr-ONp as substrate, absorbances at 410 nm were measured.
IP I I (16 nM) was incul
rature. The inrubatioi
l.-Tyr-ONp (final mola
of 760 ul PBS. Absorbanres
were measured.
RESULTS
i fornKinetics of serpin-rat mast cell protelnase-complc
Aliquots of RMCP II and RMCP I were added to RSI and RSI I In an equimolar ratio i
incubated for 10 seconds before being analysed by SDS-IO". PAGE. Stable serpin-prc
complexes were formed between RMCP II and RSI and II (Kigure Si whereas RMCP I cl
serpins to give two major cleavage products of approx. 17 and ?S kDa (Kigure 6).






The Kj of the reaction between E and I 1:
K, - fEUil
[El] (4)
i defined as kdlss/kass, which is equivalent to:
By t irrangement with respect to [E] and subst:





[E]Q 2 [ E ] o
The constant Kj can be determined experimentally by reacting E with Increasing <
for 30 mlns, followed by addition of substrate and the measurement of residual proteinase
activity. The addition of substrate will initially upset the equilibrium of the reaction
mixture but after 2 minutes a steady state Is reached (Boudler and Bleth, 1989). The rate i
steady state substrate hydrolysis was used to determined [E] for a given [I] . The
fractional activity, ([E]/[E]0), can then be used to determine the substrate-dependent Kt
by fitting the data to equation 7 using non-linear regression analysis. Figure 8 shows an
example of an experiment in which the substrate-dependent Kj was determined for the
reaction between RMCP II and RSI and RSI I. The substrate-dependent Kj (K1app) can be
converted to the true Kj by using equation 8:
Kj - Kjapp/(1♦ [S]0/Km) (8)
The Km for the RMCP II/Cbz-L-Tyr-ONp system was measured independently by classical means
and found to be 2.46 uM In the buffer conditions used for all experiments described. All
values of K. are tabulated (Table 1).
. and the half-life of diss : shown in Table 1
E F
Lane A: molecular weight standards. lane B; 1 Jig RMCP II. lane C; 2 Jig RSI. lane D; 1
Mg RMCP 11/2 Pi RSI, lane E; 2 Mg RSII. lane F; 1 Mg RMCP II/2 Mg RSII. Lanes D and F
contain serpin:enzyme complex (band staining at 79kDA). Electrophoresis performed as
outlined In experimental section using the buffer system of Schagger and von Jagow.
rib ig the i l of • a rp i' i and protein,
tere K and 1 stand for proteir
; given by equation I:
-d[E] =■ kassreiin-kd|Ssi
dt
dis: at ic of El occurred during the a!
i time period (100 seconds) c




[E] = (kass t
The concentration o
hydrolysis. The ; cia
>n 2 for [E].fll yie
/[E]ol
:,[E]. at any time w. derived frc
insiderably short
■rm of equation I
in
(using the DNRP53 program of R.G. Duggleby, University of
which fitted the experimental data to equation 3).
Figure 7 shows an example of the time-dependent decrease of RMCP I
bovine trypsin activity due to inhibition by RSI and RSII: there i:
experimental data and the theoretical curve generated using equatit
data are shown in Table 1.
D. 2 Mg RSII. la
eight standards. lane B 2 Mg RSI. lane C 2 Mg RSI & 200 ng RMCP I lane
i E, 2 Mg RSII & 200 ng RMCP I. Electrophoresis performed as outlined In
using the buffer system of Schagger and von Jagow.
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Decrease In the activity of RMCPII as a result of Incubation with equimolar amounts of RSI
(Figure 7a) and RSII (Plgure 7b) for Increasing lengths of time. Molarity of RMCP1I was 9nM.
Details of procedure are In experimental section. The theoretical line was fitted using non¬
linear regression as described.
Decrease In the activity of trypsin as a result of Incubation with equlmolar amounts of RSI
(Plgure 7e) and RSII (Plgure 7f) for Increasing lengths of time. Molarity of trypsin was
6.75nM. Details of procedure are In experimental section. The theoretical line was fitted
using non-linear regression as described.
24 48 72 96
TIME (seconds)
24 48 72 96
TIME (seconds)
Decrease In the activity of chymotrypsin as a result of Incubation with equlraolar amounts <
RSI (Plgure 7c) and RSII (Plgure 7d) for Increasing lengths of time. Molarity of
chymotrypsln was 9.5nM. Details of procedure are In experimental section. The theoretical
line was fitted using non-linear regression as described.
Inhibition of RMCPII activity plotted against Increasing concentrations of RSI (Plgure 8a;
and RSII (Plgure 8b). Conditions were as described In the experimental section. The
theoretical curve was fitted to experimental data using non-linear regression analysis as
outlined. The between RMCPII and RSI was 15nH, the KjaPP between RMCPII and RSII w;
«5nM.
